Processing 00000000.tx.1: Selective activation of central NPY Y1 vs. 

Phrase: "Selective activation of central NPY Y1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1879547:Activation [Activity]

Phrase: "vs."
Processing 00000000.tx.2: Y5 receptor elicits hyperinsulinemia via distinct mechanisms Jun Gao, Lorraine Ghibaudi, and Joyce J. 

Phrase: "Y5 receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3642156:Y5 Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "elicits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449265:elicit [Qualitative Concept]

Phrase: "hyperinsulinemia via distinct mechanisms Jun Gao,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0020459:Hyperinsulinaemia [Disease or Syndrome]

Phrase: "Lorraine Ghibaudi,"

Phrase: "and"

Phrase: "Joyce J."
Processing 00000000.tx.3: Hwa Department of Cardiovascular/Metabolic Diseases, Schering-Plough Research Institute, Kenilworth, New Jersey 07033 Submitted 20 November 2003 ; accepted in final form 30 May 2004  ABSTRACT TOP ABSTRACT METHODS RESULTS DISCUSSION REFERENCES  Central administration of neuropeptide Y (NPY) stimulates hyperphagia and hyperinsulinemia. 

Phrase: "Hwa Department of Cardiovascular/Metabolic Diseases,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1704729:Department [Organization]

Phrase: "Schering-Plough Research Institute,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0035172:Research Institute [Organization]
   812   C0021622:institute [Organization]
   812   C0035168:research [Research Activity]
   812   C0242481:Research [Research Activity]
   812   C1272753:Institute [Idea or Concept]

Phrase: "Kenilworth,"

Phrase: "New Jersey 07033"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0027971:New Jersey [Geographic Area]
   827   C0205314:New [Temporal Concept]
   827   C0454673:Jersey [Geographic Area]

Phrase: "Submitted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515023:Submitted [Functional Concept]

Phrase: "20 November 2003"

Phrase: ";"

Phrase: "accepted in final form 30 May 2004  ABSTRACT TOP ABSTRACT METHODS RESULTS DISCUSSION"
Meta Candidates (Total=21; Excluded=2; Pruned=0; Remaining=19)
   735   C0000857:Abstract [Occupational Activity]
   735   C0025663:Methods [Intellectual Product]
   735   C0025664:methods [Intellectual Product]
   735   C0205088:Final [Temporal Concept]
   735   C0348078:Form [Qualitative Concept]
   735   C0376315:Form [Manufactured Object]
   735   C0449851:Methods [Functional Concept]
   735   C0557061:Discussion [Therapeutic or Preventive Procedure]
   735   C0600678:Abstract [Intellectual Product]
   735   C1272684:Accepted [Qualitative Concept]
   735   C1522492:Form [Functional Concept]
   735   C1546485:Final [Idea or Concept]
   735   C1548435:Accepted [Idea or Concept]
   735   C1552863:Abstract [Idea or Concept]
   735   C1704458:Top [Spatial Concept]
   735   C2584313:Discussion [Social Behavior]
   702 E C0871511:METHOD [Intellectual Product]
   702   C1274040:Result [Functional Concept]
   702   C1546471:Result [Idea or Concept]
   702 E C1548601:Accept [Idea or Concept]
   702   C2825142:Result [Finding]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Central administration of neuropeptide Y (NPY)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0001554:Administration [Occupational Activity]
   760   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "stimulates"

Phrase: "hyperphagia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020505:Hyperphagia [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "hyperinsulinemia."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020459:Hyperinsulinaemia [Disease or Syndrome]
Processing 00000000.tx.4: Recent evidence has suggested that the Y1 and Y5 receptor subtypes may both mediate NPY-stimulated feeding. 

Phrase: "Recent evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "has"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the Y1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419589:Y1 [Gene or Genome]

Phrase: "and"

Phrase: "Y5 receptor subtypes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0449560:subtypes [Classification]
   734   C3642156:Y5 Receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "may"

Phrase: "both"

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "NPY-stimulated feeding."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0204695:Feeding [Health Care Activity]
   812   C2987508:Feeding [Activity]
Processing 00000000.tx.5: The present study attempts to further characterize the role of central NPY receptor subtypes involved in hyperinsulinemia. 

Phrase: "The present study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "attempts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516084:Attempt [Event]

Phrase: "to further"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1517331:Further [Spatial Concept]
   861   C1883351:To [Qualitative Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "characterize"

Phrase: "the role of central NPY receptor subtypes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "involved in hyperinsulinemia."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020459:Hyperinsulinaemia [Disease or Syndrome]
   790   C1314939:Involved [Functional Concept]
Processing 00000000.tx.6: NPY and peptide analogs of NPY that selectively activated the NPY Y1 or Y5 receptor subtype induced feeding and hyperinsulinemia in satiated Long Evans rats, whereas NPY analogs that selectively activated the NPY Y2 or Y4 receptor subtype did not. 

Phrase: "NPY"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
  1000   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   861   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "and"

Phrase: "peptide analogs of NPY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0597191:peptide analog [Amino Acid, Peptide, or Protein]
   760   C0243071:analogs [Chemical Viewed Structurally]

Phrase: "that selectively"

Phrase: "activated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:Activated [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: "the NPY Y1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1419589:Y1 [Gene or Genome]
   734   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   734   C1417815:NEUROPEPTIDE Y [Gene or Genome]

Phrase: "or"

Phrase: "Y5 receptor subtype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0449560:Subtype [Classification]
   734   C3642156:Y5 Receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "feeding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0204695:Feeding [Health Care Activity]
  1000   C2987508:Feeding [Activity]

Phrase: "and"

Phrase: "hyperinsulinemia in satiated Long Evans rats,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0020459:Hyperinsulinaemia [Disease or Syndrome]

Phrase: "whereas"

Phrase: "NPY analogs"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0243071:analogs [Chemical Viewed Structurally]
   734   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   734   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   721 E C0679213:analogies [Idea or Concept]

Phrase: "that selectively"

Phrase: "activated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:Activated [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: "the NPY Y2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1532188:Y2 [Quantitative Concept]
   734   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   734   C1417815:NEUROPEPTIDE Y [Gene or Genome]

Phrase: "or"

Phrase: "Y4 receptor subtype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0449560:Subtype [Classification]
   734   C0668788:Y4 receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "did"

Phrase: "not."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]
Processing 00000000.tx.7: To determine whether NPY-induced hyperinsulinemia is secondary to its hyperphagic effect, we compared the plasma insulin levels in the presence and absence of food after a 1-min central infusion of NPY and its analogs at 15, 60, and 120 min postinfusion. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "NPY-induced hyperinsulinemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0020459:Hyperinsulinaemia [Disease or Syndrome]

Phrase: "is"

Phrase: "secondary to its hyperphagic effect,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0175668:Secondary to [Temporal Concept]
           Secondary
   760   C0027627:secondary [Neoplastic Process]
   760   C0205436:Secondary [Quantitative Concept]

Phrase: "we"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "the plasma insulin levels in the presence"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   780   C1276042:Plasma insulin level [Laboratory Procedure]
   778   C0202098:insulin levels [Laboratory Procedure]
   778   C0428405:insulin levels [Laboratory or Test Result]
   778   C0857690:plasma insulin [Laboratory Procedure]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0032105:Plasma [Body Substance]
   748   C0441889:Levels [Qualitative Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "absence of food"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0680146:absence of food [Finding]
   790   C0332197:absence [Quantitative Concept]
   790   C1689985:Absence [Anatomical Abnormality]
   718 E C2699517:ABSENT [Finding]

Phrase: "after a 1-min central infusion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0574032:Infusion [Therapeutic or Preventive Procedure]
   804   C1827465:Infusion [Functional Concept]

Phrase: "of NPY"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
  1000   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   861   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "and"

Phrase: "its analogs at 15,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0243071:analogs [Chemical Viewed Structurally]

Phrase: "60,"

Phrase: "and"

Phrase: "120 min postinfusion."
Processing 00000000.tx.8: Our data suggest that selective activation of central NPY Y1 receptor subtype induced hyperinsulinemia independent of food ingestion, whereas the NPY Y5 receptor-induced hyperinsulinemia was dependent on food ingestion. 

Phrase: "Our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that selective activation of central NPY Y1 receptor subtype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C1514758:Receptor Activation [Cell Function]
   739   C1879547:Activation [Activity]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "hyperinsulinemia independent of food ingestion,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0342332:Alimentary hyperinsulinaemia [Disease or Syndrome]
   760   C0020459:Hyperinsulinaemia [Disease or Syndrome]

Phrase: "whereas"

Phrase: "the NPY Y5 receptor-induced hyperinsulinemia"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0020459:Hyperinsulinaemia [Disease or Syndrome]
   700   C0068624:Neuropeptide Y Receptor [Amino Acid, Peptide, or Protein,Receptor]
   700   C0391255:neuropeptide Y5 receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "was"

Phrase: "dependent on food ingestion."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0851827:Dependent [Qualitative Concept]
   770   C1701901:Dependent [Qualitative Concept]
   770   C3244310:dependent [Functional Concept]
Processing 00000000.tx.9: Central administration of the selective Y1 receptor agonist D-Arg25 NPY eventually decreased plasma glucose levels 2 h postinfusion in Long Evans rats. neuropeptide Y; 

Phrase: "Central administration of the selective Y1 receptor agonist"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0001554:Administration [Occupational Activity]
   744   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "D-"

Phrase: "Arg25 NPY eventually decreased plasma glucose levels 2 h postinfusion"

Phrase: "in Long Evans rats. neuropeptide Y"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   840   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   804   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   717   C0324537:Rats, Long-Evans [Mammal]

Phrase: ";"
Processing 00000000.tx.10: insulin; 

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.11: glucagon; 

Phrase: "glucagon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.12: glucose; 

Phrase: "glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.13: food and brain NEUROPEPTIDE Y (NPY) is a 36-amino-acid neurotransmitter that is highly concentrated in the hypothalamus (8). 

Phrase: "food"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016452:Food [Food]

Phrase: "and"

Phrase: "brain NEUROPEPTIDE Y"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   901   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   827   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "(NPY"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
  1000   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   861   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: ")"

Phrase: "is"

Phrase: "a 36-amino-acid neurotransmitter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0027908:Neurotransmitter [Neuroreactive Substance or Biogenic Amine]

Phrase: "that"

Phrase: "is"

Phrase: "highly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:Highly [Qualitative Concept]

Phrase: "concentrated in the hypothalamus"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0020663:Hypothalamus [Body Part, Organ, or Organ Component]
   770   C1280712:Hypothalamus [Body Part, Organ, or Organ Component]
   770   C1880165:Concentrated [Biomedical or Dental Material]
   737 E C1880310:Concentrate [Manufactured Object]
   737 E C2003864:Concentrate [Substance]

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.14: In the hypothalamus, NPY is synthesized in the arcuate nucleus, which projects into the paraventricular nuclei and the dorsomedial nuclei to release NPY (1). 

Phrase: "In the hypothalamus,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020663:Hypothalamus [Body Part, Organ, or Organ Component]
  1000   C1280712:Hypothalamus [Body Part, Organ, or Organ Component]

Phrase: "NPY"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
  1000   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   861   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "is"

Phrase: "synthesized in the arcuate nucleus,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0003741:Arcuate Nucleus [Body Part, Organ, or Organ Component]
   760   C0007610:Nucleus [Cell Component]
   760   C0205130:Arcuate [Spatial Concept]
   760   C1883254:Synthesized [Activity]

Phrase: "which"

Phrase: "projects into the paraventricular nuclei"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   806   C0175253:Paraventricular nuclei [Body Part, Organ, or Organ Component]
   773 E C0030532:Paraventricular Nucleus [Body Part, Organ, or Organ Component]
   773 E C1289558:Paraventricular nucleus [Body Location or Region]
   760   C1709701:Project [Conceptual Entity]
   726   C0007610:Nucleus [Cell Component]

Phrase: "and"

Phrase: "the dorsomedial nuclei to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   867   C0228329:Dorsomedial Nucleus [Body Part, Organ, or Organ Component]
   793   C0007610:Nucleus [Cell Component]

Phrase: "release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030685:Release [Health Care Activity]
  1000   C0391871:Release [Functional Concept]
  1000   C0439180:% release [Quantitative Concept]
  1000   C0680255:release [Health Care Activity]
  1000   C1283071:Release [Functional Concept]
  1000   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "NPY"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
  1000   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   861   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.15: In the periphery, NPY is colocalized with norepinephrine in sympathetic nerve endings (32). 

Phrase: "In the periphery,"

Phrase: "NPY"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
  1000   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   861   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "is"

Phrase: "colocalized with norepinephrine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0028351:Norepinephrine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]

Phrase: "in sympathetic nerve endings"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0027747:Nerve Endings [Cell Component]
   793   C0444930:ending [Spatial Concept]
   793   C2746065:Ending [Temporal Concept]
   734   C0459521:Sympathetic nerve [Body Part, Organ, or Organ Component]
   734   C1278872:Sympathetic nerve [Body Part, Organ, or Organ Component]

Phrase: "(32"

Phrase: ")."
Processing 00000000.tx.16: A variety of studies have linked NPY to physiological processes related to feeding behavior, energy homeostasis, neuroendocrine interactions, cardiovascular regulation, and emotional integration (9, 12, 15, 19, 35). 

Phrase: "A variety of studies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1883525:Variety [Conceptual Entity]
   770   C2346866:Variety [Conceptual Entity]

Phrase: "have"

Phrase: "linked NPY to physiological processes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   790   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   783   C2748900:Y-linked [Finding]
   753   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "related to feeding behavior,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C0015745:Feeding Behavior [Individual Behavior]
   770   C0004927:Behavior [Individual Behavior]
   770   C0204695:Feeding [Health Care Activity]
   770   C0439849:Related [Qualitative Concept]
   770   C0445223:Related [Finding]
   770   C2707008:Behavior [Clinical Attribute]
   770   C2987508:Feeding [Activity]
   737 E C0163712:Relate [Organic Chemical]

Phrase: "energy homeostasis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3157043:energy homeostasis [Biologic Function]
   861   C0019868:Homeostasis [Biologic Function]

Phrase: "neuroendocrine interactions,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1704675:Interaction [Functional Concept]

Phrase: "cardiovascular regulation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0851285:Regulation [Governmental or Regulatory Activity]
   861   C1327622:Regulation [Biologic Function]

Phrase: "and"

Phrase: "emotional integration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1158478:Integration [Genetic Function]
   861   C1705422:Integration [Machine Activity]

Phrase: "(9,"

Phrase: "12,"

Phrase: "15,"

Phrase: "19,"

Phrase: "35"

Phrase: ")."
Processing 00000000.tx.17: NPY is a member of the pancreatic polypeptide family, which elicits a wide variety of physiological effects via the activation of G protein-coupled receptors (Y1, Y2, Y4, Y5, and y6) (5). 

Phrase: "NPY"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
  1000   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   861   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "is"

Phrase: "a member of the pancreatic polypeptide family,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0086282:Family member [Family Group]
   774   C1611821:Family Member [Intellectual Product]
   748   C0680022:member [Population Group]
   748   C2698041:Member [Professional or Occupational Group]

Phrase: "which"

Phrase: "elicits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449265:elicit [Qualitative Concept]

Phrase: "a wide variety of physiological effects"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1883525:Variety [Conceptual Entity]
   753   C2346866:Variety [Conceptual Entity]

Phrase: "via the activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: "of G protein-coupled receptors"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C0682972:G-Protein-Coupled Receptors [Amino Acid, Peptide, or Protein,Receptor]
   875   C0597357:protein receptors [Amino Acid, Peptide, or Protein,Receptor]
           receptors
   861   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0439267:g% [Quantitative Concept]
   812   C1948027:Coupled [Functional Concept]
   779 E C0010222:couple [Family Group]

Phrase: "(Y1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419589:Y1 [Gene or Genome]

Phrase: "Y2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1532188:Y2 [Quantitative Concept]

Phrase: "Y4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418858:Y4 [Gene or Genome]
  1000   C1419591:Y4 [Gene or Genome]

Phrase: "Y5,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419595:Y5 [Gene or Genome]

Phrase: "and"

Phrase: "y6"

Phrase: ")"

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.18: NPY receptor subtypes are all present in the hypothalamus (30) and have been suggested to play a role in modulating food intake and energy expenditure (4, 16). 

Phrase: "NPY receptor subtypes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0449560:subtypes [Classification]
   756   C0068624:Neuropeptide Y Receptor [Amino Acid, Peptide, or Protein,Receptor]
   708   C0206476:Neuropeptide Receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "are"

Phrase: "all"

Phrase: "present in the hypothalamus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0020663:Hypothalamus [Body Part, Organ, or Organ Component]
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]
   770   C1280712:Hypothalamus [Body Part, Organ, or Organ Component]

Phrase: "(30"

Phrase: ")"

Phrase: "and"

Phrase: "have"

Phrase: "been"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role in modulating food intake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "energy expenditure"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0014272:Energy Expenditure [Physiologic Function]
   861   C0015316:expenditure [Quantitative Concept]
   861   C0424589:Energy [Finding]
   861   C0542479:Energy [Natural Phenomenon or Process]
   861   C1442080:Energy [Quantitative Concept]

Phrase: "(4,"

Phrase: "16"

Phrase: ")."
Processing 00000000.tx.19: However, whether one of the receptor subtypes is the most likely candidate for central NPY-induced hyperinsulinemia has not been clearly elucidated. 

Phrase: "However,"

Phrase: "whether"

Phrase: "one of the receptor subtypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205447:One [Quantitative Concept]

Phrase: "is"

Phrase: "the most likely candidate for central NPY-induced hyperinsulinemia"

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "clearly"

Phrase: "elucidated."
Processing 00000000.tx.20: Chronic and acute administration of NPY intracerebroventricularly (icv) elicits hyperinsulinemia in a variety of species (10, 11, 20, 26, 39, 47). 

Phrase: "Chronic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205191:chronic [Temporal Concept]

Phrase: "and"

Phrase: "acute administration of NPY intracerebroventricularly (icv)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0001554:Administration [Occupational Activity]
   753   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "elicits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449265:elicit [Qualitative Concept]

Phrase: "hyperinsulinemia in a variety of species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0020459:Hyperinsulinaemia [Disease or Syndrome]

Phrase: "(10,"

Phrase: "11,"

Phrase: "20,"

Phrase: "26,"

Phrase: "39,"

Phrase: "47"

Phrase: ")."
Processing 00000000.tx.21: The insulinemic response to hypothalamic or icv NPY is largely dependent on the consumption of food (20, 24, 26) but also occurs when eating is prevented (24, 39). 

Phrase: "The insulinemic response to hypothalamic"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0871261:Response [Organism Attribute]
   760   C1704632:Response [Finding]
   760   C1706817:Response [Intellectual Product]
   760   C2911692:Response [Mental Process]

Phrase: "or"

Phrase: "icv NPY"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   901   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   827   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "is"

Phrase: "largely dependent on the consumption of food"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0851827:Dependent [Qualitative Concept]
   748   C1701901:Dependent [Qualitative Concept]
   748   C3244310:dependent [Functional Concept]

Phrase: "(20,"

Phrase: "24,"

Phrase: "26"

Phrase: ")"

Phrase: "but"

Phrase: "also"

Phrase: "occurs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "when"

Phrase: "eating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013470:Eating [Organism Function]

Phrase: "is"

Phrase: "prevented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "(24,"

Phrase: "39"

Phrase: ")."
Processing 00000000.tx.22: It has been suggested that central administration of NPY could stimulate insulin release through modulation of the autonomic nervous system (38), because NPY activates the parasympathetic nervous system (14) and causes increased firing of the vagus nerve (11, 25). 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that central administration of NPY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0001554:Administration [Occupational Activity]
   753   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "could"

Phrase: "stimulate"

Phrase: "insulin release through modulation of the autonomic nervous system"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0030685:Release [Health Care Activity]
   742   C0391871:Release [Functional Concept]
   742   C0439180:% release [Quantitative Concept]
   742   C0680255:release [Health Care Activity]
   742   C1283071:Release [Functional Concept]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1579433:Insulin [Pharmacologic Substance]
   742   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "(38"

Phrase: ")"

Phrase: ","

Phrase: "because"

Phrase: "NPY"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
  1000   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   861   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "the parasympathetic nervous system"
Meta Candidates (Total=18; Excluded=7; Pruned=0; Remaining=11)
  1000   C0030510:Parasympathetic Nervous System [Body System]
   901   C0027763:Nervous System [Body System]
   901   C0422837:NERVOUS SYSTEM [Finding]
   901   C1269560:Nervous system [Body System]
   845 E C0205494:Neurologic [Qualitative Concept]
   843   C0459522:Parasympathetic nerve [Body Part, Organ, or Organ Component]
   843   C1280879:Parasympathetic nerve [Body Part, Organ, or Organ Component]
   827   C0027769:Nervous [Sign or Symptom]
   827   C0449913:System [Functional Concept]
   827   C0599851:Nervous [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   808 E C0027855:Neurology [Biomedical Occupation or Discipline]
   790 E C2707261:Neurological [Clinical Attribute]
   755 E C0205373:Systemic [Functional Concept]
   711 E C0027740:Nerve [Tissue]
   711 E C0027757:NERVE [Tissue]
   711 E C1280541:Nerve [Body Part, Organ, or Organ Component]

Phrase: "(14"

Phrase: ")"

Phrase: "and"

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "increased firing of the vagus nerve"

Phrase: "(11,"

Phrase: "25"

Phrase: ")."
Processing 00000000.tx.23: The resulting hyperinsulinemia could contribute substantially to the anabolic effects of NPY (33). 

Phrase: "The resulting hyperinsulinemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020459:Hyperinsulinaemia [Disease or Syndrome]

Phrase: "could"

Phrase: "contribute"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880177:Contribute [Activity]

Phrase: "substantially to the anabolic effects of NPY"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   770   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   770   C3179309:Anabolic Effects [Physiologic Function]
   744   C0002744:Anabolic [Pharmacologic Substance,Steroid]
   744   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   744   C1280500:effects [Qualitative Concept]
   711 E C2348382:Effect [Qualitative Concept]

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.24: The aim of this study was to evaluate the effects of selective NPY Y1, Y2, Y4, and Y5 receptor agonists on plasma insulin, glucose, and glucagon levels in the presence and absence of food to determine the role of each NPY receptor subtype on NPY-induced hyperinsulinemia. 

Phrase: "The aim of this study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1947946:Aim [Idea or Concept]
   760   C2948600:Aim [Pharmacologic Substance]
   760   C3540471:AIM [Gene or Genome]
   760   C3540472:AIM [Functional Concept]

Phrase: "was"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "the effects of selective NPY Y1,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "Y2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1532188:Y2 [Quantitative Concept]

Phrase: "Y4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418858:Y4 [Gene or Genome]
  1000   C1419591:Y4 [Gene or Genome]

Phrase: "and"

Phrase: "Y5 receptor agonists on plasma insulin,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   820   C1373092:Insulin Receptor Agonists [Molecular Function]
   753   C0243192:agonists [Pharmacologic Substance]
   753   C2987634:agonists [Pharmacologic Substance]

Phrase: "glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "glucagon levels in the presence"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0337437:Glucagon level [Laboratory Procedure]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "absence of food to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   909   C0680146:absence of food [Finding]
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "determine"

Phrase: "the role of each NPY receptor subtype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "on NPY-induced hyperinsulinemia."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0020459:Hyperinsulinaemia [Disease or Syndrome]
Processing 00000000.tx.25: The Y1 selective peptide chosen, D-Arg25 NPY, binds the Y1 receptor with 12-, 82-, and 48-fold higher affinity than the Y2, Y4, and Y5 receptor subtypes, respectively (28). 

Phrase: "The Y1 selective peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "chosen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707391:Chosen [Activity]

Phrase: ","

Phrase: "D-"

Phrase: "Arg25 NPY,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   901   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   827   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "the Y1 receptor with 12-,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "82-,"

Phrase: "and"

Phrase: "48-fold higher affinity than the Y2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "Y4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418858:Y4 [Gene or Genome]
  1000   C1419591:Y4 [Gene or Genome]

Phrase: "and"

Phrase: "Y5 receptor subtypes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0449560:subtypes [Classification]
   734   C3642156:Y5 Receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "respectively"

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.26: For Y2 receptor activation, we used C2-NPY, which is 51-, 43-, and 46-fold more selective for the Y2 receptor over the Y1, Y4, and Y5 receptor subtypes, respectively (16). 

Phrase: "For Y2 receptor activation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1514758:Receptor Activation [Cell Function]
   827   C1879547:Activation [Activity]
   734   C3642155:Y2 Receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "C2-NPY,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   901   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   827   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "which"

Phrase: "is"

Phrase: "51-,"

Phrase: "43-,"

Phrase: "and"

Phrase: "46-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: "more selective for the Y2 receptor"

Phrase: "over the Y1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419589:Y1 [Gene or Genome]

Phrase: "Y4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418858:Y4 [Gene or Genome]
  1000   C1419591:Y4 [Gene or Genome]

Phrase: "and"

Phrase: "Y5 receptor subtypes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0449560:subtypes [Classification]
   734   C3642156:Y5 Receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "respectively"

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.27: To selectively activate the Y4 receptor, we used rat pancreatic polypeptide (rPP), which is 20,000-fold more selective for the Y4 receptor subtype than the Y1 and Y2 receptor subtypes and 2,000-fold more selective than the Y5 receptor subtype (16). 

Phrase: "To selectively"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "the Y4 receptor,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0668788:Y4 receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "rat pancreatic polypeptide (rPP),"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0030298:Pancreatic Polypeptide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   901   C1418856:pancreatic polypeptide [Gene or Genome]
   827   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   827   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: "which"

Phrase: "is"

Phrase: "20,000-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: "more selective for the Y4 receptor subtype"

Phrase: "than the Y1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419589:Y1 [Gene or Genome]

Phrase: "and"

Phrase: "Y2 receptor subtypes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0449560:subtypes [Classification]
   734   C3642155:Y2 Receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "2,000-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: "more selective than the Y5 receptor subtype"

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.28: To clarify the role of the Y5 receptor subtype on NPY-induced hyperinsulinemia, we used D-Trp34 NPY, a Y5 agonist, which is 7-, 29-, and 4-fold more selective for the Y5 receptor over the Y1, Y2, and Y4 receptor subtypes, respectively (29). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "clarify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986669:Clarify [Activity]

Phrase: "the role of the Y5 receptor subtype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "on NPY-induced hyperinsulinemia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0020459:Hyperinsulinaemia [Disease or Syndrome]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "D-"

Phrase: "Trp34 NPY,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   901   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   827   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "a Y5 agonist,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2987634:Agonist [Pharmacologic Substance]

Phrase: "which"

Phrase: "is"

Phrase: "7-,"

Phrase: "29-,"

Phrase: "and"

Phrase: "4-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: "more selective for the Y5 receptor"

Phrase: "over the Y1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419589:Y1 [Gene or Genome]

Phrase: "Y2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1532188:Y2 [Quantitative Concept]

Phrase: "and"

Phrase: "Y4 receptor subtypes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0449560:subtypes [Classification]
   734   C0668788:Y4 receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "respectively"

Phrase: "(29"

Phrase: ")."
Processing 00000000.tx.29: We also used a selective Y5 agonistic peptide reported by Cabrele et al., [cPP17, NPY1923, Ala31, Aib32, Gln34]hPP (cPP NPY) (7). 

Phrase: "We also"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a selective Y5 agonistic peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "reported by Cabrele et al.,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C1709908:Reported By [Group]
   760   C0684224:Reported [Intellectual Product]
   760   C0700287:Reported [Health Care Activity]
   760   C3496591:Reported [Clinical Attribute]
   726 E C3273238:Report [Intellectual Product]

Phrase: "[cPP17,"

Phrase: "NPY1923,"

Phrase: "Ala31,"

Phrase: "Aib32,"

Phrase: "Gln34"

Phrase: "]hPP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0520739:HPP [Disease or Syndrome]
  1000   C1840392:HPP [Disease or Syndrome]

Phrase: "(cPP NPY"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   901   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   827   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: ")"

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.30: This peptide is 12-fold more potent than D-Trp34 NPY at the Y5 receptor. 

Phrase: "This peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "is"

Phrase: "12-fold more potent than"

Phrase: "D-"

Phrase: "Trp34 NPY at the Y5 receptor."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   831   C1417818:NEUROPEPTIDE Y RECEPTOR Y5 [Gene or Genome]
   804   C0068624:Neuropeptide Y Receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C0391255:neuropeptide Y5 receptor [Amino Acid, Peptide, or Protein,Receptor]
   778   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   778   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   774   C0206476:Neuropeptide Receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
Processing 00000000.tx.31: In addition, cPP has over 2,000-fold greater affinity for Y5 over the Y1 or Y2 receptor, over 200-fold greater affinity for the Y4 receptor subtype, and is 3-fold more potent than the native ligand NPY. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "cPP"

Phrase: "has"

Phrase: "over 2,000-fold greater affinity for Y5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "over the Y1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419589:Y1 [Gene or Genome]

Phrase: "or"

Phrase: "Y2 receptor,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3642155:Y2 Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "over 200-fold greater affinity for the Y4 receptor subtype,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "is"

Phrase: "3-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: "more potent than the native ligand NPY."
Processing 00000000.tx.32: Previously, our laboratory has demonstrated that central activation of either Y1 receptors by D-Arg25 NPY or Y5 receptors by D-Trp34 NPY induced hyperphagia in satiated Long-Evans (LE) rats (28, 29). 

Phrase: "Previously,"

Phrase: "our laboratory"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022877:Laboratory [Manufactured Object,Organization]
  1000   C3244292:laboratory [Functional Concept]

Phrase: "has"

Phrase: "demonstrated"

Phrase: "that central activation of either Y1 receptors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C1514758:Receptor Activation [Cell Function]
   748   C1879547:Activation [Activity]

Phrase: "by"

Phrase: "D-"

Phrase: "Arg25 NPY"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   901   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   827   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "or"

Phrase: "Y5 receptors by"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   866   C3642156:Y5 Receptor [Amino Acid, Peptide, or Protein,Receptor]
   790   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "D-"

Phrase: "Trp34 NPY induced hyperphagia in satiated Long-Evans (LE) rats"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0020505:Hyperphagia [Mental or Behavioral Dysfunction]

Phrase: "(28,"

Phrase: "29"

Phrase: ")."
Processing 00000000.tx.33: However, selective activation of either Y2 receptors by C2-NPY or Y4 receptors by rPP did not elicit hyperphagia in satiated LE rats (16). 

Phrase: "However,"

Phrase: "selective activation of either Y2 receptors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1514758:Receptor Activation [Cell Function]
   753   C1879547:Activation [Activity]

Phrase: "by C2-NPY"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   901   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   827   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "or"

Phrase: "Y4 receptors by rPP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   820   C0070015:pancreatic polypeptide receptors [Amino Acid, Peptide, or Protein,Receptor]
   773   C0668788:Y4 receptor [Amino Acid, Peptide, or Protein,Receptor]
   767   C0312527:Polypeptide receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "elicit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449265:elicit [Qualitative Concept]

Phrase: "hyperphagia in satiated LE rats"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0020505:Hyperphagia [Mental or Behavioral Dysfunction]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.34: This study further indicates that activation of central Y1 or Y5, but not Y2 or Y4, receptor subtypes induces hyperinsulinemia. 

Phrase: "This study further"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "indicates"

Phrase: "that activation of central Y1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1879547:Activation [Activity]

Phrase: "or"

Phrase: "Y5,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419595:Y5 [Gene or Genome]

Phrase: "but"

Phrase: "not Y2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532188:Y2 [Quantitative Concept]

Phrase: "or"

Phrase: "Y4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418858:Y4 [Gene or Genome]
  1000   C1419591:Y4 [Gene or Genome]

Phrase: "receptor subtypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449560:subtypes [Classification]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "hyperinsulinemia."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020459:Hyperinsulinaemia [Disease or Syndrome]
Processing 00000000.tx.35: However, the mechanisms involved in Y1- vs. 

Phrase: "However,"

Phrase: "the mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "involved in Y1-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1314939:Involved [Functional Concept]
   790   C1419589:Y1 [Gene or Genome]

Phrase: "vs."
Processing 00000000.tx.36: Y5-induced hyperinsulinemia are different. 

Phrase: "Y5-induced hyperinsulinemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0020459:Hyperinsulinaemia [Disease or Syndrome]

Phrase: "are"

Phrase: "different."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1705242:Different [Qualitative Concept]
   928 E C1705241:*Difference [Quantitative Concept]
   900 E C0443199:Differential [Qualitative Concept]
Processing 00000000.tx.37: Y5-induced hyperinsulinemia is dependent on food ingestion, whereas Y1-induced hyperinsulinemia is independent of the presence of food.  

Phrase: "Y5-induced hyperinsulinemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0020459:Hyperinsulinaemia [Disease or Syndrome]

Phrase: "is"

Phrase: "dependent on food ingestion,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0851827:Dependent [Qualitative Concept]
   770   C1701901:Dependent [Qualitative Concept]
   770   C3244310:dependent [Functional Concept]

Phrase: "whereas"

Phrase: "Y1-induced hyperinsulinemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0020459:Hyperinsulinaemia [Disease or Syndrome]

Phrase: "is independent of the presence of food."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   800   C0680145:presence of food [Finding]
   778   C0332291:Independent of [Functional Concept]
   748   C0016452:Food [Food]
   748   C0085862:Independent [Idea or Concept]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C1299583:Independent [Finding]
Processing 00000000.tx.38: METHODS TOP ABSTRACT METHODS RESULTS DISCUSSION REFERENCES  Animals. 

Phrase: "METHODS TOP ABSTRACT METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0557061:Discussion [Therapeutic or Preventive Procedure]
   799   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Animals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]
Processing 00000000.tx.39: Adult male LE rats (250300 g; Charles River, MA) were housed individually and maintained in a temperature- and light-controlled environment on a 12:12-h light-dark cycle (lights on at 4:00 AM). 

Phrase: "Adult male LE rats"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0324537:Rats, Long-Evans [Mammal]
   840   C2697858:Long Evans [Mammal]
   804   C0034693:rats [Mammal]
   804   C0034721:Rats [Mammal]
   804   C0205166:Long [Qualitative Concept]
   804   C1706317:Long [Qualitative Concept]

Phrase: "(250300 g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "; Charles River,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0337050:River [Natural Phenomenon or Process]

Phrase: "MA)"

Phrase: "were"

Phrase: "housed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0020056:Housed [Manufactured Object]
   966 E C0442519:house [Conceptual Entity]
   966 E C2003847:House [Manufactured Object]

Phrase: "individually"

Phrase: "and"

Phrase: "maintained in a temperature-"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0005903:temperature [Organism Attribute]
   770   C0039476:*Temperature [Quantitative Concept]
   770   C1314677:Maintained [Functional Concept]
   737 E C0024501:Maintain [Activity]

Phrase: "and"

Phrase: "light-controlled environment on a 12"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0014409:Environment, Controlled [Human-caused Phenomenon or Process]
   753   C0014406:Environment [Spatial Concept]

Phrase: ":"

Phrase: "12-h light-dark cycle"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   884   C2718082:Light-Dark Cycle [Temporal Concept]
           Light Cycle
   804   C0023693:Light [Natural Phenomenon or Process]
   804   C0332582:Dark [Qualitative Concept]
   804   C1306462:Light [Functional Concept]
   804   C1511572:Cycle [Temporal Concept]
   804   C1881376:Light [Qualitative Concept]

Phrase: "(lights on"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   833   C0023693:lights [Natural Phenomenon or Process]
   799 E C1306462:Light [Functional Concept]
   799 E C1881376:Light [Qualitative Concept]

Phrase: "at 4"

Phrase: ":"

Phrase: "00"

Phrase: "AM"

Phrase: ")."
Processing 00000000.tx.40: Animals had free access to food and water. 

Phrase: "Animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "had"

Phrase: "free access to food"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0444454:Access [Spatial Concept]
   770   C1554204:access [Idea or Concept]

Phrase: "and"

Phrase: "water."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
  1000   C0599638:WATER [Substance]
  1000   C1550678:Water [Inorganic Chemical]
   928 E C0443350:Watery [Qualitative Concept]
Processing 00000000.tx.41: All studies were conducted in a facility accredited by the American Association for Accreditation of Laboratory Animal Care. 

Phrase: "All studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "were"

Phrase: "conducted in a facility"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1547538:Facility [Idea or Concept]
   737   C0004927:Conduct [Individual Behavior]

Phrase: "accredited by the American Association"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596070:American [Population Group]
   760   C0596306:Association [Phenomenon or Process]
   760   C0680883:accredited [Governmental or Regulatory Activity]
   760   C0699792:association [Social Behavior]

Phrase: "for Accreditation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000941:Accreditation [Governmental or Regulatory Activity]

Phrase: "of Laboratory Animal Care."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0178478:animal care [Occupation or Discipline]
   827   C1947933:Care [Activity]
   734   C0003064:Laboratory Animal [Animal]
Processing 00000000.tx.42: The following protocols were approved by the Schering-Plough Research Institute's Animal Care and Use Committee according to the guideline of the National Institutes of Health for the care and use of laboratory animals. 

Phrase: "The following protocols"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0442711:Protocols [Intellectual Product]
   827 E C1507394:Protocol [Intellectual Product]
   827 E C1522729:Protocol [Intellectual Product]
   827 E C2348563:Protocol [Intellectual Product]

Phrase: "were"

Phrase: "approved by the Schering-Plough Research Institute's Animal Care"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   764   C0035172:Research Institute [Organization]
   764   C0178478:animal care [Occupation or Discipline]
   764   C0331973:Schering-Plough [Health Care Related Organization]
   762   C0003048:Animal Research [Research Activity]
   742   C0003062:Animal [Animal]
   742   C0021622:institute [Organization]
   742   C0035168:research [Research Activity]
   742   C0205540:Approved [Qualitative Concept]
   742   C0242481:Research [Research Activity]
   742   C1272753:Institute [Idea or Concept]
   742   C1947933:Care [Activity]

Phrase: "and"

Phrase: "Use Committee according to the guideline of the National Institutes of Health"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C2699414:Committee [Group]

Phrase: "for the care"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947933:Care [Activity]

Phrase: "and"

Phrase: "use of laboratory animals."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1524063:Use of [Functional Concept]
   770   C0042153:use [Functional Concept]
   770   C0457083:Use [Functional Concept]
   770   C1947944:Use [Intellectual Product]
Processing 00000000.tx.43: Surgery. 

Phrase: "Surgery."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0038894:Surgery [Biomedical Occupation or Discipline]
  1000   C0038895:surgery [Functional Concept]
  1000   C0543467:Surgery [Health Care Activity]
Processing 00000000.tx.44: A single 22-gauge stainless steel guide cannula (Plastics One, Roanoke, VA) was chronically implanted in the lateral ventricle of a rat under ketamine-xylazine (100:10 mg/kg ip) anesthesia by use of the following coordinates: 1.0 mm posterior to bregma, 1.5 mm lateral to midline, and 3.6 mm ventral to dura (16). 

Phrase: "A single 22-gauge stainless steel guide cannula"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   795   C0520453:Cannula [Medical Device]
   795   C1706091:Cannula [Medical Device]
   795   C3463845:Cannula [Eukaryote]

Phrase: "(Plastics One,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205447:One [Quantitative Concept]

Phrase: "Roanoke,"

Phrase: "VA)"

Phrase: "was"

Phrase: "chronically"

Phrase: "implanted in the lateral ventricle of a rat"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   770   C0152279:Lateral ventricle [Body Space or Junction]
   770   C1268982:Lateral ventricle [Body Space or Junction]
   744   C0018827:Ventricle [Body Part, Organ, or Organ Component]
   744   C0021102:Implanted [Medical Device]
   744   C0034693:Rat, NOS [Mammal]
   744   C0034721:Rat [Mammal]
   744   C0205093:Lateral [Spatial Concept]
   744   C2355627:Ventricle [Body Part, Organ, or Organ Component]
   711 E C0021107:implant [Therapeutic or Preventive Procedure]
   711 E C0332837:Implant [Injury or Poisoning]
   711 E C1711357:Implant [Functional Concept]

Phrase: "under ketamine-xylazine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043366:Xylazin [Organic Chemical,Pharmacologic Substance]

Phrase: "(100"

Phrase: ":"

Phrase: "10 mg/kg ip) anesthesia by use of the following coordinates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0002903:Anesthesia [Therapeutic or Preventive Procedure]
   738   C0002930:Anaesthesia [Biomedical Occupation or Discipline]

Phrase: ":"

Phrase: "1.0 mm"

Phrase: "posterior to bregma,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205095:Posterior [Spatial Concept]

Phrase: "1.5 mm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0450316:1/5 [Quantitative Concept]

Phrase: "lateral to midline,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205093:Lateral [Spatial Concept]

Phrase: "and"

Phrase: "3.6 mm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0442759:3 6 [Finding]

Phrase: "ventral to dura"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704448:Ventral [Spatial Concept]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.45: The cannula was secured to the surface of the skull with jeweler's screws and dental cement, and a 28-gauge obturator was inserted into the cannula to maintain patency. 

Phrase: "The cannula"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0520453:Cannula [Medical Device]
  1000   C1706091:Cannula [Medical Device]
  1000   C3463845:Cannula [Eukaryote]

Phrase: "was"

Phrase: "secured to the surface of the skull"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   804   C0925568:Surface of skull [Body Location or Region]
           Skull surface
   748   C0037303:Skull [Body Part, Organ, or Organ Component]
   748   C0205148:Surface [Spatial Concept]
   714   C0659450:secure [Biomedical or Dental Material]
   714   C1519222:Secure [Conceptual Entity]
   714   C3146231:Secure [Mental Process]

Phrase: "with jeweler's screws"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0301559:screws [Medical Device]
   827 E C0005975:Screw [Medical Device]
   827 E C1704683:Screw [Medical Device]

Phrase: "and"

Phrase: "dental cement,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C1706094:Dental Cement [Biomedical or Dental Material]
           Cement
   950 E C0011343:Dental Cementum [Body Part, Organ, or Organ Component]
           Cement
   861   C0226984:Dental [Qualitative Concept]
   861   C0303744:Cement [Manufactured Object]
   861   C1704479:Cement [Biomedical or Dental Material]

Phrase: "and"

Phrase: "a 28-gauge obturator"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0182021:Obturator [Medical Device]
   827   C0223670:Obturator [Body Space or Junction]
   734   C3164740:28 gauge [Quantitative Concept]

Phrase: "was"

Phrase: "inserted into the cannula to"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0441587:Inserted [Health Care Activity]
   760   C0520453:Cannula [Medical Device]
   760   C1706091:Cannula [Medical Device]
   760   C3463845:Cannula [Eukaryote]
   726 E C1743766:Insert [Medical Device]
   726 E C1883719:Insert [Functional Concept]

Phrase: "maintain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024501:Maintain [Activity]

Phrase: "patency."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0175566:Patency [Spatial Concept]
   928 E C0030650:patent [Intellectual Product]
Processing 00000000.tx.46: After a 3-wk recovery period, all animals were tested for cannula placement by central infusion of 0.3 nmol of NPY. 

Phrase: "After a 3-wk recovery period,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C2983655:Recovery Period [Temporal Concept]
   812   C0439531:/period [Temporal Concept]
   812   C1948053:Period [Temporal Concept]
   741 E C0332182:Periodic [Temporal Concept]
   741 E C1706381:PERIODIC [Intellectual Product]
   712 E C0031084:Periodicities [Temporal Concept]

Phrase: "all animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "tested for cannula placement"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0392366:tested [Intellectual Product]
   770   C0441587:Placement [Health Care Activity]
   770   C0520453:Cannula [Medical Device]
   770   C1524072:Placement [Qualitative Concept]
   770   C1706091:Cannula [Medical Device]
   770   C3463845:Cannula [Eukaryote]
   737 E C0022885:Test [Laboratory Procedure]
   737 E C0039593:Test [Functional Concept]

Phrase: "by central infusion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0574032:Infusion [Therapeutic or Preventive Procedure]
   861   C1827465:Infusion [Functional Concept]

Phrase: "of 0.3 nmol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439191:NMOLE [Quantitative Concept]

Phrase: "of NPY."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
  1000   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   861   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
Processing 00000000.tx.47: Only animals demonstrating a prompt and robust feeding effect (>2.0 g intake within 1 h of infusion) were retained for the study. 

Phrase: "Only animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]

Phrase: "demonstrating"

Phrase: "a prompt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0871157:prompt [Functional Concept]
  1000   C1602245:Prompt [Pharmacologic Substance]

Phrase: "and"

Phrase: "robust feeding effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1280500:Effect [Qualitative Concept]
   827   C2348382:Effect [Qualitative Concept]

Phrase: "("

Phrase: ">2.0 g intake within 1 h of infusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1512806:Intake [Functional Concept]

Phrase: ")"

Phrase: "were"

Phrase: "retained for the study."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0333118:Retained [Functional Concept]
   770   C0557651:Study [Manufactured Object]
   770   C2603343:Study [Research Activity]
Processing 00000000.tx.48: Peptide and infusion protocols. 

Phrase: "Peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "infusion protocols."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0442711:Protocols [Intellectual Product]
   827 E C1507394:Protocol [Intellectual Product]
   827 E C1522729:Protocol [Intellectual Product]
   827 E C2348563:Protocol [Intellectual Product]
Processing 00000000.tx.49: About 1 wk after the NPY challenge, rats were icv infused with sterile saline during the nadir of the light cycle, and their food intake was monitored for 2 h. 

Phrase: "About 1 wk"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332174:/wk [Temporal Concept]
   861   C0439230:wk [Temporal Concept]

Phrase: "after the NPY challenge,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0798503:Challenge [Clinical Attribute]
   827   C0805586:Challenge [Health Care Activity]
   827   C3274764:Challenge [Conceptual Entity]
   734   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   734   C1417815:NEUROPEPTIDE Y [Gene or Genome]

Phrase: "rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "were"

Phrase: "icv"

Phrase: "infused with sterile saline"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0036082:Saline [Substance]
   770   C0232920:Sterile [Qualitative Concept]
   770   C0678108:Sterile [Pathologic Function]

Phrase: "during the nadir"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708760:Nadir [Qualitative Concept]

Phrase: "of the light cycle,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2718082:Light Cycle [Temporal Concept]
   861   C1511572:Cycle [Temporal Concept]

Phrase: "and"

Phrase: "their food intake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013470:Food Intake [Organism Function]
   861   C1512806:Intake [Functional Concept]

Phrase: "was"

Phrase: "monitored for 2 h."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   819   C0011744:h 2 [Element, Ion, or Isotope]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   737   C0030695:monitor [Health Care Activity]
   737   C0150369:monitor [Health Care Activity]
   737   C0181904:Monitor [Medical Device]
   737   C0596972:Monitor [Medical Device]
   737   C1521743:Monitor [Professional or Occupational Group]
   737   C1704646:Monitor [Manufactured Object]
Processing 00000000.tx.50: Cannulated rats were balanced into six study groups (NPY, Y1, Y2, Y4, Y5, and saline control) on the basis of their NPY-induced food intake and saline-induced food intake. 

Phrase: "Cannulated rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]

Phrase: "were"

Phrase: "balanced into six study groups"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   760   C0205415:Balanced [Functional Concept]
   760   C0205452:Six [Quantitative Concept]
   760   C0441833:Group [Idea or Concept]
   760   C0557651:Study [Manufactured Object]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1552839:groups [Idea or Concept]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]
   760   C2603343:Study [Research Activity]
   726 E C0014653:Balance [Organism Function]
   726 E C0560184:Balance [Finding]

Phrase: "(NPY,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
  1000   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   861   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "Y1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419589:Y1 [Gene or Genome]

Phrase: "Y2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1532188:Y2 [Quantitative Concept]

Phrase: "Y4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418858:Y4 [Gene or Genome]
  1000   C1419591:Y4 [Gene or Genome]

Phrase: "Y5,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419595:Y5 [Gene or Genome]

Phrase: "and"

Phrase: "saline control"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0036082:Saline [Substance]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: "on the basis of their NPY-induced food intake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0013470:Food Intake [Organism Function]
   804   C1512806:Intake [Functional Concept]

Phrase: "and"

Phrase: "saline-induced food intake."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013470:Food Intake [Organism Function]
   812   C1512806:Intake [Functional Concept]
Processing 00000000.tx.51: Rats were evenly divided into the "with food" and "without food" paradigms within each study group. 

Phrase: "Rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "were"

Phrase: "evenly"

Phrase: "divided into the ""with food"""
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0016452:Food [Food]
   760   C0332849:Divided [Functional Concept]

Phrase: "and ""without food"" paradigms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0016452:Food [Food]
   770   C0681797:paradigms [Research Activity]
   770   C1515981:And [Idea or Concept]

Phrase: "within each study group."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0441833:Group [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]
   861   C2603343:Study [Research Activity]
Processing 00000000.tx.52: Human NPY, rPP, D-Trp34 NPY, D-Arg25 NPY, C2-NPY, and cPP NPY were synthesized by AnaSpec (San Jose, CA). 

Phrase: "Human NPY,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   901   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   827   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "rPP,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0030298:Pancreatic Polypeptide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   901   C1418856:pancreatic polypeptide [Gene or Genome]
   827   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   827   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: "D-"

Phrase: "Trp34 NPY,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   901   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   827   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "D-"

Phrase: "Arg25 NPY,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   901   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   827   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "C2-NPY,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   901   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   827   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "and"

Phrase: "cPP NPY"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   901   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   827   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "were"

Phrase: "synthesized by AnaSpec"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1883254:Synthesized [Activity]

Phrase: "(San Jose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "CA)."
Processing 00000000.tx.53: All peptides were dissolved in 0.9% sterile saline (Sigma, St. Louis, MO) and infused icv at 1 nmol, which was the minimal effective dose of D-Trp34 NPY and D-Arg25 NPY on feeding at the 1-h time point (28, 29). 

Phrase: "All peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "dissolved in 0.9% sterile saline"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0036082:Saline [Substance]
   753   C0232920:Sterile [Qualitative Concept]
   753   C0678108:Sterile [Pathologic Function]
   719   C1549535:Dissolve [Functional Concept]

Phrase: "(Sigma,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: "St. Louis,"

Phrase: "MO)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538743:MO [Idea or Concept]

Phrase: "and"

Phrase: "infused"

Phrase: "icv at 1 nmol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439191:NMOLE [Quantitative Concept]

Phrase: "which"

Phrase: "was"

Phrase: "the minimal effective dose of"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   862   C0429197:Minimal effective dose [Laboratory or Test Result]
   760   C0178602:Dose [Quantitative Concept]
   760   C0547040:Minimal [Qualitative Concept]
   760   C0869039:Dose [Quantitative Concept]
   760   C1114758:Dose # [Clinical Attribute]
   760   C1280519:effective [Qualitative Concept]
   760   C1524031:MINIMAL [Qualitative Concept]
   760   C1704419:Effective [Qualitative Concept]
   760   C2945599:Minimal [Qualitative Concept]

Phrase: "D-"

Phrase: "Trp34 NPY"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   901   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   827   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "and"

Phrase: "D-"

Phrase: "Arg25 NPY on feeding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   806   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   760   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "at the 1-h time point"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C2348792:Time Point [Temporal Concept]
   812   C0040223:Time [Temporal Concept]
   812   C1552961:Point [Quantitative Concept]
   812   C2347617:point [Quantitative Concept]
   812   C3541383:Time [Temporal Concept]
   756 E C0442043:Temporal [Spatial Concept]
   756 E C2362314:Temporal [Temporal Concept]
   729 E C1632851:Times [Quantitative Concept]

Phrase: "(28,"

Phrase: "29"

Phrase: ")."
Processing 00000000.tx.54: Hamilton infusion pumps and syringes (Bioanalytical System, N. Lafayette, IN) were used at a rate of 5 l/min for 1 min. 

Phrase: "Hamilton infusion pumps"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   901   C0021436:Infusion Pumps [Medical Device]
   867 E C1547123:Infusion pump [Spatial Concept]
   827   C0182537:pumps [Medical Device]
   827   C0574032:Infusion [Therapeutic or Preventive Procedure]
   827   C1827465:Infusion [Functional Concept]
   793 E C1706421:Pump [Manufactured Object]

Phrase: "and"

Phrase: "syringes"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0039142:Syringes [Medical Device]
  1000   C0039147:Syringes [Anatomical Abnormality]
   966 E C0278423:Syrinx [Body Part, Organ, or Organ Component]
   966 E C1706072:Syringe [Manufactured Object]

Phrase: "(Bioanalytical System,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]

Phrase: "N. Lafayette,"

Phrase: "IN)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:In [Quantitative Concept]
  1000   C0332285:In [Spatial Concept]

Phrase: "were"

Phrase: "used at a rate of 5 l/min"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   750   C1524063:Use of [Functional Concept]
   744   C0702093:/min [Temporal Concept]
   744   C0871208:Rate [Activity]
   744   C1273517:used [Finding]
   744   C1521828:Rate [Quantitative Concept]
   711 E C0042153:use [Functional Concept]
   711 E C0457083:Use [Functional Concept]
   711 E C1947944:Use [Intellectual Product]

Phrase: "for 1 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.55: The infusion cannula remained inserted for an additional minute to prevent diffusion up the needle track. 

Phrase: "The infusion cannula"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0520453:Cannula [Medical Device]
   861   C1706091:Cannula [Medical Device]
   861   C3463845:Cannula [Eukaryote]

Phrase: "remained"

Phrase: "inserted for an additional minute to"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   753   C0439232:minute [Temporal Concept]
   753   C0441587:Inserted [Health Care Activity]
   753   C0700321:minute [Quantitative Concept]
   753   C0702093:/minute [Temporal Concept]
   753   C1282918:Minute [Quantitative Concept]
   753   C1524062:Additional [Functional Concept]
   753   C2347166:Minute [Quantitative Concept]
   719 E C1743766:Insert [Medical Device]
   719 E C1883719:Insert [Functional Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "diffusion up the needle track."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0012222:Diffusion [Natural Phenomenon or Process]
   760   C1696141:Diffusion [Functional Concept]
Processing 00000000.tx.56: The chow-filled feeder (Purina Rodent Chow no. 5053, St. Louis, MO) was weighed during the infusion period and then returned to the home cage with the animal immediately after treatment. 

Phrase: "The chow-filled feeder"

Phrase: "(Purina Rodent Chow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0324335:chow [Mammal]

Phrase: "no. 5053,"

Phrase: "St. Louis,"

Phrase: "MO)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538743:MO [Idea or Concept]

Phrase: "was"

Phrase: "weighed during the infusion period"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439531:/period [Temporal Concept]
   760   C0574032:Infusion [Therapeutic or Preventive Procedure]
   760   C1827465:Infusion [Functional Concept]
   760   C1948053:Period [Temporal Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "returned to the home cage"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C0579192:Returned home [Finding]
   790   C0332156:Return to [Qualitative Concept]
           Return
   760   C0337189:Cage [Manufactured Object]
   760   C0441239:Cage [Medical Device]
   760   C0442519:Home [Conceptual Entity]

Phrase: "with the animal immediately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animal [Animal]

Phrase: "after"

Phrase: "treatment."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.57: The feeder was not returned to the home cages with animals in the "without food" group. 

Phrase: "The feeder"

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "returned to the home cages"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   797   C0579192:Returned home [Finding]
   790   C0332156:Return to [Qualitative Concept]
           Return
   760   C0337189:cages [Manufactured Object]
   760   C0442519:Home [Conceptual Entity]
   726 E C0441239:Cage [Medical Device]

Phrase: "with animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "in the ""without food"" group."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1552516:Group [Health Care Related Organization]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]
Processing 00000000.tx.58: Food consumption was monitored, and blood samples were collected by heart puncture at 15, 60, or 120 min after the 1-min icv infusion. 

Phrase: "Food consumption"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2983605:Food Consumption [Activity]
   861   C0009830:Consumption [Activity]
   861   C1947907:Consumption [Physiologic Function]

Phrase: "was"

Phrase: "monitored"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0030695:monitor [Health Care Activity]
   966   C0150369:monitor [Health Care Activity]
   966   C0181904:Monitor [Medical Device]
   966   C0596972:Monitor [Medical Device]
   966   C1521743:Monitor [Professional or Occupational Group]
   966   C1704646:Monitor [Manufactured Object]

Phrase: ","

Phrase: "and"

Phrase: "blood samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0178913:blood samples [Body Substance]
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "collected by heart puncture"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0018787:Heart [Body Part, Organ, or Organ Component]
   770   C0033119:Puncture [Finding]
   770   C0034117:Puncture [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1281570:Heart [Body Part, Organ, or Organ Component]
   770   C1516695:Collected [Idea or Concept]
   770   C1516698:Collected [Functional Concept]
   770   C1881711:PUNCTURE [Phenomenon or Process]

Phrase: "at 15,"

Phrase: "60,"

Phrase: "or"

Phrase: "120 min after the 1-min icv infusion."
Processing 00000000.tx.59: Because the protruding icv cannula may get caught in the wire cage, rats were individually housed in plastic cages with corn cob bedding (bed-o-cobs, 1/4 in.; Anderson Cob Mills, Malumee, OH). 

Phrase: "Because"

Phrase: "the protruding icv cannula"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0520453:Cannula [Medical Device]
   827   C1706091:Cannula [Medical Device]
   827   C3463845:Cannula [Eukaryote]

Phrase: "may"

Phrase: "get"

Phrase: "caught in the wire cage,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0231617:Catch [Sign or Symptom]

Phrase: "rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "were"

Phrase: "individually"

Phrase: "housed in plastic cages"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0020056:Housed [Manufactured Object]
   770   C0032167:Plastic [Substance]
   770   C0337189:cages [Manufactured Object]
   737 E C0441239:Cage [Medical Device]
   737 E C0442519:house [Conceptual Entity]
   737 E C2003847:House [Manufactured Object]

Phrase: "with corn cob bedding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0004914:Bedding [Manufactured Object]

Phrase: "(bed-o-cobs,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1523097:CobS [Molecular Function]
   793 E C0056020:COB [Therapeutic or Preventive Procedure]
   793 E C1537988:COB [Gene or Genome]

Phrase: "1/4 in."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C2827734:1+ [Quantitative Concept]
   790   C2981698:1+ [Classification]

Phrase: "; Anderson Cob Mills,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0599997:mills [Manufactured Object]

Phrase: "Malumee,"

Phrase: "OH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220853:OH- [Element, Ion, or Isotope]

Phrase: ")."
Processing 00000000.tx.60: Minor powdery food spillage was not recorded, which may potentially overestimate the food intake of the treated groups at the 1-h and 2-h time points. 

Phrase: "Minor powdery food spillage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0015376:Spillage [Pathologic Function]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "recorded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0034869:Record [Intellectual Product]

Phrase: ","

Phrase: "which"

Phrase: "may"

Phrase: "potentially"

Phrase: "overestimate"

Phrase: "the food intake of the treated groups"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0013470:Food Intake [Organism Function]
   748   C1512806:Intake [Functional Concept]

Phrase: "at the 1-h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "2-h time points."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   827   C2348792:Time Point [Temporal Concept]
   812   C0040223:Time [Temporal Concept]
   812   C3541383:Time [Temporal Concept]
   779   C1552961:Point [Quantitative Concept]
   779   C2347617:point [Quantitative Concept]
   756 E C0442043:Temporal [Spatial Concept]
   756 E C2362314:Temporal [Temporal Concept]
   729 E C1632851:Times [Quantitative Concept]
Processing 00000000.tx.61: All rats were infused at the nadir of the light cycle, which is 67 h after lights on. 

Phrase: "All rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "were"

Phrase: "infused at the nadir of the light cycle,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C2718082:Light Cycle [Temporal Concept]
   744   C0023693:Light [Natural Phenomenon or Process]
   744   C1306462:Light [Functional Concept]
   744   C1511572:Cycle [Temporal Concept]
   744   C1708760:Nadir [Qualitative Concept]
   744   C1881376:Light [Qualitative Concept]

Phrase: "which"

Phrase: "is"

Phrase: "67 h after lights"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]

Phrase: "on."
Processing 00000000.tx.62: After the study, rat brains were infused with dye, fixed in 10% Formalin saline solution, and sectioned, and injection sites were determined under light microscopy. 

Phrase: "After the study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "rat brains"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C1882598:Rat Brain [Body Part, Organ, or Organ Component]
   861   C0006104:Brains [Body Part, Organ, or Organ Component]
   827 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "infused with dye,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0013343:Dye [Indicator, Reagent, or Diagnostic Aid]

Phrase: "fixed in 10% Formalin saline solution,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0036082:Saline Solution [Substance]
           Saline
   790   C1550067:10% Formalin [Biomedical or Dental Material,Organic Chemical]
   790   C1561470:10% Formalin [Intellectual Product]
   753   C0037633:Solution [Substance]
   753   C0231441:Fixed [Finding]
   753   C0443218:Fixed [Qualitative Concept]
   753   C0525069:Solution [Biomedical or Dental Material]
   753   C0949307:Formalin [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   753   C2827483:Fixed [Body Substance]

Phrase: "and"

Phrase: "sectioned,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "and"

Phrase: "injection sites"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0179694:injection sites [Medical Device]
  1000   C0600077:Injection sites [Functional Concept]
   983 E C0221208:Injection site [Injury or Poisoning]
   983 E C2700396:Injection site [Spatial Concept]
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]

Phrase: "were"

Phrase: "determined under light microscopy."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0430389:Light microscopy [Laboratory Procedure]
   770   C0023693:Light [Natural Phenomenon or Process]
   770   C0026018:Microscopy [Laboratory Procedure]
   770   C1306462:Light [Functional Concept]
   770   C1881376:Light [Qualitative Concept]
Processing 00000000.tx.63: All rats were killed between 11:00 AM and 12:00 PM (78 h after lights on) for blood sample collection after icv infusion (15 min, 1 h, or 2 h). 

Phrase: "All rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "were"

Phrase: "killed between 11"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0162388:killed [Social Behavior]
   756 E C0681205:Kill [Idea or Concept]
   756 E C1550555:kill [Functional Concept]

Phrase: ":"

Phrase: "00"

Phrase: "AM"

Phrase: "and"

Phrase: "12"

Phrase: ":"

Phrase: "00 PM (78 h after lights"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441932:H+ [Classification]
   753   C0564385:/h [Quantitative Concept]

Phrase: "on) for blood sample collection"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1720176:On [Functional Concept]
   760   C1720294:On [Intellectual Product]

Phrase: "after icv infusion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0574032:Infusion [Therapeutic or Preventive Procedure]
   861   C1827465:Infusion [Functional Concept]

Phrase: "(15 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "1 h,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "or"

Phrase: "2 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:2 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.64: Blood samples were collected into heparinized tubes, and plasma was isolated for assays after centrifugation at 3,000 rpm. 

Phrase: "Blood samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0178913:blood samples [Body Substance]
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "collected into heparinized tubes,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0175730:tubes [Medical Device]
   770   C1516695:Collected [Idea or Concept]
   770   C1516698:Collected [Functional Concept]
   770   C1547937:Tubes [Intellectual Product]
   770   C1704474:Tubes [Quantitative Concept]
   737 E C1561954:tube [Conceptual Entity]
   737 E C1704730:TUBE [Medical Device]

Phrase: "and"

Phrase: "plasma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032105:Plasma [Body Substance]
  1000   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "was"

Phrase: "isolated for assays"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0205409:Isolated [Functional Concept]
   790   C1548221:Isolated [Idea or Concept]
   756   C0005507:Assay [Laboratory Procedure]
   756   C0243073:assay [Qualitative Concept]
   756 E C0370215:Isolate [Substance]
   756   C1510438:Assay [Laboratory Procedure]
   756 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "after centrifugation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007703:Centrifugation [Laboratory Procedure]

Phrase: "at 3,000 rpm."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0582523:rpm [Quantitative Concept]
Processing 00000000.tx.65: Plasma insulin, glucagon, and glucose assays. 

Phrase: "Plasma insulin,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0857690:plasma insulin [Laboratory Procedure]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0032105:Plasma [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "glucagon,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "glucose assays."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.66: Both insulin and glucagon were analyzed by ELISA kits from ALPCO Diagnostics (Windham, NH) and Peninsula Laboratories (San Carlos, CA), respectively. 

Phrase: "Both insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "glucagon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "were"

Phrase: "analyzed by ELISA kits"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   770   C0014441:ELISA [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1690540:Kits [Qualitative Concept]
   737 E C0812225:KIT [Medical Device]
   737 E C1150635:KIT [Molecular Function]
   737 E C1705212:Kit [Medical Device]
   737 E C1705213:KIT [Medical Device]
   737 E C3273202:Kit [Manufactured Object]

Phrase: "from ALPCO Diagnostics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0011900:Diagnostic [Finding]
   827   C0348026:Diagnostic [Functional Concept]

Phrase: "(Windham,"

Phrase: "NH)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0268059:NH [Disease or Syndrome]

Phrase: "and"

Phrase: "Peninsula Laboratories"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0022877:Laboratories [Manufactured Object,Organization]
   861   C1619828:Laboratories [Intellectual Product]
   827 E C3244292:laboratory [Functional Concept]

Phrase: "(San Carlos,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0445462:Carlos [Intellectual Product]

Phrase: "CA),"

Phrase: "respectively."
Processing 00000000.tx.67: The coefficients of variation for insulin and glucagon ELISA assays were 4.9  1.2 and 8.4  1.9%, respectively. 

Phrase: "The coefficients of variation for insulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0681921:Coefficient of Variation [Quantitative Concept]
   753   C0205419:Variation [Qualitative Concept]
   719   C1707429:*Coefficient [Quantitative Concept]

Phrase: "and"

Phrase: "glucagon ELISA assays"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   884   C0014441:ELISA assay [Laboratory Procedure]
   793   C0005507:Assay [Laboratory Procedure]
   793   C0243073:assay [Qualitative Concept]
   793   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "4.9  1.2"

Phrase: "and"

Phrase: "8.4  1.9%,"

Phrase: "respectively."
Processing 00000000.tx.68: Glucose was analyzed by Sigma Diagnostic Glucose Trinder Agent (St. Louis, MO). 

Phrase: "Glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "was"

Phrase: "analyzed by Sigma Diagnostic Glucose Trinder Agent"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   774   C0358514:Diagnostic Agent [Indicator, Reagent, or Diagnostic Aid]
   748   C0011900:Diagnostic [Finding]
   748   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   748   C0348026:Diagnostic [Functional Concept]
   748   C0450442:Agent [Chemical Viewed Functionally]
   748   C0936012:Analyzed [Research Activity]
   748   C1254351:Agent [Pharmacologic Substance]
   748   C1521826:Agent [Intellectual Product]
   748   C1719918:Sigma [Intellectual Product]

Phrase: "(St. Louis,"

Phrase: "MO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538743:MO [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.69: Statistical analysis. 

Phrase: "Statistical analysis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871424:statistical analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.70: Results are given as means  SE. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "given as means  SE."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C1442162:GIVEN [Conceptual Entity]
   770   C1550718:given [Idea or Concept]
   770   C1704970:Means [Conceptual Entity]
   770   C3244317:given [Intellectual Product]
   737 E C0444504:Mean [Quantitative Concept]
   737 E C1947971:Give [Functional Concept]
   737 E C2347634:Mean [Quantitative Concept]
   737 E C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.71: For each time point, plasma insulin, glucose, and glucagon levels were compared by two-way ANOVA (peptide treatment x food access). 

Phrase: "For each time point,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C2348792:Time Point [Temporal Concept]
   861   C0040223:Time [Temporal Concept]
   861   C1552961:Point [Quantitative Concept]
   861   C2347617:point [Quantitative Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "plasma insulin,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0857690:plasma insulin [Laboratory Procedure]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0032105:Plasma [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "glucagon levels"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   983   C0337437:Glucagon level [Laboratory Procedure]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "compared by two-way ANOVA (peptide treatment x food access"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   782   C1710497:Two-way ANOVA [Quantitative Concept]
   739   C0016452:Food [Food]
   739   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   739   C0039798:treatment [Functional Concept]
   739   C0087111:Treatment [Therapeutic or Preventive Procedure]
   739   C0205448:Two [Quantitative Concept]
   739   C0444454:Access [Spatial Concept]
   739   C1522326:Treatment [Functional Concept]
   739   C1533734:Treatment [Therapeutic or Preventive Procedure]
   739   C1554204:access [Idea or Concept]
   739   C1705169:Treatment [Conceptual Entity]
   739   C1707455:Compared [Activity]
   739   C3538994:TREATMENT [Research Activity]

Phrase: ")."
Processing 00000000.tx.72: Whenever the overall model was statistically significant, with significant food effects, data were further separated into "with food" vs. 

Phrase: "Whenever"

Phrase: "the overall model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]

Phrase: "was"

Phrase: "statistically significant,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0237881:statistically significant [Quantitative Concept]
           significant
   928 E C1709380:Statistical Significance [Quantitative Concept]
   861   C0038215:Statistically [Occupation or Discipline]
   861   C0750502:Significant [Idea or Concept]
   861   C1546944:Significant [Qualitative Concept]

Phrase: "with significant food effects,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   884   C3274396:FOOD EFFECT [Research Activity]
   827   C1280500:effects [Qualitative Concept]
   793 E C2348382:Effect [Qualitative Concept]

Phrase: "data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "separated into """
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0086972:Separated [Finding]
   833   C0443299:separated [Spatial Concept]
   833   C0687118:Separated [Functional Concept]

Phrase: "with food"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016452:Food [Food]

Phrase: "vs."
Processing 00000000.tx.73: "without food" groups and analyzed against the respective saline control groups. 

Phrase: """"

Phrase: "without food"" groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "and"

Phrase: "analyzed against the respective saline control groups."
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   778   C0009932:Control Groups [Group]
   748   C0036082:Saline [Substance]
   748   C0243148:control [Qualitative Concept]
   748   C0441833:Group [Idea or Concept]
   748   C0687744:group [Population Group]
   748   C0936012:Analyzed [Research Activity]
   748   C1257890:Group [Population Group]
   748   C1550141:Control [Substance]
   748   C1552516:Group [Health Care Related Organization]
   748   C1552839:groups [Idea or Concept]
   748   C1705428:Group [Conceptual Entity]
   748   C1705429:Group [Population Group]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.74: When Bartlett's test indicated that the group comparisons had equal variances, one-way ANOVA and Dunnett's multiple comparison post hoc tests were used. 

Phrase: "When"

Phrase: "Bartlett's test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0022885:Test [Laboratory Procedure]
   861   C0039593:Test [Functional Concept]
   861   C0392366:test [Intellectual Product]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that"

Phrase: "the group comparisons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1707455:Comparison [Activity]

Phrase: "had"

Phrase: "equal variances,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1711260:Variance [Qualitative Concept]
   827   C2348152:Variance [Quantitative Concept]
   777 E C0205419:Variant [Qualitative Concept]

Phrase: "one-way ANOVA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709320:One-way ANOVA [Quantitative Concept]

Phrase: "and"

Phrase: "Dunnett's multiple comparison post hoc tests"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   799   C0022885:Tests [Laboratory Procedure]
   799   C0392366:Tests [Intellectual Product]
   766 E C0039593:Test [Functional Concept]

Phrase: "were"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.75: When the group data showed unequal variances, the nonparametric Wilcoxon/Kruskal-Wallis and Dunn's multiple comparison post hoc tests were used. 

Phrase: "When"

Phrase: "the group data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "unequal variances,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1711260:Variance [Qualitative Concept]
   827   C2348152:Variance [Quantitative Concept]
   777 E C0205419:Variant [Qualitative Concept]

Phrase: "the nonparametric Wilcoxon/Kruskal-Wallis"

Phrase: "and"

Phrase: "Dunn's multiple comparison post hoc tests"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   799   C0022885:Tests [Laboratory Procedure]
   799   C0392366:Tests [Intellectual Product]
   766 E C0039593:Test [Functional Concept]

Phrase: "were"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.76: Comparisons between the paired groups in the presence or absence of food were analyzed by Student's t-tests. 

Phrase: "Comparisons between the paired groups"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0086766:Paired Comparisons [Quantitative Concept]
   726   C1707455:Comparison [Activity]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "absence of food"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0680146:absence of food [Finding]
   790   C0332197:absence [Quantitative Concept]
   790   C1689985:Absence [Anatomical Abnormality]
   718 E C2699517:ABSENT [Finding]

Phrase: "were"

Phrase: "analyzed by Student's t-tests."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0022885:Tests [Laboratory Procedure]
   760   C0038492:student [Professional or Occupational Group]
   760   C0392366:Tests [Intellectual Product]
   760   C0936012:Analyzed [Research Activity]
   760   C1551041:student [Idea or Concept]
   760   C1552573:student [Intellectual Product]
   726 E C0039593:Test [Functional Concept]
Processing 00000000.tx.77: P < 0.05 was considered to be significant. 

Phrase: "P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "was"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "significant."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0237881:significant [Quantitative Concept]
  1000   C0750502:Significant [Idea or Concept]
  1000   C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.78: These statistical tests were performed using JMP 4.0.4 (SAS Institute, Cary, NC) and Prism 3.0 (GraphPad Software, San Diego, CA).  

Phrase: "These statistical tests"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0237913:statistical tests [Intellectual Product]
   861   C0022885:Tests [Laboratory Procedure]
   861   C0392366:Tests [Intellectual Product]
   827 E C0039593:Test [Functional Concept]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "JMP 4.0.4"

Phrase: "(SAS Institute,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021622:institute [Organization]
   861   C1272753:Institute [Idea or Concept]

Phrase: "Cary,"

Phrase: "NC)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027964:NC [Geographic Area]
  1000   C0028407:NC [Geographic Area]
  1000   C0067895:NC [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Prism 3.0"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0814195:PRISM [Intellectual Product]
   771 E C0138404:prisma [Organic Chemical,Pharmacologic Substance]

Phrase: "(GraphPad Software,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "San Diego,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "CA)."
Processing 00000000.tx.79: RESULTS TOP ABSTRACT METHODS RESULTS DISCUSSION REFERENCES  Fifteen minutes after icv infusion of saline vs. 

Phrase: "RESULTS TOP ABSTRACT METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0557061:Discussion [Therapeutic or Preventive Procedure]
   799   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Fifteen minutes after icv infusion of saline"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0439232:minute [Temporal Concept]
   748   C0700321:minute [Quantitative Concept]
   748   C0702093:/minute [Temporal Concept]
   748   C1282918:Minute [Quantitative Concept]
   748   C2347166:Minute [Quantitative Concept]

Phrase: "vs."
Processing 00000000.tx.80: 1 nmol of NPY or NPY analogs. 

Phrase: "1 nmol of NPY"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439191:NMOLE [Quantitative Concept]

Phrase: "or"

Phrase: "NPY analogs."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0243071:analogs [Chemical Viewed Structurally]
   734   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   734   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   721 E C0679213:analogies [Idea or Concept]
Processing 00000000.tx.81: Central administration of NPY and its analogs did not induce increased food intake (Fig. 1A) or any significant changes in plasma glucagon and glucose levels (Fig. 1, C and D) at the 15-min postinfusion time. 

Phrase: "Central administration of NPY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0001554:Administration [Occupational Activity]
   760   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "its analogs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0243071:analogs [Chemical Viewed Structurally]
   893 E C0679213:analogies [Idea or Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "increased food intake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0013470:Food Intake [Organism Function]
   827   C1512806:Intake [Functional Concept]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")"

Phrase: "or"

Phrase: "any significant changes in plasma glucagon"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0392747:changes [Functional Concept]
   753   C0443172:changes [Quantitative Concept]
   719 E C1705241:Change [Quantitative Concept]

Phrase: "and"

Phrase: "glucose levels"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0428548:glucose levels [Laboratory or Test Result]
   966 E C0337438:glucose level [Laboratory Procedure]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "(Fig. 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "C"

Phrase: "and"

Phrase: "D) at the 15-min postinfusion time."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0040223:Time [Temporal Concept]
   748   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0702093:/min [Temporal Concept]
   748   C3541383:Time [Temporal Concept]
Processing 00000000.tx.82: However, plasma insulin levels were significantly elevated after icv infusion of the selective Y1 agonist D-Arg25 NPY (1 nmol) compared with the saline control groups [Fig. 1B, two-way ANOVA F(11,59) = 6.02, P < 0.0001]. 

Phrase: "However,"

Phrase: "plasma insulin levels"
Meta Candidates (Total=15; Excluded=5; Pruned=0; Remaining=10)
   966   C1276042:Plasma insulin level [Laboratory Procedure]
   901   C0202098:insulin levels [Laboratory Procedure]
   901   C0428405:insulin levels [Laboratory or Test Result]
   901   C0857690:plasma insulin [Laboratory Procedure]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0032105:Plasma [Body Substance]
   827   C0441889:Levels [Qualitative Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "were"

Phrase: "significantly"

Phrase: "elevated after icv infusion of the selective Y1 agonist"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   742   C0205250:Elevated [Qualitative Concept]
   742   C0574032:Infusion [Therapeutic or Preventive Procedure]
   742   C1419589:Y1 [Gene or Genome]
   742   C1827465:Infusion [Functional Concept]
   742   C2987634:Agonist [Pharmacologic Substance]
   742   C3163633:Elevated [Qualitative Concept]

Phrase: "D-"

Phrase: "Arg25 NPY"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   901   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   827   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "(1 nmol)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439191:NMOLE [Quantitative Concept]

Phrase: "compared with the saline control groups"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   790   C0009932:Control Groups [Group]
   753   C0036082:Saline [Substance]
   753   C0243148:control [Qualitative Concept]
   753   C0441833:Group [Idea or Concept]
   753   C0687744:group [Population Group]
   753   C1257890:Group [Population Group]
   753   C1550141:Control [Substance]
   753   C1552516:Group [Health Care Related Organization]
   753   C1552839:groups [Idea or Concept]
   753   C1705428:Group [Conceptual Entity]
   753   C1705429:Group [Population Group]
   753   C1707455:Compared [Activity]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]

Phrase: "[Fig. 1B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: "two-way ANOVA F(11,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   884   C1710497:Two-way ANOVA [Quantitative Concept]
   804   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   804   C0205448:Two [Quantitative Concept]
   804   C0439133:(f) [Intellectual Product]
   804   C1553038:[f] [Quantitative Concept]

Phrase: "59"

Phrase: ")"

Phrase: "= 6.02,"

Phrase: "P < 0.0001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "]."
Processing 00000000.tx.83: Kruskal-Wallis and Dunn's multiple comparison tests showed that the combined Y1 treatment effects, with and without food, were significantly different from control, P < 0.001. 

Phrase: "Kruskal-Wallis"

Phrase: "and"

Phrase: "Dunn's multiple comparison tests"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0022885:Tests [Laboratory Procedure]
   812   C0392366:Tests [Intellectual Product]
   779 E C0039593:Test [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the combined Y1 treatment effects,"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   875   C0009429:combined treatment [Therapeutic or Preventive Procedure]
   875   C1704537:Combined Treatment [Therapeutic or Preventive Procedure]
   827   C1518681:Treatment Effect [Finding]
   812   C0039798:treatment [Functional Concept]
   812   C0087111:Treatment [Therapeutic or Preventive Procedure]
   812   C1280500:effects [Qualitative Concept]
   812   C1522326:Treatment [Functional Concept]
   812   C1533734:Treatment [Therapeutic or Preventive Procedure]
   812   C1705169:Treatment [Conceptual Entity]
   812   C3538994:TREATMENT [Research Activity]
   779 E C2348382:Effect [Qualitative Concept]

Phrase: "with"

Phrase: "and without food,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0016452:Food [Food]
   790   C1515981:And [Idea or Concept]

Phrase: "were"

Phrase: "significantly different from control,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1705242:Different [Qualitative Concept]

Phrase: "P < 0.001."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.84: In contrast, plasma insulin levels were not significantly different from control with NPY or with NPY analogs that selectively stimulate Y2, Y4, or Y5 receptor subtypes (Fig. 1B). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "plasma insulin levels"
Meta Candidates (Total=15; Excluded=5; Pruned=0; Remaining=10)
   966   C1276042:Plasma insulin level [Laboratory Procedure]
   901   C0202098:insulin levels [Laboratory Procedure]
   901   C0428405:insulin levels [Laboratory or Test Result]
   901   C0857690:plasma insulin [Laboratory Procedure]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0032105:Plasma [Body Substance]
   827   C0441889:Levels [Qualitative Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "were"

Phrase: "not significantly different from control"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1705242:Different [Qualitative Concept]

Phrase: "with NPY"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
  1000   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   861   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "or with NPY analogs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   806   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   760   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   760   C0243071:analogs [Chemical Viewed Structurally]

Phrase: "that selectively"

Phrase: "stimulate"

Phrase: "Y2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1532188:Y2 [Quantitative Concept]

Phrase: "Y4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418858:Y4 [Gene or Genome]
  1000   C1419591:Y4 [Gene or Genome]

Phrase: "or"

Phrase: "Y5 receptor subtypes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0449560:subtypes [Classification]
   734   C3642156:Y5 Receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.85: View larger version (27K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(27K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.86: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.87: Fifteen minutes after treatments, effects of intracerebroventricular (icv) injection of saline, and 1 nmol of neuropeptide Y (NPY), Y1 (D-Arg25 NPY), Y2 (C2-NPY), Y4 (rat pancreatic polypeptide, or rPP), and Y5 (cPP NPY) agonists on food intake (A) and plasma levels of insulin (B), glucagon (C), and glucose (D) were determined. 

Phrase: "Fifteen minutes after treatments,"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   861   C0001758:After-Treatments [Health Care Activity]
   812   C0087111:Treatments [Therapeutic or Preventive Procedure]
   779 E C0039798:treatment [Functional Concept]
   779 E C1522326:Treatment [Functional Concept]
   779 E C1533734:Treatment [Therapeutic or Preventive Procedure]
   779 E C1705169:Treatment [Conceptual Entity]
   779 E C3538994:TREATMENT [Research Activity]

Phrase: "effects of intracerebroventricular"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1280500:effects [Qualitative Concept]
   756 E C2348382:Effect [Qualitative Concept]

Phrase: "(icv"

Phrase: ")"

Phrase: "injection of saline,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0021485:injection [Therapeutic or Preventive Procedure]
   790   C1272883:Injection [Biomedical or Dental Material]
   790   C1533685:Injection [Therapeutic or Preventive Procedure]
   790   C1828121:Injection [Functional Concept]

Phrase: "and"

Phrase: "1 nmol of neuropeptide Y"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439191:NMOLE [Quantitative Concept]

Phrase: "(NPY"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
  1000   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   861   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: ")"

Phrase: ","

Phrase: "Y1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419589:Y1 [Gene or Genome]

Phrase: "("

Phrase: "D-"

Phrase: "Arg25 NPY"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   901   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   827   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: ")"

Phrase: ","

Phrase: "Y2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1532188:Y2 [Quantitative Concept]

Phrase: "(C2-NPY"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   901   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   827   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: ")"

Phrase: ","

Phrase: "Y4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418858:Y4 [Gene or Genome]
  1000   C1419591:Y4 [Gene or Genome]

Phrase: "(rat pancreatic polypeptide,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0030298:Pancreatic Polypeptide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   901   C1418856:pancreatic polypeptide [Gene or Genome]
   827   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   827   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: "or rPP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0030298:Pancreatic Polypeptide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   861   C1418856:pancreatic polypeptide [Gene or Genome]
   812   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   812   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "Y5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419595:Y5 [Gene or Genome]

Phrase: "(cPP NPY"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   901   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   827   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: ")"

Phrase: "agonists on food intake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0243192:agonists [Pharmacologic Substance]
   770   C2987634:agonists [Pharmacologic Substance]

Phrase: "(A)"

Phrase: "and"

Phrase: "plasma levels of insulin"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   856   C1276042:Plasma insulin level [Laboratory Procedure]
   819   C0202098:insulin levels [Laboratory Procedure]
   819   C0428405:insulin levels [Laboratory or Test Result]
   819   C0857690:plasma insulin [Laboratory Procedure]
   770   C0032105:Plasma [Body Substance]
   770   C0441889:Levels [Qualitative Concept]
   770   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "glucagon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(C),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "("

Phrase: "D)"

Phrase: "were"

Phrase: "determined."
Processing 00000000.tx.88: Filled bars, data in the presence of food; 

Phrase: "Filled bars,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: "data in the presence of food"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1511726:Data [Idea or Concept]
   753   C3245479:data [Medical Device]

Phrase: ";"
Processing 00000000.tx.89: open bars, data in the absence of food. 

Phrase: "open bars,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: "data in the absence of food."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1511726:Data [Idea or Concept]
   753   C3245479:data [Medical Device]
Processing 00000000.tx.90: Values are means  SE. 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "means  SE."
Processing 00000000.tx.91: Nos. of rats/group are shown inside bars. 

Phrase: "Nos."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518425:{NOS} [Qualitative Concept]

Phrase: "of rats/group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "are"

Phrase: "shown inside bars."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1707156:BARS [Gene or Genome]
   790   C3274014:BARS [Intellectual Product]
   790   C3541345:BARS [Intellectual Product]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.92: *P < 0.001, combined Y1 treatment effects vs. saline control groups with and without food, by nonparametric Kruskal-Wallis and Dunn's multiple comparison tests.  

Phrase: "*P < 0.001,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "combined Y1 treatment effects"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   875   C0009429:combined treatment [Therapeutic or Preventive Procedure]
   875   C1704537:Combined Treatment [Therapeutic or Preventive Procedure]
   827   C1518681:Treatment Effect [Finding]
   812   C0039798:treatment [Functional Concept]
   812   C0087111:Treatment [Therapeutic or Preventive Procedure]
   812   C1280500:effects [Qualitative Concept]
   812   C1522326:Treatment [Functional Concept]
   812   C1533734:Treatment [Therapeutic or Preventive Procedure]
   812   C1705169:Treatment [Conceptual Entity]
   812   C3538994:TREATMENT [Research Activity]
   779 E C2348382:Effect [Qualitative Concept]

Phrase: "vs. saline control groups with"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   806   C0009932:Control Groups [Group]
   760   C0036082:Saline [Substance]
   760   C0243148:control [Qualitative Concept]
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1550141:Control [Substance]
   760   C1552516:Group [Health Care Related Organization]
   760   C1552839:groups [Idea or Concept]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "and without food,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0016452:Food [Food]
   790   C1515981:And [Idea or Concept]

Phrase: "by nonparametric Kruskal-Wallis"

Phrase: "and"

Phrase: "Dunn's multiple comparison tests."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0022885:Tests [Laboratory Procedure]
   812   C0392366:Tests [Intellectual Product]
   779 E C0039593:Test [Functional Concept]
Processing 00000000.tx.93: One hour after icv infusion of saline vs. 

Phrase: "One hour after icv infusion of saline"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0439227:Hour [Temporal Concept]
   748   C0564385:/hour [Quantitative Concept]

Phrase: "vs."
Processing 00000000.tx.94: 1 nmol of NPY or NPY analogs. 

Phrase: "1 nmol of NPY"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439191:NMOLE [Quantitative Concept]

Phrase: "or"

Phrase: "NPY analogs."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0243071:analogs [Chemical Viewed Structurally]
   734   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   734   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   721 E C0679213:analogies [Idea or Concept]
Processing 00000000.tx.95: Central administration of 1 nmol of NPY, the Y1-selective agonist (D-Arg25 NPY), or the Y5-selective agonists (cPP NPY) produced an increase in food intake that was significantly greater than the saline control group 1 h postinfusion (Fig. 

Phrase: "Central administration of 1 nmol of NPY,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0001554:Administration [Occupational Activity]
   744   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "the Y1-selective agonist"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2987634:Agonist [Pharmacologic Substance]

Phrase: "("

Phrase: "D-"

Phrase: "Arg25 NPY"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   901   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   827   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "the Y5-selective agonists"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0243192:agonists [Pharmacologic Substance]
   827   C2987634:agonists [Pharmacologic Substance]

Phrase: "(cPP NPY"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   901   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   827   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: ")"

Phrase: "produced"

Phrase: "an increase in food intake"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "that"

Phrase: "was"

Phrase: "significantly greater than the saline control group 1 h postinfusion"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0439093:Greater Than [Quantitative Concept]
   739   C0443228:greater [Quantitative Concept]
   739   C1704243:Greater [Quantitative Concept]
   706 E C0549177:Great [Quantitative Concept]

Phrase: "(Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.96: 2A; 

Phrase: "2A"

Phrase: ";"
Processing 00000000.tx.97: Kruskal-Wallis and Dunn's multiple comparison tests, NPY: P < 0.001, Y1: P < 0.05, Y5: P < 0.01). 

Phrase: "Kruskal-Wallis"

Phrase: "and"

Phrase: "Dunn's multiple comparison tests,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0022885:Tests [Laboratory Procedure]
   812   C0392366:Tests [Intellectual Product]
   779 E C0039593:Test [Functional Concept]

Phrase: "NPY"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
  1000   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   861   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: ":"

Phrase: "P < 0.001,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "Y1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419589:Y1 [Gene or Genome]

Phrase: ":"

Phrase: "P < 0.05,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "Y5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419595:Y5 [Gene or Genome]

Phrase: ":"

Phrase: "P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.98: In the presence of food, icv infusion of NPY, Y1, or Y5 agonists resulted in elevated levels of plasma insulin that were significantly higher than the level of saline control animals [Fig. 

Phrase: "In the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of food,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016452:Food [Food]

Phrase: "icv infusion of NPY,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0574032:Infusion [Therapeutic or Preventive Procedure]
   760   C1827465:Infusion [Functional Concept]

Phrase: "Y1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419589:Y1 [Gene or Genome]

Phrase: "or"

Phrase: "Y5 agonists"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243192:agonists [Pharmacologic Substance]
   861   C2987634:agonists [Pharmacologic Substance]

Phrase: "resulted in elevated levels of plasma insulin"
Meta Candidates (Total=20; Excluded=3; Pruned=0; Remaining=17)
   804   C1855518:Elevated plasma insulin [Finding]
   788   C1276042:Plasma insulin level [Laboratory Procedure]
   778   C0428405:Insulin level result [Laboratory or Test Result]
           insulin levels
   778   C0857690:plasma insulin [Laboratory Procedure]
   774   C0202098:insulin levels [Laboratory Procedure]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0032105:Plasma [Body Substance]
   748   C0205250:Elevated [Qualitative Concept]
   748   C0441889:Levels [Qualitative Concept]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   748   C3163633:Elevated [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714 E C1547707:Level [Geographic Area]
   714   C2825142:Result [Finding]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "that"

Phrase: "were"

Phrase: "significantly higher than the level of saline control animals"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C0684068:higher animals [Animal]
   708   C0205250:High [Qualitative Concept]
   708   C1299351:High [Qualitative Concept]
   708   C2700149:HIGH [Intellectual Product]

Phrase: "[Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.99: 2B; 

Phrase: "2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450354:2b [Intellectual Product]
  1000   C1706096:2B [Research Activity]

Phrase: ";"
Processing 00000000.tx.100: two-way ANOVA, F(11,103) = 14.0, P < 0.001; 

Phrase: "two-way ANOVA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1710497:Two-way ANOVA [Quantitative Concept]
   827   C0205448:Two [Quantitative Concept]

Phrase: "F(11,103"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]

Phrase: ")"

Phrase: "= 14.0,"

Phrase: "P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.101: Kruskal-Wallis and Dunn's multiple comparison tests, NPY: P < 0.01, Y1: P < 0.01, Y5: P < 0.01]. 

Phrase: "Kruskal-Wallis"

Phrase: "and"

Phrase: "Dunn's multiple comparison tests,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0022885:Tests [Laboratory Procedure]
   812   C0392366:Tests [Intellectual Product]
   779 E C0039593:Test [Functional Concept]

Phrase: "NPY"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
  1000   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   861   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: ":"

Phrase: "P < 0.01,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "Y1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419589:Y1 [Gene or Genome]

Phrase: ":"

Phrase: "P < 0.01,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "Y5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419595:Y5 [Gene or Genome]

Phrase: ":"

Phrase: "P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "]."
Processing 00000000.tx.102: In the absence of food after icv infusion, only the selective Y1 agonist produced increased plasma insulin levels (Fig. 

Phrase: "In the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of food"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016452:Food [Food]

Phrase: "after icv infusion,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0574032:Infusion [Therapeutic or Preventive Procedure]
   861   C1827465:Infusion [Functional Concept]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "the selective Y1 agonist"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2987634:Agonist [Pharmacologic Substance]

Phrase: "produced"

Phrase: "increased plasma insulin levels"
Meta Candidates (Total=17; Excluded=5; Pruned=0; Remaining=12)
   906   C1295675:Increased insulin level [Finding]
   890   C1276042:Plasma insulin level [Laboratory Procedure]
   875   C0020459:increased insulin [Disease or Syndrome]
   861   C0202098:insulin levels [Laboratory Procedure]
   861   C0428405:insulin levels [Laboratory or Test Result]
   861   C0857690:plasma insulin [Laboratory Procedure]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0032105:Plasma [Body Substance]
   812   C0441889:Levels [Qualitative Concept]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.103: 2B, Kruskal-Wallis and Dunn's multiple comparison tests, Y1: P < 0.01). 

Phrase: "2B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450354:2b [Intellectual Product]
  1000   C1706096:2B [Research Activity]

Phrase: "Kruskal-Wallis"

Phrase: "and"

Phrase: "Dunn's multiple comparison tests,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0022885:Tests [Laboratory Procedure]
   812   C0392366:Tests [Intellectual Product]
   779 E C0039593:Test [Functional Concept]

Phrase: "Y1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419589:Y1 [Gene or Genome]

Phrase: ":"

Phrase: "P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.104: Moreover, plasma insulin levels induced by icv NPY, Y1, and Y5 agonists in animals with food were significantly higher than those in rats without food (Student's t-test, P < 0.05; Fig. 2B). 

Phrase: "Moreover,"

Phrase: "plasma insulin levels"
Meta Candidates (Total=15; Excluded=5; Pruned=0; Remaining=10)
   966   C1276042:Plasma insulin level [Laboratory Procedure]
   901   C0202098:insulin levels [Laboratory Procedure]
   901   C0428405:insulin levels [Laboratory or Test Result]
   901   C0857690:plasma insulin [Laboratory Procedure]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0032105:Plasma [Body Substance]
   827   C0441889:Levels [Qualitative Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "induced by icv NPY,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   806   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   760   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   760   C0205263:Induced [Functional Concept]

Phrase: "Y1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419589:Y1 [Gene or Genome]

Phrase: "and"

Phrase: "Y5 agonists in animals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0243192:agonists [Pharmacologic Substance]
   770   C2987634:agonists [Pharmacologic Substance]

Phrase: "with food"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016452:Food [Food]

Phrase: "were"

Phrase: "significantly higher than those"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0205250:High [Qualitative Concept]
   737   C1299351:High [Qualitative Concept]
   737   C2700149:HIGH [Intellectual Product]

Phrase: "in rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "without food"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016452:Food [Food]

Phrase: "(Student's t-test,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0022885:Test [Laboratory Procedure]
   827   C0038492:student [Professional or Occupational Group]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]
   827   C1551041:student [Idea or Concept]
   827   C1552573:student [Intellectual Product]

Phrase: "P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "; Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.105: View larger version (28K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(28K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.106: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.107: Sixty minutes after treatments, effects of icv injection of saline, and of 1 nmol of NPY, Y1 (D-Arg25 NPY), Y2 (C2-NPY), Y4 (rPP), and Y5 (cPP NPY) agonists on food intake (A) and plasma levels of insulin (B) and glucagon (C) were determined. 

Phrase: "Sixty minutes after treatments,"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   861   C0001758:After-Treatments [Health Care Activity]
   812   C0087111:Treatments [Therapeutic or Preventive Procedure]
   779 E C0039798:treatment [Functional Concept]
   779 E C1522326:Treatment [Functional Concept]
   779 E C1533734:Treatment [Therapeutic or Preventive Procedure]
   779 E C1705169:Treatment [Conceptual Entity]
   779 E C3538994:TREATMENT [Research Activity]

Phrase: "effects of icv injection of saline,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "and of 1 nmol of NPY,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   778   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   748   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   748   C0439191:NMOLE [Quantitative Concept]
   748   C1515981:And [Idea or Concept]

Phrase: "Y1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419589:Y1 [Gene or Genome]

Phrase: "("

Phrase: "D-"

Phrase: "Arg25 NPY"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   901   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   827   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: ")"

Phrase: ","

Phrase: "Y2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1532188:Y2 [Quantitative Concept]

Phrase: "(C2-NPY"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   901   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   827   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: ")"

Phrase: ","

Phrase: "Y4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418858:Y4 [Gene or Genome]
  1000   C1419591:Y4 [Gene or Genome]

Phrase: "(rPP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0030298:Pancreatic Polypeptide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   901   C1418856:pancreatic polypeptide [Gene or Genome]
   827   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   827   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "Y5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419595:Y5 [Gene or Genome]

Phrase: "(cPP NPY"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   901   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   827   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: ")"

Phrase: "agonists on food intake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0243192:agonists [Pharmacologic Substance]
   770   C2987634:agonists [Pharmacologic Substance]

Phrase: "(A)"

Phrase: "and"

Phrase: "plasma levels of insulin"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   856   C1276042:Plasma insulin level [Laboratory Procedure]
   819   C0202098:insulin levels [Laboratory Procedure]
   819   C0428405:insulin levels [Laboratory or Test Result]
   819   C0857690:plasma insulin [Laboratory Procedure]
   770   C0032105:Plasma [Body Substance]
   770   C0441889:Levels [Qualitative Concept]
   770   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "(B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "glucagon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "were"

Phrase: "determined."
Processing 00000000.tx.108: With a different group of rats, plasma glucose (D) levels were also measured. 

Phrase: "With a different group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "of rats,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "plasma glucose"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0202042:Plasma glucose [Laboratory Procedure]
  1000   C0455280:plasma glucose [Laboratory or Test Result]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0032105:Plasma [Body Substance]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "("

Phrase: "D)"

Phrase: "levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "also"

Phrase: "measured."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.109: Values are means  SE; 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "means  SE"

Phrase: ";"
Processing 00000000.tx.110: nos. of rats/group are shown inside bars. 

Phrase: "nos."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518425:{NOS} [Qualitative Concept]

Phrase: "of rats/group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "are"

Phrase: "shown inside bars."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1707156:BARS [Gene or Genome]
   790   C3274014:BARS [Intellectual Product]
   790   C3541345:BARS [Intellectual Product]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.111: *P < 0.05 vs. saline with food, #P < 0.05 vs. saline without food, +P < 0.05 vs. with food of same peptide treatment.  

Phrase: "*P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs. saline with food,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0036082:Saline [Substance]

Phrase: "#P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs. saline without food,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0036082:Saline [Substance]

Phrase: "+P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs."

Phrase: "with food"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016452:Food [Food]

Phrase: "of same peptide treatment."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.112: Plasma glucagon levels in Y2 agonist-treated rats were significantly lower than the level in the saline group with or without food 1 h postinfusion [Fig. 2C; two-way ANOVA, F(11,103) = 4.34, P < 0.001; Kruskal-Wallis and Dunn's multiple comparison tests, with food, P < 0.01; without food, P < 0.05]. 

Phrase: "Plasma glucagon levels in Y2 agonist-treated rats"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   789   C1278023:Plasma glucagon level [Laboratory Procedure]
   754   C0337437:Glucagon level [Laboratory Procedure]
   744   C0441889:Levels [Qualitative Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "significantly lower than the level"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0441994:Lower [Spatial Concept]
   760   C1548802:Lower [Body Location or Region]
   760   C2003888:Lower [Activity]

Phrase: "in the saline group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "with"

Phrase: "or without food 1 h postinfusion"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C0700308:h 1 [Element, Ion, or Isotope]
   753   C0016452:Food [Food]
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441932:H+ [Classification]
   753   C0564385:/h [Quantitative Concept]

Phrase: "[Fig. 2C"

Phrase: "; two-way ANOVA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1710497:Two-way ANOVA [Quantitative Concept]
   827   C0205448:Two [Quantitative Concept]

Phrase: "F(11,103"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]

Phrase: ")"

Phrase: "= 4.34,"

Phrase: "P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "; Kruskal-Wallis"

Phrase: "and"

Phrase: "Dunn's multiple comparison tests,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0022885:Tests [Laboratory Procedure]
   812   C0392366:Tests [Intellectual Product]
   779 E C0039593:Test [Functional Concept]

Phrase: "with food,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016452:Food [Food]

Phrase: "P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"

Phrase: "without food,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016452:Food [Food]

Phrase: "P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "]."
Processing 00000000.tx.113: However, plasma glucagon levels of all other treatments were not significantly different from control. 

Phrase: "However,"

Phrase: "plasma glucagon levels of all"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   851   C1278023:Plasma glucagon level [Laboratory Procedure]
   790   C0337437:Glucagon level [Laboratory Procedure]
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "other treatments"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0087111:Treatments [Therapeutic or Preventive Procedure]
   966 E C0039798:treatment [Functional Concept]
   966 E C1522326:Treatment [Functional Concept]
   966 E C1533734:Treatment [Therapeutic or Preventive Procedure]
   966 E C1705169:Treatment [Conceptual Entity]
   966 E C3538994:TREATMENT [Research Activity]

Phrase: "were"

Phrase: "not significantly different from control."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1705242:Different [Qualitative Concept]
Processing 00000000.tx.114: In a different group of rats, plasma glucose levels were measured 1 h after icv infusion of these peptides. 

Phrase: "In a different group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "of rats,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "plasma glucose levels"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   966   C0455280:plasma glucose level [Laboratory or Test Result]
           plasma glucose
   901   C0202042:Plasma glucose [Laboratory Procedure]
   901   C0428548:glucose levels [Laboratory or Test Result]
   867 E C0337438:glucose level [Laboratory Procedure]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0032105:Plasma [Body Substance]
   827   C0441889:Levels [Qualitative Concept]
   827   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "1 h after icv infusion of these peptides."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0700308:1 H [Element, Ion, or Isotope]
   744   C0033727:H+ [Element, Ion, or Isotope]
   744   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0441932:H+ [Classification]
   744   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.115: We did not observe any significant change of plasma glucose levels 1 h after icv infusion (Fig. 2D). 

Phrase: "We"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observe"

Phrase: "any significant change of plasma glucose levels 1 h"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0392747:Change [Functional Concept]
   742   C0443172:change [Quantitative Concept]
   742   C1705241:Change [Quantitative Concept]

Phrase: "after icv infusion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0574032:Infusion [Therapeutic or Preventive Procedure]
   861   C1827465:Infusion [Functional Concept]

Phrase: "(Fig. 2D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1705052:2D [Spatial Concept]
   861   C2986796:2D [Functional Concept]

Phrase: ")."
Processing 00000000.tx.116: Two hours after icv infusion of saline vs. 

Phrase: "Two hours after icv infusion of saline"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0439227:hours [Temporal Concept]
   714 E C0564385:/hour [Quantitative Concept]

Phrase: "vs."
Processing 00000000.tx.117: 1 nmol of NPY or NPY analogs. 

Phrase: "1 nmol of NPY"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439191:NMOLE [Quantitative Concept]

Phrase: "or"

Phrase: "NPY analogs."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0243071:analogs [Chemical Viewed Structurally]
   734   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   734   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   721 E C0679213:analogies [Idea or Concept]
Processing 00000000.tx.118: Rats given NPY, the Y1 agonist (D-Arg25 NPY), or the Y5 agonist (D-Trp34 NPY) consumed significantly more food than the saline control group 2 h after icv infusion [one-way ANOVA, F(5,30) = 11.7, P < 0.0001, with Dunnett's multiple comparisons posttests, NPY: P < 0.01, Y1: P < 0.01, Y5: P < 0.05; 

Phrase: "Rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "NPY,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
  1000   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   861   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "the Y1 agonist"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2987634:Agonist [Pharmacologic Substance]

Phrase: "("

Phrase: "D-"

Phrase: "Arg25 NPY"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   901   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   827   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "the Y5 agonist"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2987634:Agonist [Pharmacologic Substance]

Phrase: "("

Phrase: "D-"

Phrase: "Trp34 NPY"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   901   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   827   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: ")"

Phrase: "consumed"

Phrase: "significantly more food than the saline control group 2 h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0016452:Food [Food]

Phrase: "after icv infusion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0574032:Infusion [Therapeutic or Preventive Procedure]
   861   C1827465:Infusion [Functional Concept]

Phrase: "[one-way ANOVA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709320:One-way ANOVA [Quantitative Concept]

Phrase: "F(5,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "30"

Phrase: ")"

Phrase: "= 11.7,"

Phrase: "P < 0.0001,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "with Dunnett's multiple comparisons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1707455:Comparison [Activity]

Phrase: "posttests"

Phrase: ","

Phrase: "NPY"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
  1000   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   861   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: ":"

Phrase: "P < 0.01,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "Y1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419589:Y1 [Gene or Genome]

Phrase: ":"

Phrase: "P < 0.01,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "Y5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419595:Y5 [Gene or Genome]

Phrase: ":"

Phrase: "P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.119: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.120: 3A]. 

Phrase: "3A"

Phrase: "]."
Processing 00000000.tx.121: However, only NPY and the Y1-selective agonist (D-Arg25 NPY) induced a significant increase in plasma insulin levels 2 h postinfusion compared with the saline control group with food [Fig. 

Phrase: "However,"

Phrase: "only NPY"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   901   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   827   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "and"

Phrase: "the Y1-selective agonist"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2987634:Agonist [Pharmacologic Substance]

Phrase: "("

Phrase: "D-"

Phrase: "Arg25 NPY"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   901   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   827   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: ")"

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "a significant increase in plasma insulin levels 2 h postinfusion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0020459:INSULIN INCREASE [Disease or Syndrome]
   739   C0442805:Increase [Functional Concept]

Phrase: "compared with the saline control group"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   790   C0009932:Control Group [Group]
   753   C0036082:Saline [Substance]
   753   C0243148:control [Qualitative Concept]
   753   C0441833:Group [Idea or Concept]
   753   C0687744:group [Population Group]
   753   C1257890:Group [Population Group]
   753   C1550141:Control [Substance]
   753   C1552516:Group [Health Care Related Organization]
   753   C1705428:Group [Conceptual Entity]
   753   C1705429:Group [Population Group]
   753   C1707455:Compared [Activity]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]

Phrase: "with food"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016452:Food [Food]

Phrase: "[Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.122: 3B; 

Phrase: "3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450365:3b [Intellectual Product]
  1000   C1706097:3B [Research Activity]

Phrase: ";"
Processing 00000000.tx.123: two-way ANOVA, F(11,59) = 5.18, P < 0.0001; 

Phrase: "two-way ANOVA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1710497:Two-way ANOVA [Quantitative Concept]
   827   C0205448:Two [Quantitative Concept]

Phrase: "F(11,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "59"

Phrase: ")"

Phrase: "= 5.18,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439084:>5 [Quantitative Concept]
   861   C0728893:+5 [Quantitative Concept]

Phrase: "P < 0.0001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.124: Kruskal-Wallis and Dunn's multiple comparison tests with food, NPY: P < 0.01; 

Phrase: "Kruskal-Wallis"

Phrase: "and"

Phrase: "Dunn's multiple comparison"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1707455:Comparison [Activity]

Phrase: "tests with food,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0016452:Food [Food]
   790   C0022885:Test [Laboratory Procedure]
   790   C0039593:Test [Functional Concept]
   790   C0392366:Tests [Intellectual Product]

Phrase: "NPY"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
  1000   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   861   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: ":"

Phrase: "P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.125: Y1: P < 0.05]. 

Phrase: "Y1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419589:Y1 [Gene or Genome]

Phrase: ":"

Phrase: "P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "]."
Processing 00000000.tx.126: In the absence of food, the plasma levels of insulin remained the same across all groups (Fig. 3B). 

Phrase: "In the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of food,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016452:Food [Food]

Phrase: "the plasma levels of insulin"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   824   C1276042:Plasma insulin level [Laboratory Procedure]
   797   C0202098:insulin levels [Laboratory Procedure]
   797   C0428405:insulin levels [Laboratory or Test Result]
   797   C0857690:plasma insulin [Laboratory Procedure]
   760   C0032105:Plasma [Body Substance]
   760   C0441889:Levels [Qualitative Concept]
   760   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "remained"

Phrase: "the same across all groups"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0445247:Same [Qualitative Concept]

Phrase: "(Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.127: In the presence of food, the plasma insulin levels were significantly higher than without food 2 h after NPY or Y1 agonist infusions (Kruskal-Wallis and Dunn's multiple comparison tests with food, NPY: P < 0.01; 

Phrase: "In the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of food,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016452:Food [Food]

Phrase: "the plasma insulin levels"
Meta Candidates (Total=15; Excluded=5; Pruned=0; Remaining=10)
   966   C1276042:Plasma insulin level [Laboratory Procedure]
   901   C0202098:insulin levels [Laboratory Procedure]
   901   C0428405:insulin levels [Laboratory or Test Result]
   901   C0857690:plasma insulin [Laboratory Procedure]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0032105:Plasma [Body Substance]
   827   C0441889:Levels [Qualitative Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "were"

Phrase: "significantly higher than"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   756   C0205250:High [Qualitative Concept]
   756   C1299351:High [Qualitative Concept]
   756   C2700149:HIGH [Intellectual Product]
   706 E C0489786:Height [Organism Attribute]

Phrase: "without food 2 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "after NPY"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
  1000   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   861   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "or"

Phrase: "Y1 agonist infusions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0574032:infusions [Therapeutic or Preventive Procedure]
   793 E C1827465:Infusion [Functional Concept]

Phrase: "(Kruskal-Wallis"

Phrase: "and"

Phrase: "Dunn's multiple comparison"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1707455:Comparison [Activity]

Phrase: "tests with food,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0016452:Food [Food]
   790   C0022885:Test [Laboratory Procedure]
   790   C0039593:Test [Functional Concept]
   790   C0392366:Tests [Intellectual Product]

Phrase: "NPY"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
  1000   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   861   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: ":"

Phrase: "P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.128: Y1: P < 0.01, Fig. 

Phrase: "Y1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419589:Y1 [Gene or Genome]

Phrase: ":"

Phrase: "P < 0.01,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.129: 3B). 

Phrase: "3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450365:3b [Intellectual Product]
  1000   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.130: View larger version (28K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(28K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.131: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.132: Two hours after treatments, effects of icv injection of saline, and of 1 nmol of NPY, Y1 (D-Arg25 NPY), Y2 (C2-NPY), Y4 (rPP), and Y5 (D-Trp34 NPY) agonists on food intake (A) and plasma levels of insulin (B), glucagon (C), and glucose (D) were measured. 

Phrase: "Two hours after treatments,"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   861   C0001758:After-Treatments [Health Care Activity]
   812   C0087111:Treatments [Therapeutic or Preventive Procedure]
   779 E C0039798:treatment [Functional Concept]
   779 E C1522326:Treatment [Functional Concept]
   779 E C1533734:Treatment [Therapeutic or Preventive Procedure]
   779 E C1705169:Treatment [Conceptual Entity]
   779 E C3538994:TREATMENT [Research Activity]

Phrase: "effects of icv injection of saline,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "and of 1 nmol of NPY,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   778   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   748   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   748   C0439191:NMOLE [Quantitative Concept]
   748   C1515981:And [Idea or Concept]

Phrase: "Y1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419589:Y1 [Gene or Genome]

Phrase: "("

Phrase: "D-"

Phrase: "Arg25 NPY"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   901   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   827   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: ")"

Phrase: ","

Phrase: "Y2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1532188:Y2 [Quantitative Concept]

Phrase: "(C2-NPY"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   901   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   827   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: ")"

Phrase: ","

Phrase: "Y4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418858:Y4 [Gene or Genome]
  1000   C1419591:Y4 [Gene or Genome]

Phrase: "(rPP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0030298:Pancreatic Polypeptide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   901   C1418856:pancreatic polypeptide [Gene or Genome]
   827   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   827   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "Y5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419595:Y5 [Gene or Genome]

Phrase: "("

Phrase: "D-"

Phrase: "Trp34 NPY"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   901   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   827   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: ")"

Phrase: "agonists on food intake"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0243192:agonists [Pharmacologic Substance]
   770   C2987634:agonists [Pharmacologic Substance]

Phrase: "(A)"

Phrase: "and"

Phrase: "plasma levels of insulin"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   856   C1276042:Plasma insulin level [Laboratory Procedure]
   819   C0202098:insulin levels [Laboratory Procedure]
   819   C0428405:insulin levels [Laboratory or Test Result]
   819   C0857690:plasma insulin [Laboratory Procedure]
   770   C0032105:Plasma [Body Substance]
   770   C0441889:Levels [Qualitative Concept]
   770   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "glucagon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(C),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "("

Phrase: "D)"

Phrase: "were"

Phrase: "measured."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.133: Values are means  SE; 

Phrase: "Values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "means  SE"

Phrase: ";"
Processing 00000000.tx.134: nos. of rats are shown inside bars. 

Phrase: "nos."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518425:{NOS} [Qualitative Concept]

Phrase: "of rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "are"

Phrase: "shown inside bars."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1707156:BARS [Gene or Genome]
   790   C3274014:BARS [Intellectual Product]
   790   C3541345:BARS [Intellectual Product]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.135: *P < 0.05 vs. saline with food, +P < 0.05 vs. with food of same peptide treatment.  

Phrase: "*P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs. saline with food,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0036082:Saline [Substance]

Phrase: "+P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "vs."

Phrase: "with food"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016452:Food [Food]

Phrase: "of same peptide treatment."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.136: Plasma glucagon levels in NPY-treated groups were significantly increased in the presence of food [two-way ANOVA, F(11,59) = 3.82, P < 0.001; 

Phrase: "Plasma glucagon levels in NPY-treated groups"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   789   C1278023:Plasma glucagon level [Laboratory Procedure]
   754   C0337437:Glucagon level [Laboratory Procedure]
   744   C0441889:Levels [Qualitative Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "significantly"

Phrase: "increased in the presence of food"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0680145:presence of food [Finding]
   753   C0016452:Food [Food]
   753   C0205217:Increased [Quantitative Concept]
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
   753   C0442805:Increased [Functional Concept]

Phrase: "[two-way ANOVA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1710497:Two-way ANOVA [Quantitative Concept]
   827   C0205448:Two [Quantitative Concept]

Phrase: "F(11,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "59"

Phrase: ")"

Phrase: "= 3.82,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439086:<3 [Quantitative Concept]
   861   C2827736:3+ [Quantitative Concept]
   861   C2981702:3+ [Classification]

Phrase: "P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.137: Kruskal-Wallis and Dunn's multiple comparison tests with food, NPY: P < 0.05, Fig. 

Phrase: "Kruskal-Wallis"

Phrase: "and"

Phrase: "Dunn's multiple comparison"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1707455:Comparison [Activity]

Phrase: "tests with food,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0016452:Food [Food]
   790   C0022885:Test [Laboratory Procedure]
   790   C0039593:Test [Functional Concept]
   790   C0392366:Tests [Intellectual Product]

Phrase: "NPY"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
  1000   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   861   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: ":"

Phrase: "P < 0.05,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.138: 3C]. 

Phrase: "3C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450366:3c [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.139: In addition, there was a significant difference in NPY-induced plasma glucagon levels in the presence and absence of food (ANOVA with Student's t-test, P < 0.05, Fig. 3C). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "there"

Phrase: "was"

Phrase: "a significant difference in NPY-induced plasma glucagon levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1705241:*Difference [Quantitative Concept]
   739   C1705242:Difference [Qualitative Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "absence of food"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0680146:absence of food [Finding]
   790   C0332197:absence [Quantitative Concept]
   790   C1689985:Absence [Anatomical Abnormality]
   718 E C2699517:ABSENT [Finding]

Phrase: "(ANOVA with Student's t-test,"

Phrase: "P < 0.05,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "Fig. 3C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450366:3c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.140: Two hours after icv infusion of the Y1 or Y2 agonist, plasma glucose levels were significantly decreased compared with control group in the presence of food [two-way ANOVA, F(11,59) = 2.74, P < 0.01; with Dunnett's multiple comparisons posttests, P < 0.05, Fig. 3D].  

Phrase: "Two hours after icv infusion of the Y1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0439227:hours [Temporal Concept]
   711 E C0564385:/hour [Quantitative Concept]

Phrase: "or"

Phrase: "Y2 agonist,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2987634:Agonist [Pharmacologic Substance]

Phrase: "plasma glucose levels"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   966   C0455280:plasma glucose level [Laboratory or Test Result]
           plasma glucose
   901   C0202042:Plasma glucose [Laboratory Procedure]
   901   C0428548:glucose levels [Laboratory or Test Result]
   867 E C0337438:glucose level [Laboratory Procedure]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0032105:Plasma [Body Substance]
   827   C0441889:Levels [Qualitative Concept]
   827   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "significantly"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "compared with control group"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   833   C0009932:Control Group [Group]
   770   C0243148:control [Qualitative Concept]
   770   C0441833:Group [Idea or Concept]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1550141:Control [Substance]
   770   C1552516:Group [Health Care Related Organization]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]
   770   C1707455:Compared [Activity]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of food"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016452:Food [Food]

Phrase: "[two-way ANOVA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1710497:Two-way ANOVA [Quantitative Concept]
   827   C0205448:Two [Quantitative Concept]

Phrase: "F(11,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "59"

Phrase: ")"

Phrase: "= 2.74,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"

Phrase: "with Dunnett's multiple comparisons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1707455:Comparison [Activity]

Phrase: "posttests"

Phrase: ","

Phrase: "P < 0.05,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "Fig. 3D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450363:3D [Spatial Concept]
   861   C2986797:3D [Functional Concept]

Phrase: "]."
Processing 00000000.tx.141: DISCUSSION TOP ABSTRACT METHODS RESULTS DISCUSSION REFERENCES  NPY is an important regulator of energy balance in mammals through its orexigenic, antithermogenic, and hyperinsulinemic actions. 

Phrase: "DISCUSSION TOP ABSTRACT METHODS RESULTS DISCUSSION"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "NPY"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
  1000   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   861   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "is"

Phrase: "an important regulator of energy balance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0182953:REGULATOR [Medical Device]
   753   C1704734:Regulator [Medical Device]
   753   C1704735:Regulator [Conceptual Entity]

Phrase: "in mammals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024660:Mammals [Mammal]

Phrase: "through its orexigenic, antithermogenic,"

Phrase: "and"

Phrase: "hyperinsulinemic actions."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441472:actions [Functional Concept]
   827 E C3266814:Action [Activity]
Processing 00000000.tx.142: The present study is the first to delineate the central NPY receptor subtype(s) involved in the regulation of plasma insulin, glucagon, and glucose levels by the use of selective NPY Y1, Y2, Y4, or Y5 receptor agonists. 

Phrase: "The present study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "is"

Phrase: "the first to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205435:First [Quantitative Concept]
   861   C1279901:First [Qualitative Concept]

Phrase: "delineate"

Phrase: "the central NPY receptor subtype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0449560:Subtype [Classification]
   717   C0068624:Neuropeptide Y Receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "("

Phrase: "s)"

Phrase: "involved in the regulation of plasma insulin,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0857690:plasma insulin [Laboratory Procedure]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0032105:Plasma [Body Substance]
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1314939:Involved [Functional Concept]
   748   C1327622:Regulation [Biologic Function]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   748   C1579433:Insulin [Pharmacologic Substance]

Phrase: "glucagon,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "glucose levels by the use of selective NPY Y1,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   760   C0428548:glucose levels [Laboratory or Test Result]
   739   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   739   C0441889:Levels [Qualitative Concept]
   726 E C0337438:glucose level [Laboratory Procedure]
   706 E C0456079:Level [Classification]
   706 E C1547707:Level [Geographic Area]
   706 E C2946261:Level [Pharmacologic Substance]

Phrase: "Y2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1532188:Y2 [Quantitative Concept]

Phrase: "Y4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418858:Y4 [Gene or Genome]
  1000   C1419591:Y4 [Gene or Genome]

Phrase: "or"

Phrase: "Y5 receptor agonists."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0243192:agonists [Pharmacologic Substance]
   827   C2987634:agonists [Pharmacologic Substance]
   734   C3642156:Y5 Receptor [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.143: Our data demonstrate that a selective Y1 agonist, D-Arg25 NPY, induced a significant elevation of plasma insulin levels in satiated rats at all time points measured. 

Phrase: "Our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "demonstrate"

Phrase: "that"

Phrase: "a selective Y1 agonist,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2987634:Agonist [Pharmacologic Substance]

Phrase: "D-"

Phrase: "Arg25 NPY,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   901   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   827   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "a significant elevation of plasma insulin levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0439775:Elevation [Therapeutic or Preventive Procedure]
   748   C0702240:Elevation [Spatial Concept]

Phrase: "in satiated rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]

Phrase: "at all time points"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   966   C2348792:Time Point [Temporal Concept]
   861   C0040223:Time [Temporal Concept]
   861   C3541383:Time [Temporal Concept]
   827   C1552961:Point [Quantitative Concept]
   827   C2347617:point [Quantitative Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "measured."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.144: D-Arg25 NPY also significantly raised plasma insulin levels in the absence of food 1 h after icv infusion, suggesting that Y1-induced hyperinsulinemia does not completely depend on the ingestion of food. 

Phrase: "D-"

Phrase: "Arg25 NPY also significantly raised plasma insulin levels in the absence"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   753   C0202098:insulin levels [Laboratory Procedure]
   753   C0428405:insulin levels [Laboratory or Test Result]
   753   C0857690:plasma insulin [Laboratory Procedure]
   737   C1276042:Plasma insulin level [Laboratory Procedure]
   736   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   736   C0032105:Plasma [Body Substance]
   736   C0441889:Levels [Qualitative Concept]
   736   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   736   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   736   C1579433:Insulin [Pharmacologic Substance]
   703 E C0456079:Level [Classification]
   703 E C1547707:Level [Geographic Area]
   703 E C2946261:Level [Pharmacologic Substance]

Phrase: "of food 1 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "after icv infusion,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0574032:Infusion [Therapeutic or Preventive Procedure]
   861   C1827465:Infusion [Functional Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that Y1-induced hyperinsulinemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0020459:Hyperinsulinaemia [Disease or Syndrome]

Phrase: "does"

Phrase: "not completely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205197:Completely [Qualitative Concept]
   861   C1518422:Not [Functional Concept]

Phrase: "depend on the ingestion of food."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0016452:Food [Food]
   753   C0232478:Ingestion [Biologic Function]
   753   C0725813:depend [Medical Device]
Processing 00000000.tx.145: The Y1-induced hyperinsulinemia may contribute to the significantly reduced plasma glucose levels at 2 h after icv infusion with or without food. 

Phrase: "The Y1-induced hyperinsulinemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0020459:Hyperinsulinaemia [Disease or Syndrome]

Phrase: "may"

Phrase: "contribute to the significantly reduced plasma glucose levels at 2 h"
Meta Candidates (Total=20; Excluded=4; Pruned=0; Remaining=16)
   772   C0455280:glucose levels plasma [Laboratory or Test Result]
           plasma glucose
   756   C0202042:Plasma glucose [Laboratory Procedure]
   756   C0428548:glucose levels [Laboratory or Test Result]
   754   C0011744:h 2 [Element, Ion, or Isotope]
   738   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   738   C0032105:Plasma [Body Substance]
   738   C0033727:H+ [Element, Ion, or Isotope]
   738   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   738   C0392756:Reduced [Qualitative Concept]
   738   C0441889:Levels [Qualitative Concept]
   738   C0441932:H+ [Classification]
   738   C0564385:/h [Quantitative Concept]
   738   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   738   C1880177:Contribute [Activity]
   737   C0456948:Level 2 [Intellectual Product]
   722 E C0337438:glucose level [Laboratory Procedure]
   704 E C0456079:Level [Classification]
   704 E C1547707:Level [Geographic Area]
   704 E C2946261:Level [Pharmacologic Substance]

Phrase: "after icv infusion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0574032:Infusion [Therapeutic or Preventive Procedure]
   861   C1827465:Infusion [Functional Concept]

Phrase: "with"

Phrase: "or without food."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0016452:Food [Food]
Processing 00000000.tx.146: In contrast, a selective Y5 agonist only increased plasma insulin levels in the presence of food 1 h after icv infusion. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "a selective Y5 agonist only increased plasma insulin levels in the presence"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   753   C0202098:insulin levels [Laboratory Procedure]
   753   C0428405:insulin levels [Laboratory or Test Result]
   753   C0857690:plasma insulin [Laboratory Procedure]
   751   C0020459:increased insulin [Disease or Syndrome]
   751   C1295675:Increased insulin level [Finding]
   737   C1276042:Plasma insulin level [Laboratory Procedure]
   736   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   736   C0032105:Plasma [Body Substance]
   736   C0441889:Levels [Qualitative Concept]
   736   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   736   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   736   C1579433:Insulin [Pharmacologic Substance]
   703 E C0456079:Level [Classification]
   703 E C1547707:Level [Geographic Area]
   703 E C2946261:Level [Pharmacologic Substance]

Phrase: "of food 1 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "after icv infusion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0574032:Infusion [Therapeutic or Preventive Procedure]
   861   C1827465:Infusion [Functional Concept]
Processing 00000000.tx.147: The Y5-induced hyperinsulinemia was significantly reduced in the absence of food, indicating that Y5-induced hyperinsulinemia was secondary to the ingestion of food. 

Phrase: "The Y5-induced hyperinsulinemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0020459:Hyperinsulinaemia [Disease or Syndrome]

Phrase: "was"

Phrase: "significantly"

Phrase: "reduced in the absence of food,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0680146:absence of food [Finding]
   753   C0016452:Food [Food]
   753   C0332197:absence [Quantitative Concept]
   753   C0392756:Reduced [Qualitative Concept]
   753   C1689985:Absence [Anatomical Abnormality]

Phrase: "indicating"

Phrase: "that Y5-induced hyperinsulinemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0020459:Hyperinsulinaemia [Disease or Syndrome]

Phrase: "was"

Phrase: "secondary to the ingestion of food."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0175668:Secondary to [Temporal Concept]
           Secondary
   753   C0027627:secondary [Neoplastic Process]
   753   C0205436:Secondary [Quantitative Concept]
Processing 00000000.tx.148: In addition, our data confirm our previous finding that the selective Y2 agonist C2-NPY and the selective Y4 agonist rPP do not elicit feeding behavior during the nadir of the light cycle. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "our previous finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037088:Finding [Sign or Symptom]
   861   C0243095:Finding [Finding]
   861   C2825141:Finding [Finding]

Phrase: "that"

Phrase: "the selective Y2 agonist C2-NPY"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   827   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   799   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "and"

Phrase: "the selective Y4 agonist rPP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0030298:Pancreatic Polypeptide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   827   C1418856:pancreatic polypeptide [Gene or Genome]
   799   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   799   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "elicit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449265:elicit [Qualitative Concept]

Phrase: "feeding behavior during the nadir of the light cycle."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C0015745:Feeding Behavior [Individual Behavior]
   742   C0004927:Behavior [Individual Behavior]
   742   C2707008:Behavior [Clinical Attribute]
Processing 00000000.tx.149: Furthermore, central administration of the selective Y2 agonist significantly reduced plasma glucagon levels with or without food at 1 h postinfusion and decreased plasma glucose levels 2 h postinfusion without food, whereas the Y4 agonist does not have a significant effect on plasma insulin, glucagon, or glucose levels. 

Phrase: "Furthermore,"

Phrase: "central administration of the selective Y2 agonist significantly reduced plasma glucagon levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C0001554:Administration [Occupational Activity]
   736   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "with"

Phrase: "or without food at 1 h postinfusion"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C0700308:h 1 [Element, Ion, or Isotope]
   748   C0016452:Food [Food]
   748   C0033727:H+ [Element, Ion, or Isotope]
   748   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0441932:H+ [Classification]
   748   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "decreased plasma glucose levels 2 h postinfusion without food,"

Phrase: "whereas"

Phrase: "the Y4 agonist"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2987634:Agonist [Pharmacologic Substance]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "have"

Phrase: "a significant effect on plasma insulin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "glucagon,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "or"

Phrase: "glucose levels."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0428548:glucose levels [Laboratory or Test Result]
   966 E C0337438:glucose level [Laboratory Procedure]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.150: Pancreatic insulin and glucagon secretion is a tightly regulated process that maintains energy fuel homeostasis. 

Phrase: "Pancreatic insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "glucagon secretion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2610739:glucagon secretion [Cell Function]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]

Phrase: "is"

Phrase: "a tightly regulated process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1184743:Process [Body Part, Organ, or Organ Component]
   827   C1522240:Process [Phenomenon or Process]

Phrase: "that"

Phrase: "maintains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024501:Maintain [Activity]

Phrase: "energy fuel homeostasis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C3157043:energy homeostasis [Biologic Function]
   827   C0019868:Homeostasis [Biologic Function]
Processing 00000000.tx.151: In addition to the close control of blood glucose levels, the secretion of insulin is in part regulated by the vagus nerve. 

Phrase: "In addition to the close control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "of blood glucose levels,"
Meta Candidates (Total=19; Excluded=11; Pruned=0; Remaining=8)
  1000   C0428554:blood glucose levels [Laboratory or Test Result]
   901   C0005802:Blood Glucose [Carbohydrate]
   901   C0428548:glucose levels [Laboratory or Test Result]
   867 E C0337438:glucose level [Laboratory Procedure]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0229664:Blood [Body Substance]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "the secretion of insulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C1256369:insulin secretion [Cell Function]
   770   C0036536:secretion [Biologic Function]
   770   C0036537:Secretion [Body Substance]

Phrase: "is in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "regulated by the vagus nerve."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0042276:Vagus Nerve [Body Part, Organ, or Organ Component]
           Vagus
   760   C0027740:Nerve [Tissue]
   760   C0027757:NERVE [Tissue]
   760   C0851285:Regulated [Governmental or Regulatory Activity]
   760   C1280541:Nerve [Body Part, Organ, or Organ Component]
   704 E C0599851:Neural [Functional Concept]
Processing 00000000.tx.152: Activation of the parasympathetic nervous system can stimulate the secretion of insulin (22, 44) and enhance the insulin secretory response to glucose (37). 

Phrase: "Activation of the parasympathetic nervous system"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1879547:Activation [Activity]

Phrase: "can"

Phrase: "stimulate"

Phrase: "the secretion of insulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C1256369:insulin secretion [Cell Function]
   770   C0036536:secretion [Biologic Function]
   770   C0036537:Secretion [Body Substance]

Phrase: "(22,"

Phrase: "44"

Phrase: ")"

Phrase: "and"

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "the insulin secretory response to glucose"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0871261:Response [Organism Attribute]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]

Phrase: "(37"

Phrase: ")."
Processing 00000000.tx.153: It has been suggested that central administration of NPY may act directly on the nucleus of solitary tract, which may mediate the direct link to the pancreas via a vagal pathway to enhance insulin secretion (10). 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that central administration of NPY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0001554:Administration [Occupational Activity]
   753   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "may"

Phrase: "act"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "directly on the nucleus of solitary tract,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   861   C0175518:Nucleus of the Solitary Tract [Body Part, Organ, or Organ Component]
           Nucleus of solitary tract
           Solitary Tract Nucleus
           Solitary Nucleus
   778   C0175559:Solitary tract [Body Part, Organ, or Organ Component]
   748   C0007610:Nucleus [Cell Component]
   748   C0205171:Solitary [Quantitative Concept]
   748   C1185740:Tract [Body Part, Organ, or Organ Component]
   748   C1947931:Directly [Qualitative Concept]

Phrase: "which"

Phrase: "may"

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "the direct link to the pancreas"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1517892:Link [Intellectual Product]
   753   C1704666:Link [Intellectual Product]

Phrase: "via a vagal pathway to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1704259:Pathway [Molecular Function]
   827   C1705987:Pathway [Conceptual Entity]

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.154: It has been demonstrated that the muscarinic receptor antagonist atropine or vagotomy can block icv NPY-induced insulin release or gastropancreatic secretion, which may be considered as a cephalic phase of secretion (11, 43). 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "demonstrated"

Phrase: "that"

Phrase: "the muscarinic receptor antagonist atropine"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0004259:Atropine [Organic Chemical,Pharmacologic Substance]
   812   C1161352:atropine [Pharmacologic Substance]
   708   C0003385:Muscarinic Antagonist [Pharmacologic Substance]
   708   C3536931:Muscarinic Antagonist [Pharmacologic Substance]

Phrase: "or"

Phrase: "vagotomy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0394374:Vagotomy [Therapeutic or Preventive Procedure]

Phrase: "can"

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "icv NPY-induced insulin release"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0030685:Release [Health Care Activity]
   799   C0391871:Release [Functional Concept]
   799   C0439180:% release [Quantitative Concept]
   799   C0680255:release [Health Care Activity]
   799   C1283071:Release [Functional Concept]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   799   C1963578:Release [Therapeutic or Preventive Procedure]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "or"

Phrase: "gastropancreatic secretion,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]

Phrase: "which"

Phrase: "may"

Phrase: "be"

Phrase: "considered as a cephalic phase of secretion"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0036536:secretion [Biologic Function]
   748   C0036537:Secretion [Body Substance]
   748   C0205096:Cephalic [Spatial Concept]
   748   C0205390:Phase [Temporal Concept]
   748   C0750591:considered [Idea or Concept]

Phrase: "(11,"

Phrase: "43"

Phrase: ")."
Processing 00000000.tx.155: High densities of Y1, Y2, and Y4 NPY receptor subtypes have been reported within the dorsal vagal complex, including nucleus of the solitary tract and dorsal motor nucleus of vagus (3, 18, 21). 

Phrase: "High densities of Y1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0178587:densities [Quantitative Concept]

Phrase: "Y2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1532188:Y2 [Quantitative Concept]

Phrase: "and"

Phrase: "Y4 NPY receptor subtypes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0449560:subtypes [Classification]
   717   C0068624:Neuropeptide Y Receptor [Amino Acid, Peptide, or Protein,Receptor]
   708   C0668788:Y4 receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "have"

Phrase: "been"

Phrase: "reported within the dorsal vagal complex,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0205095:Dorsal [Spatial Concept]
   753   C0439855:Complex [Qualitative Concept]
   753   C0684224:Reported [Intellectual Product]
   753   C0700287:Reported [Health Care Activity]
   753   C1704241:Complex [Chemical Viewed Structurally]
   753   C3496591:Reported [Clinical Attribute]
   719 E C3273238:Report [Intellectual Product]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "nucleus of the solitary tract"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0175518:Nucleus of the Solitary Tract [Body Part, Organ, or Organ Component]
           Nucleus of solitary tract
           Solitary Tract Nucleus
           Solitary Nucleus
   760   C0007610:Nucleus [Cell Component]

Phrase: "and"

Phrase: "dorsal motor nucleus of vagus"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   862   C0596458:Dorsal Motor Nucleus [Body Part, Organ, or Organ Component]
   797   C0228767:Vagus nucleus [Body Part, Organ, or Organ Component]
   760   C0007610:Nucleus [Cell Component]
   760   C0205095:Dorsal [Spatial Concept]
   760   C1513492:Motor [Functional Concept]
   760   C1705994:Motor [Manufactured Object]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "18,"

Phrase: "21"

Phrase: ")."
Processing 00000000.tx.156: Recent studies have also indicated that Y1 receptors in the dorsal vagal complex may be involved in NPY-induced bile secretion as well as peptide YY-induced gastric acid secretion (45, 46). 

Phrase: "Recent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "also"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that Y1 receptors in the dorsal vagal complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   750   C1523873:receptor complex [Cell Component]
   744   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "may"

Phrase: "be"

Phrase: "involved in NPY-induced bile secretion"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   778   C0232754:Bile secretion [Organ or Tissue Function]
   778   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   748   C0005388:Bile [Body Substance]
   748   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   748   C0036536:secretion [Biologic Function]
   748   C0036537:Secretion [Body Substance]
   748   C0205263:Induced [Functional Concept]
   748   C1314939:Involved [Functional Concept]

Phrase: "as well as"

Phrase: "peptide YY-induced gastric acid secretion"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   895   C1819802:peptide secretion [Cell Function]
   861   C0232552:Gastric acid secretion [Organ or Tissue Function]
   861   C2984576:Gastric acid secretion [Functional Concept]
   839   C0017133:Gastric Secretion [Body Substance]
   839   C0232539:Gastric secretion [Organ or Tissue Function]
   827   C0017119:Gastric Acid [Body Substance]
   827   C1160577:acid secretion [Cell Function]
   799   C0001128:Acid [Chemical]
   799   C0036536:secretion [Biologic Function]
   799   C0036537:Secretion [Body Substance]
   799   C0038351:Gastric [Body Part, Organ, or Organ Component]
   799   C0202406:Acid [Laboratory Procedure]
   799   C1704242:Gastric [Qualitative Concept]

Phrase: "(45,"

Phrase: "46"

Phrase: ")."
Processing 00000000.tx.157: Our data suggest that selective activation of the Y1 receptor, but not Y2, Y4, or Y5 receptors, significantly elevated plasma insulin levels independent of food ingestion. 

Phrase: "Our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that selective activation of the Y1 receptor,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1514758:Receptor Activation [Cell Function]
   748   C1879547:Activation [Activity]

Phrase: "but"

Phrase: "not Y2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532188:Y2 [Quantitative Concept]

Phrase: "Y4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418858:Y4 [Gene or Genome]
  1000   C1419591:Y4 [Gene or Genome]

Phrase: "or"

Phrase: "Y5 receptors,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C3642156:Y5 Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "significantly elevated plasma insulin levels independent of food ingestion."
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   790   C1855518:Elevated plasma insulin [Finding]
   764   C0202098:insulin levels [Laboratory Procedure]
   764   C0428405:insulin levels [Laboratory or Test Result]
   764   C0857690:plasma insulin [Laboratory Procedure]
   756   C1276042:Plasma insulin level [Laboratory Procedure]
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0032105:Plasma [Body Substance]
   742   C0441889:Levels [Qualitative Concept]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   742   C1579433:Insulin [Pharmacologic Substance]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.158: Because we administered these peptides by lateral ventricle icv infusion, these peptides may have multiple sites of action in the brain. 

Phrase: "Because"

Phrase: "we"

Phrase: "administered"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521801:Administered [Functional Concept]
   966 E C1621583:Administer [Functional Concept]

Phrase: "these peptides by lateral ventricle icv infusion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "these peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "may"

Phrase: "have"

Phrase: "multiple sites of action"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   819   C0581718:action sites [Intellectual Product]
   816   C2945843:Site of [Qualitative Concept]
   770   C0205145:Sites [Spatial Concept]
   737 E C1515974:Site [Body Location or Region]
   737 E C2825164:Site [Spatial Concept]

Phrase: "in the brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.159: Therefore, additional studies including fourth ventricle or site-specific injection of NPY or a Y1 selective peptide will be necessary to provide further insight into the role of NPY and the Y1 receptor on insulin response. 

Phrase: "Therefore,"

Phrase: "additional studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "fourth ventricle"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0149556:Fourth Ventricle [Body Space or Junction]
  1000   C1278832:Fourth ventricle [Body Space or Junction]
   861   C0018827:Ventricle [Body Part, Organ, or Organ Component]
   861   C0205438:Fourth [Quantitative Concept]
   861   C1706303:Fourth [Qualitative Concept]
   861   C2355627:Ventricle [Body Part, Organ, or Organ Component]
   789 E C1522565:Ventricular [Spatial Concept]
   761 E C0038351:Ventriculus [Body Part, Organ, or Organ Component]

Phrase: "or"

Phrase: "site-specific injection of NPY"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C0221208:Injection site [Injury or Poisoning]
   783   C2700396:Injection site [Spatial Concept]
   753   C0021485:injection [Therapeutic or Preventive Procedure]
   753   C1272883:Injection [Biomedical or Dental Material]
   753   C1533685:Injection [Therapeutic or Preventive Procedure]
   753   C1828121:Injection [Functional Concept]

Phrase: "or"

Phrase: "a Y1 selective peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "will"

Phrase: "be"

Phrase: "necessary to"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "further insight into the role of NPY"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0233820:Insight [Mental Process]

Phrase: "and"

Phrase: "the Y1 receptor on insulin response."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0034818:Insulin Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   783   C1334133:INSULIN RECEPTOR [Gene or Genome]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.160: Alternatively, NPY-induced hyperinsulinemia may be partly caused by decreasing insulin clearance. 

Phrase: "Alternatively,"

Phrase: "NPY-induced hyperinsulinemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0020459:Hyperinsulinaemia [Disease or Syndrome]

Phrase: "may"

Phrase: "be"

Phrase: "partly"

Phrase: "caused by decreasing insulin clearance."
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0442797:Decreasing [Qualitative Concept]
   760   C0449297:Clearance [Qualitative Concept]
   760   C1382187:Clearance [Clinical Attribute]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C2825073:Clearance [Natural Phenomenon or Process]
   726   C0015127:cause [Functional Concept]
   726 E C0392756:Decrease [Qualitative Concept]
   726 E C0547047:Decrease [Quantitative Concept]
   726   C1524003:Cause [Conceptual Entity]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.161: Obesity and high levels of free fatty acids can reduce insulin clearance by lowering hepatic insulin extraction and inhibiting insulin-degradating enzyme (13, 36, 41). 

Phrase: "Obesity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0028754:Obesity [Disease or Syndrome]
  1000   C1963185:Obesity [Finding]

Phrase: "and"

Phrase: "high levels of free fatty acids"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   787   C1281901:Fatty acid level [Laboratory Procedure]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "can"

Phrase: "reduce"

Phrase: "insulin clearance by lowering hepatic insulin extraction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0449297:Clearance [Qualitative Concept]
   748   C1382187:Clearance [Clinical Attribute]
   748   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "inhibiting insulin-degradating enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "(13,"

Phrase: "36,"

Phrase: "41"

Phrase: ")."
Processing 00000000.tx.162: Chronic central infusion of NPY can induce an obesity syndrome, which includes hyperphagia, hyperinsulinemia, hypertriglyceridemia, hypercorticosteronemia, and weight gain in rodents (33). 

Phrase: "Chronic central infusion of NPY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0574032:Infusion [Therapeutic or Preventive Procedure]
   753   C1827465:Infusion [Functional Concept]

Phrase: "can"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "an obesity syndrome,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039082:Syndrome [Disease or Syndrome]

Phrase: "which"

Phrase: "includes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:Includes [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "hyperphagia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020505:Hyperphagia [Mental or Behavioral Dysfunction]

Phrase: "hyperinsulinemia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020459:Hyperinsulinaemia [Disease or Syndrome]

Phrase: "hypertriglyceridemia,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020557:Hypertriglyceridaemia [Finding]
  1000   C1522137:Hypertriglyceridemia [Finding]

Phrase: "hypercorticosteronemia,"

Phrase: "and"

Phrase: "weight gain in rodents"
Meta Candidates (Total=15; Excluded=8; Pruned=0; Remaining=7)
   833   C0043094:Weight Gain [Finding]
   833   C2911647:Weight gain [Finding]
   791 E C0231246:weight gaining [Sign or Symptom]
   770   C0005910:weight [Organism Attribute]
   770   C0043100:Weight [Quantitative Concept]
   770   C1305866:weight [Diagnostic Procedure]
   770   C1517378:Gain [Quantitative Concept]
   770   C1705104:Weight [Idea or Concept]
   715 E C0205217:Increased [Quantitative Concept]
   715 E C0439661:Acquired [Temporal Concept]
   715 E C0442805:Increase [Functional Concept]
   715 E C0442808:Increasing [Functional Concept]
   715 E C1301820:Obtain [Functional Concept]
   715 E C1706701:Acquire [Activity]
   715 E C3245488:acquired [Intellectual Product]

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.163: It is known that the proportions of insulin, proinsulin, and conversion intermediates in plasma and pancreas are not affected by chronic central infusion of NPY (33). 

Phrase: "It"

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "that"

Phrase: "the proportions of insulin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1709707:Proportion [Quantitative Concept]

Phrase: "proinsulin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "conversion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439836:Conversion [Functional Concept]

Phrase: "intermediates in plasma"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0032105:Plasma [Body Substance]
   790   C0205103:Intermediate [Spatial Concept]
   790   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   790   C1550465:intermediate [Idea or Concept]
   790   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "and"

Phrase: "pancreas"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030274:Pancreas [Body Part, Organ, or Organ Component]
  1000   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affected by chronic central infusion of NPY"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   770   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   770   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   744   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   744   C0205099:Central [Spatial Concept]
   744   C0205191:chronic [Temporal Concept]
   744   C0392760:Affected [Functional Concept]
   744   C0574032:Infusion [Therapeutic or Preventive Procedure]
   744   C1314939:Affected [Functional Concept]
   744   C1827465:Infusion [Functional Concept]
   744   C1879652:Central - [Laboratory Procedure]
   711 E C0001721:Affect [Mental Process]

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.164: It is not clear whether acute icv infusion of NPY or its analogs may have any effect on insulin clearance. 

Phrase: "It"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "whether"

Phrase: "acute icv infusion of NPY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0574032:Infusion [Therapeutic or Preventive Procedure]
   753   C1827465:Infusion [Functional Concept]

Phrase: "or"

Phrase: "its analogs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0243071:analogs [Chemical Viewed Structurally]
   893 E C0679213:analogies [Idea or Concept]

Phrase: "may"

Phrase: "have"

Phrase: "any effect on insulin clearance."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.165: Hyperinsulinemia induced by central administration of NPY in rats can be prevented by adrenalectomy, a surgery that eliminates glucocorticoid production in the adrenal gland. 

Phrase: "Hyperinsulinemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020459:Hyperinsulinaemia [Disease or Syndrome]

Phrase: "induced by central administration of NPY"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   778   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   748   C0001554:Administration [Occupational Activity]
   748   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   748   C0205099:Central [Spatial Concept]
   748   C0205263:Induced [Functional Concept]
   748   C1533734:Administration [Therapeutic or Preventive Procedure]
   748   C1879652:Central - [Laboratory Procedure]

Phrase: "in rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "can"

Phrase: "be"

Phrase: "prevented by adrenalectomy,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0001632:Adrenalectomy [Therapeutic or Preventive Procedure]
   756   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "a surgery"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0038894:Surgery [Biomedical Occupation or Discipline]
  1000   C0038895:surgery [Functional Concept]
  1000   C0543467:Surgery [Health Care Activity]

Phrase: "that"

Phrase: "eliminates"

Phrase: "glucocorticoid production in the adrenal gland."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033268:production [Occupational Activity]
Processing 00000000.tx.166: This effect was associated with a concommitant reduction in Y1 and Y5 receptor mRNA expression in the ventral medial hypothalamus (43). 

Phrase: "This effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "associated with a concommitant reduction"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0301630:Reduction [Natural Phenomenon or Process]
   760   C0392756:Reduction [Qualitative Concept]
   760   C0441610:Reduction [Therapeutic or Preventive Procedure]
   760   C0521115:Concomitant [Temporal Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in Y1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419589:Y1 [Gene or Genome]

Phrase: "and"

Phrase: "Y5 receptor mRNA expression in the ventral medial hypothalamus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C1515670:mRNA Expression [Genetic Function]
   762   C0597360:receptor expression [Genetic Function]
   742   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(43"

Phrase: ")."
Processing 00000000.tx.167: Glucocorticoids may have a direct effect in controlling insulin release via NPY-regulated pathways, since the Y1 receptor gene is known to have a putative glucocorticoid response element (2). 

Phrase: "Glucocorticoids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017710:Glucocorticoids [Hormone,Steroid]

Phrase: "may"

Phrase: "have"

Phrase: "a direct effect in controlling insulin release"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "via NPY-regulated pathways,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1704259:Pathways [Molecular Function]
   812   C1705987:Pathways [Conceptual Entity]

Phrase: "since"

Phrase: "the Y1 receptor gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1335671:Receptor Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "a putative glucocorticoid response element"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0013879:Element [Element, Ion, or Isotope]
   812   C0017710:Glucocorticoid [Hormone,Steroid]
   812   C0871261:Response [Organism Attribute]
   812   C1704632:Response [Finding]
   812   C1705248:Element [Conceptual Entity]
   812   C1706817:Response [Intellectual Product]
   812   C2911692:Response [Mental Process]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.168: In addition to the centrally mediated hyperinsulinemic effect of NPY, it has been known that NPY regulates insulin secretion by a peripheral mechanism. 

Phrase: "In addition to the centrally"

Phrase: "mediated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086597:mediated [Social Behavior]
  1000   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: "hyperinsulinemic effect of NPY,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "that NPY"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
  1000   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   861   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "regulates"

Phrase: "insulin secretion by a peripheral mechanism."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1256369:insulin secretion [Cell Function]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0036536:secretion [Biologic Function]
   753   C0036537:Secretion [Body Substance]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
Processing 00000000.tx.169: NPY can inhibit insulin secretion when given intravenously or when applied directly to isolated pancreatic islets (31, 40). 

Phrase: "NPY"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
  1000   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   861   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "can"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "when"

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "intravenously"

Phrase: "or"

Phrase: "when"

Phrase: "applied"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0185125:Applied [Health Care Activity]
   966 E C1632850:Apply [Functional Concept]
   966 E C1879355:Apply [Functional Concept]

Phrase: "directly to isolated pancreatic islets"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   760   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   760   C0205409:Isolated [Functional Concept]
   760   C1548221:Isolated [Idea or Concept]
   760   C1947931:Directly [Qualitative Concept]

Phrase: "(31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.170: Expression of the Y1 receptor, but not the Y5 receptor, has been detected in Langerhans islet cells (27). 

Phrase: "Expression of the Y1 receptor,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0597360:receptor expression [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the Y5 receptor,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C3642156:Y5 Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "has"

Phrase: "been"

Phrase: "detected in Langerhans islet cells"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   806   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
           islet langerhans
   797   C0023005:Langerhans Cells [Cell]
   773 E C1522529:Islet Cell [Cell]
   760   C0007634:Cells [Cell]
   760   C0442726:Detected [Finding]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.171: The Y1 receptor antagonist BIBP3226 has been shown to block NPY-induced inhibition of insulin secretion via a Gi-mediated inhibition of adenyl cyclase in RIN 5AH rat insulinoma cells (27). 

Phrase: "The Y1 receptor antagonist BIBP3226"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0296215:BIBP3226 [Organic Chemical,Pharmacologic Substance]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "NPY-induced inhibition of insulin secretion"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   853   C2250323:inhibition of insulin secretion [Cell Function]
   804   C2259158:inhibition of secretion [Cell Function]
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "via a Gi-mediated inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0021467:Inhibition [Mental Process]
   827   C0021469:Inhibition [Molecular Function]
   827   C1628982:% inhibition [Quantitative Concept]
   827   C3463820:Inhibition [Activity]
   755 E C0311403:Inhibited [Qualitative Concept]

Phrase: "of adenyl cyclase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001492:Adenyl Cyclase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "in RIN 5AH rat insulinoma cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   804   C0007634:Cells [Cell]
   804   C0021670:insulinoma [Neoplastic Process]
   804   C0034693:Rat, NOS [Mammal]
   804   C0034721:Rat [Mammal]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.172: The divergent central vs. peripheral effects of NPY on insulin secretion suggest that the passage of exogenous NPY to venous blood via its bulk flow in cerebrospinal fluid through the arachnoid villi could mask icv NPY-induced insulin secretion (17, 34). 

Phrase: "The divergent central"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205099:Central [Spatial Concept]
   861   C1879652:Central - [Laboratory Procedure]

Phrase: "vs. peripheral effects of NPY"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "on insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the passage of exogenous NPY"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439799:Passage [Spatial Concept]

Phrase: "to venous blood"
Meta Candidates (Total=15; Excluded=7; Pruned=0; Remaining=8)
  1000   C0229667:Venous blood [Tissue]
  1000   C1550615:Venous Blood [Body Substance]
  1000   C2338243:Venous blood [Tissue]
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0042449:Venous [Body Part, Organ, or Organ Component]
   861   C0229664:Blood [Body Substance]
   861   C0348013:Venous [Spatial Concept]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "via its bulk flow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0806140:Flow [Natural Phenomenon or Process]

Phrase: "in cerebrospinal fluid"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0007806:Cerebrospinal Fluid [Body Substance]
  1000   C0007807:cerebrospinal fluid [Functional Concept]
   861   C0005889:FLUID [Body Substance]
   861   C0302908:fluid [Substance]
   861   C0444611:Fluid [Qualitative Concept]
   861   C1704353:Fluid [Substance]

Phrase: "through the arachnoid villi"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0228130:Arachnoid villi [Body Part, Organ, or Organ Component]
   861   C0003707:Arachnoid [Body Part, Organ, or Organ Component]
   827   C0227266:Villus [Body Part, Organ, or Organ Component]
   827   C1519988:Villus [Body Part, Organ, or Organ Component]

Phrase: "could"

Phrase: "mask"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024861:Mask [Medical Device]
  1000   C1538279:MASK [Gene or Genome]
  1000   C1845191:MASK [Gene or Genome]

Phrase: "icv NPY-induced insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   827   C1256369:insulin secretion [Cell Function]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0036536:secretion [Biologic Function]
   799   C0036537:Secretion [Body Substance]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(17,"

Phrase: "34"

Phrase: ")."
Processing 00000000.tx.173: The elevated insulin levels and glucose turnover rate in fasting NPY Y1-deficient mice also confirm the tonic role of the peripheral Y1 receptor in plasma insulin regulation (6). 

Phrase: "The elevated insulin levels"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   901   C0202098:insulin levels [Laboratory Procedure]
   901   C0428405:insulin levels [Laboratory or Test Result]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0441889:Levels [Qualitative Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "glucose turnover rate in fasting NPY Y1-deficient mice also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0871208:Rate [Activity]
   738   C1521828:Rate [Quantitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "the tonic role of the peripheral Y1 receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "in plasma insulin regulation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0851285:Regulation [Governmental or Regulatory Activity]
   827   C1327622:Regulation [Biologic Function]
   734   C0857690:plasma insulin [Laboratory Procedure]

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.174: Central administration of NPY has a number of effects on glucose metabolism. 

Phrase: "Central administration of NPY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0001554:Administration [Occupational Activity]
   760   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "has"

Phrase: "a number of effects"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "on glucose metabolism."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0596620:glucose metabolism [Molecular Function]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.175: In addition to NPY-induced hyperinsulinemia, NPY also increases hepatic glucose output (42), stimulates glucose turnover (23), and changes peripheral tissue responsiveness to insulin (48). 

Phrase: "In addition to NPY-induced hyperinsulinemia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0020459:Hyperinsulinaemia [Disease or Syndrome]

Phrase: "NPY also"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   901   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   827   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "hepatic glucose output"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0599782:glucose output [Organ or Tissue Function]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0205054:Hepatic [Body Location or Region]
   827   C1709366:Output [Conceptual Entity]

Phrase: "(42"

Phrase: ")"

Phrase: ","

Phrase: "stimulates"

Phrase: "glucose turnover"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0031227:turnover [Quantitative Concept]
   861   C0243127:turnover [Functional Concept]
   861   C0443331:Turnover [Health Care Activity]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "changes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "peripheral tissue responsiveness to insulin"

Phrase: "(48"

Phrase: ")."
Processing 00000000.tx.176: The opposing effects of increasing hepatic glucose output and stimulating glucose turnover may partly explain why we did not observe significant changes in plasma glucose levels at 15 or 60 min postinfusion. 

Phrase: "The opposing effects of increasing hepatic glucose output"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   767   C0595938:effects increasing [Pathologic Function]
   750   C1158774:glucose effect [Genetic Function]
   744   C1280500:effects [Qualitative Concept]
   711 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "stimulating glucose turnover"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0031227:turnover [Quantitative Concept]
   827   C0243127:turnover [Functional Concept]
   827   C0443331:Turnover [Health Care Activity]

Phrase: "may"

Phrase: "partly"

Phrase: "explain"

Phrase: "why"

Phrase: "we"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observe"

Phrase: "significant changes in plasma glucose levels"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0392747:changes [Functional Concept]
   753   C0443172:changes [Quantitative Concept]
   719 E C1705241:Change [Quantitative Concept]

Phrase: "at 15"

Phrase: "or"

Phrase: "60 min postinfusion."
Processing 00000000.tx.177: These data were consistent with literature reports that plasma glucose levels did not change within 90 min after acute NPY infusion in nondiabetic animals (42). 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "consistent with literature"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332290:Consistent with [Idea or Concept]
           Consistent
   718 E C0332529:Consistencies [Qualitative Concept]
   718 E C1547017:Consistency [Quantitative Concept]

Phrase: "reports"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "that plasma glucose levels"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   966   C0455280:plasma glucose level [Laboratory or Test Result]
           plasma glucose
   901   C0202042:Plasma glucose [Laboratory Procedure]
   901   C0428548:glucose levels [Laboratory or Test Result]
   867 E C0337438:glucose level [Laboratory Procedure]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0032105:Plasma [Body Substance]
   827   C0441889:Levels [Qualitative Concept]
   827   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "change within 90 min"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0392747:Change [Functional Concept]
   770   C0439083:>90 [Quantitative Concept]
   770   C0439087:<90 [Quantitative Concept]
   770   C0443172:change [Quantitative Concept]
   770   C0702093:/min [Temporal Concept]
   770   C1705241:Change [Quantitative Concept]

Phrase: "after acute NPY infusion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0574032:Infusion [Therapeutic or Preventive Procedure]
   812   C1827465:Infusion [Functional Concept]

Phrase: "in nondiabetic animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]

Phrase: "(42"

Phrase: ")."
Processing 00000000.tx.178: However, we have noticed a reduction in plasma glucose levels and an increase in plasma glucagon levels after NPY infusion at the 2-h time point. 

Phrase: "However,"

Phrase: "we"

Phrase: "have"

Phrase: "noticed"

Phrase: "a reduction in plasma glucose levels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0301630:Reduction [Natural Phenomenon or Process]
   753   C0392756:Reduction [Qualitative Concept]
   753   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "an increase in plasma glucagon levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "after NPY infusion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0574032:Infusion [Therapeutic or Preventive Procedure]
   827   C1827465:Infusion [Functional Concept]
   734   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   734   C1417815:NEUROPEPTIDE Y [Gene or Genome]

Phrase: "at the 2-h time point."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C2348792:Time Point [Temporal Concept]
   812   C0040223:Time [Temporal Concept]
   812   C1552961:Point [Quantitative Concept]
   812   C2347617:point [Quantitative Concept]
   812   C3541383:Time [Temporal Concept]
   756 E C0442043:Temporal [Spatial Concept]
   756 E C2362314:Temporal [Temporal Concept]
   729 E C1632851:Times [Quantitative Concept]
Processing 00000000.tx.179: Because one of the physiological functions of glucagon is to counter hypoglycemia, it is likely that the increase in glucagon levels was not directly induced by receptor activation but was triggered by the decrease in plasma glucose levels. 

Phrase: "Because"

Phrase: "one of the physiological functions of glucagon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205447:One [Quantitative Concept]

Phrase: "is to counter hypoglycemia,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0020615:Hypoglycaemia [Disease or Syndrome]
   770   C0677601:Counter [Manufactured Object]
   770   C1705206:Counter [Medical Device]

Phrase: "it"

Phrase: "is"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "that"

Phrase: "the increase in glucagon levels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "was"

Phrase: "not directly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1518422:Not [Functional Concept]
   861   C1947931:Directly [Qualitative Concept]

Phrase: "induced by receptor activation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1514758:Receptor Activation [Cell Function]
   770   C0205263:Induced [Functional Concept]
   770   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   770   C1879547:Activation [Activity]

Phrase: "but"

Phrase: "was"

Phrase: "triggered by the decrease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1444748:Triggered by [Qualitative Concept]
           Trigger
   770   C0392756:Decrease [Qualitative Concept]
   770   C0547047:Decrease [Quantitative Concept]
   737   C0032930:Trigger [Clinical Attribute]

Phrase: "in plasma glucose levels."
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   966   C0455280:plasma glucose level [Laboratory or Test Result]
           plasma glucose
   901   C0202042:Plasma glucose [Laboratory Procedure]
   901   C0428548:glucose levels [Laboratory or Test Result]
   867 E C0337438:glucose level [Laboratory Procedure]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0032105:Plasma [Body Substance]
   827   C0441889:Levels [Qualitative Concept]
   827   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.180: Alternatively, central infusion of NPY has been shown to increase glucagon secretion in the hyperinsulinemic euglycemic clamp, suggesting that a direct effect of icv NPY on glucagon secretion is possible (42). 

Phrase: "Alternatively,"

Phrase: "central infusion of NPY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0574032:Infusion [Therapeutic or Preventive Procedure]
   760   C1827465:Infusion [Functional Concept]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "glucagon secretion in the hyperinsulinemic euglycemic clamp,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C2610739:glucagon secretion [Cell Function]
   748   C0036536:secretion [Biologic Function]
   748   C0036537:Secretion [Body Substance]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "a direct effect of icv NPY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "on glucagon secretion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2610739:glucagon secretion [Cell Function]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "(42"

Phrase: ")."
Processing 00000000.tx.181: Although hypothalamic Y1 and Y5 receptors are both involved in icv NPY-induced hyperphagia and hyperinsulinemia, our data suggest that the mechanisms by which these receptors regulate insulin secretion may not be the same. 

Phrase: "Although"

Phrase: "hypothalamic Y1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419589:Y1 [Gene or Genome]

Phrase: "and"

Phrase: "Y5 receptors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C3642156:Y5 Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "are"

Phrase: "both"

Phrase: "involved in icv NPY-induced hyperphagia"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   778   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   748   C0020505:Hyperphagia [Mental or Behavioral Dysfunction]
   748   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   748   C0205263:Induced [Functional Concept]
   748   C1314939:Involved [Functional Concept]

Phrase: "and"

Phrase: "hyperinsulinemia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020459:Hyperinsulinaemia [Disease or Syndrome]

Phrase: "our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the mechanisms by which"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0441712:Mechanisms [Functional Concept]
   737 E C1706376:Mechanism [Manufactured Object]

Phrase: "these receptors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "regulate"

Phrase: "insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "may"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "the same."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0445247:Same [Qualitative Concept]
Processing 00000000.tx.182: Y1 agonist-induced hyperinsulinemia was not solely dependent on food intake, whereas Y5 agonist-induced hyperinsulinemia was dependent on food ingestion. 

Phrase: "Y1 agonist-induced hyperinsulinemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0020459:Hyperinsulinaemia [Disease or Syndrome]

Phrase: "was"

Phrase: "not solely dependent on food intake,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0851827:Dependent [Qualitative Concept]
   753   C1701901:Dependent [Qualitative Concept]
   753   C3244310:dependent [Functional Concept]

Phrase: "whereas"

Phrase: "Y5 agonist-induced hyperinsulinemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0020459:Hyperinsulinaemia [Disease or Syndrome]

Phrase: "was"

Phrase: "dependent on food ingestion."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0851827:Dependent [Qualitative Concept]
   770   C1701901:Dependent [Qualitative Concept]
   770   C3244310:dependent [Functional Concept]
Processing 00000000.tx.183: In addition, plasma glucose levels were significantly reduced by central infusion of the Y1 agonist, but not the Y5 agonist. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "plasma glucose levels"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   966   C0455280:plasma glucose level [Laboratory or Test Result]
           plasma glucose
   901   C0202042:Plasma glucose [Laboratory Procedure]
   901   C0428548:glucose levels [Laboratory or Test Result]
   867 E C0337438:glucose level [Laboratory Procedure]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0032105:Plasma [Body Substance]
   827   C0441889:Levels [Qualitative Concept]
   827   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "significantly"

Phrase: "reduced by central infusion of the Y1 agonist,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0205099:Central [Spatial Concept]
   744   C0392756:Reduced [Qualitative Concept]
   744   C0574032:Infusion [Therapeutic or Preventive Procedure]
   744   C1419589:Y1 [Gene or Genome]
   744   C1827465:Infusion [Functional Concept]
   744   C1879652:Central - [Laboratory Procedure]
   744   C2987634:Agonist [Pharmacologic Substance]

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the Y5 agonist."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2987634:Agonist [Pharmacologic Substance]
Processing 00000000.tx.184: In summary, central administration of NPY and its analogs could stimulate insulin release through activation of Y1 or Y5, but not Y2 or Y4, receptors. 

Phrase: "In summary,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "central administration of NPY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0001554:Administration [Occupational Activity]
   760   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "its analogs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0243071:analogs [Chemical Viewed Structurally]
   893 E C0679213:analogies [Idea or Concept]

Phrase: "could"

Phrase: "stimulate"

Phrase: "insulin release through activation of Y1"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0030685:Release [Health Care Activity]
   753   C0391871:Release [Functional Concept]
   753   C0439180:% release [Quantitative Concept]
   753   C0680255:release [Health Care Activity]
   753   C1283071:Release [Functional Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "Y5,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419595:Y5 [Gene or Genome]

Phrase: "but"

Phrase: "not Y2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532188:Y2 [Quantitative Concept]

Phrase: "or"

Phrase: "Y4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418858:Y4 [Gene or Genome]
  1000   C1419591:Y4 [Gene or Genome]

Phrase: "receptors."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.185: Our data suggest that selective activation of the central Y1 receptors can induce hyperinsulinemia independently of food, whereas the Y5-mediated hyperinsulinemia is dependent on food ingestion.  

Phrase: "Our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that selective activation of the central Y1 receptors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   750   C1514758:Receptor Activation [Cell Function]
   744   C1879547:Activation [Activity]

Phrase: "can"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "hyperinsulinemia independently of food,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0342332:Alimentary hyperinsulinaemia [Disease or Syndrome]
   770   C0020459:Hyperinsulinaemia [Disease or Syndrome]

Phrase: "whereas"

Phrase: "the Y5-mediated hyperinsulinemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0020459:Hyperinsulinaemia [Disease or Syndrome]

Phrase: "is"

Phrase: "dependent on food ingestion."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0851827:Dependent [Qualitative Concept]
   770   C1701901:Dependent [Qualitative Concept]
   770   C3244310:dependent [Functional Concept]
Processing 00000000.tx.186: FOOTNOTES  Address for reprint requests and other correspondence: J. 

Phrase: "FOOTNOTES  Address for reprint requests"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0376649:Address [Intellectual Product]
   760   C1442065:Address [Spatial Concept]

Phrase: "and"

Phrase: "other correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: ":"

Phrase: "J."
Processing 00000000.tx.187: J. 

Phrase: "J."
Processing 00000000.tx.188: Hwa, CV/Metabolic Diseases, Schering-Plough Research Institute, 2015 Galloping Hill Road, K152600, Kenilworth, NJ 07033-0530 (E-Mail: joyce.hwa{at}spcorp.com ) The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "Hwa,"

Phrase: "CV/Metabolic Diseases,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   901   C0025517:Metabolic Diseases [Disease or Syndrome]
   827   C0012634:Diseases [Disease or Syndrome]
   827   C0311400:Metabolic [Functional Concept]
   827   C1524026:Metabolic [Cell Function]
   827   C2707259:Metabolic [Clinical Attribute]
   755 E C1836721:MALS [Finding]
   755 E C3538764:MALS [Gene or Genome]
   755 E C3540595:MAL [Gene or Genome]

Phrase: "Schering-Plough Research Institute,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0035172:Research Institute [Organization]
   812   C0021622:institute [Organization]
   812   C0035168:research [Research Activity]
   812   C0242481:Research [Research Activity]
   812   C1272753:Institute [Idea or Concept]

Phrase: "2015 Galloping Hill Road,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0442650:Road [Manufactured Object]

Phrase: "K152600,"

Phrase: "Kenilworth,"

Phrase: "NJ 07033-0530"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0027971:NJ [Geographic Area]

Phrase: "(E-Mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "joyce.hwa{at}spcorp.com )"

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.189: The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. 

Phrase: "The article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18 U.S.C."
Processing 00000000.tx.190: Section 1734 solely to indicate this fact.  

Phrase: "Section 1734 solely to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0205155:Section [Spatial Concept]
   812   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   812   C1522472:Section [Substance]
   812   C1552923:Section [Quantitative Concept]
   812   C1705191:Section [Physical Object]

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.191: REFERENCES TOP ABSTRACT METHODS RESULTS DISCUSSION REFERENCES  Bai FL, Yamano M, Shiotani Y, Emson PC, Smith AD, Powell JF, and Tohyama M. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0557061:Discussion [Therapeutic or Preventive Procedure]
   804   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Bai FL,"

Phrase: "Yamano M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Shiotani Y,"

Phrase: "Emson PC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540812:PC [Gene or Genome]

Phrase: "Smith AD,"

Phrase: "Powell JF,"

Phrase: "and"

Phrase: "Tohyama M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.192: An arcuato-paraventricular and -dorsomedial hypothalamic neuropeptide Y-containing system which lacks noradrenaline in the rat. 

Phrase: "An arcuato-paraventricular"

Phrase: "and -"

Phrase: "dorsomedial hypothalamic neuropeptide Y-containing system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   799   C0449913:System [Functional Concept]
   799   C1553451:System [Manufactured Object]
   799   C1704459:System [Medical Device]
   727 E C0205373:Systemic [Functional Concept]

Phrase: "which"

Phrase: "lacks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:lack [Qualitative Concept]

Phrase: "noradrenaline in the rat."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0028351:Noradrenalin [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.193: Brain Res 331: 172175, 1985.[CrossRef][ISI][Medline] Ball HJ, Shine J, and Herzog H. 

Phrase: "Brain Res 331"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C2347379:RES [Finding]

Phrase: ":"

Phrase: "172175,"

Phrase: "1985."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ball HJ,"

Phrase: "Shine J,"

Phrase: "and"

Phrase: "Herzog H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.194: Multiple promoters regulate tissue-specific expression of the human NPY-Y1 receptor gene. 

Phrase: "Multiple promoters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086860:promoters [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "regulate"

Phrase: "tissue-specific expression of the human NPY-Y1 receptor gene."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   788   C1519516:Tissue-Specific Gene Expression [Genetic Function]
   754   C0017262:Gene Expression [Genetic Function]
   754   C0597360:receptor expression [Genetic Function]
   738   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.195: J Biol Chem 270: 2727227276, 1995.[Abstract/Free FullText] Barraco RA, Ergene E, Dunbar JC, Ganduri YL, and Anderson GF. 

Phrase: "J Biol Chem 270"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "2727227276,"

Phrase: "1995."

Phrase: "[Abstract/Free FullText"

Phrase: "] Barraco RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "Ergene E,"

Phrase: "Dunbar JC,"

Phrase: "Ganduri YL,"

Phrase: "and"

Phrase: "Anderson GF."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0016703:GF [Geographic Area]
   861   C1551081:gf [Quantitative Concept]
Processing 00000000.tx.196: Y2 receptors for neuropeptide Y in the nucleus of the solitary tract mediate depressor responses. 

Phrase: "Y2 receptors for neuropeptide Y"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   871   C1417817:NEUROPEPTIDE Y RECEPTOR Y2 [Gene or Genome]
   844   C0068624:Receptors, Neuropeptide Y [Amino Acid, Peptide, or Protein,Receptor]
   844   C0382066:neuropeptide Y2 receptors [Amino Acid, Peptide, or Protein,Receptor]
   797   C0206476:Receptors, Neuropeptide [Amino Acid, Peptide, or Protein,Receptor]
   790   C3642155:Y2 Receptor [Amino Acid, Peptide, or Protein,Receptor]
   760   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "in the nucleus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007610:Nucleus [Cell Component]

Phrase: "of the solitary tract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0175559:Solitary tract [Body Part, Organ, or Organ Component]
   861   C0205171:Solitary [Quantitative Concept]
   861   C1185740:Tract [Body Part, Organ, or Organ Component]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "depressor responses."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0871261:responses [Organism Attribute]
   827 E C1704632:Response [Finding]
   827 E C1706817:Response [Intellectual Product]
   827 E C2911692:Response [Mental Process]
Processing 00000000.tx.197: Peptides 12: 691698, 1991.[CrossRef][ISI][Medline] Billington CJ, Briggs JE, Grace M, and Levine AS. 

Phrase: "Peptides 12"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: ":"

Phrase: "691698,"

Phrase: "1991."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Billington CJ,"

Phrase: "Briggs JE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0454673:JE [Geographic Area]
   861   C1550752:JE [Temporal Concept]

Phrase: "Grace M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Levine"

Phrase: "AS."
Processing 00000000.tx.198: Effects of intracerebroventricular injection of neuropeptide Y on energy metabolism. 

Phrase: "Effects of intracerebroventricular injection of neuropeptide Y"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "on energy metabolism."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0014272:Energy Metabolism [Physiologic Function]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]
   861   C0424589:Energy [Finding]
   861   C0542479:Energy [Natural Phenomenon or Process]
   861   C1442080:Energy [Quantitative Concept]
Processing 00000000.tx.199: Am J Physiol Regul Integr Comp Physiol 260: R321R327, 1991.[Abstract/Free FullText] Blomqvist AG and Herzog H. 

Phrase: "Am"

Phrase: "J Physiol Regul Integr Comp Physiol 260"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0056167:COMP [Therapeutic or Preventive Procedure]
   795   C1456376:COMP [Gene or Genome]

Phrase: ":"

Phrase: "R321R327,"

Phrase: "1991."

Phrase: "[Abstract/Free FullText"

Phrase: "] Blomqvist AG"

Phrase: "and"

Phrase: "Herzog H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.200: Y-receptor subtypeshow many more? 

Phrase: "Y-receptor subtypeshow"

Phrase: "many more?"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]
Processing 00000000.tx.201: Trends Neurosci 20: 294298, 1997.[CrossRef][ISI][Medline] Burcelin R, Brunner H, Seydoux J, Thorensa B, and Pedrazzini T. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Neurosci 20"

Phrase: ":"

Phrase: "294298,"

Phrase: "1997."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Burcelin R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Brunner H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Seydoux J,"

Phrase: "Thorensa B,"

Phrase: "and"

Phrase: "Pedrazzini T."
Processing 00000000.tx.202: Increased insulin concentrations and glucose storage in neuropeptide Y Y1 receptor-deficient mice. 

Phrase: "Increased insulin concentrations"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]
   734   C0020459:increased insulin [Disease or Syndrome]

Phrase: "and"

Phrase: "glucose storage in neuropeptide Y Y1 receptor-deficient mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0337174:Storage [Spatial Concept]
   742   C1698986:Storage [Functional Concept]
   742   C1753314:storage [Cell Component]
Processing 00000000.tx.203: Peptides 22: 421427, 2001.[CrossRef][ISI][Medline] Cabrele C, Langer M, Bader R, Wieland HA, Doods HN, Zerbe O, and Beck-Sickinger AG. 

Phrase: "Peptides 22"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: ":"

Phrase: "421427,"

Phrase: "2001."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Cabrele C,"

Phrase: "Langer M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Bader R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Wieland HA,"

Phrase: "Doods HN,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0019905:HN [Geographic Area]
   861   C1537997:HN [Gene or Genome]
   861   C1853668:HN [Gene or Genome]

Phrase: "Zerbe O,"

Phrase: "and"

Phrase: "Beck-Sickinger AG."
Processing 00000000.tx.204: The first selective agonist for the neuropeptide YY5 receptor increases food intake in rats. 

Phrase: "The first selective agonist for the neuropeptide YY5 receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C2987634:Agonist [Pharmacologic Substance]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "food intake in rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0013470:Food Intake [Organism Function]
   770   C1512806:Intake [Functional Concept]
Processing 00000000.tx.205: J Biol Chem 275: 3604336048, 2000.[Abstract/Free FullText] Chronwall BM, DiMaggio DA, Massari VJ, Pickel VM, Ruggiero DA, and O'Donohue TL. 

Phrase: "J Biol Chem 275"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "3604336048,"

Phrase: "2000."

Phrase: "[Abstract/Free FullText"

Phrase: "] Chronwall BM,"

Phrase: "DiMaggio DA,"

Phrase: "Massari VJ,"

Phrase: "Pickel VM,"

Phrase: "Ruggiero DA,"

Phrase: "and"

Phrase: "O'Donohue TL."
Processing 00000000.tx.206: The anatomy of neuropeptide-Y-containing neurons in rat brain. 

Phrase: "The anatomy of neuropeptide-Y-containing neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0002808:Anatomy [Biomedical Occupation or Discipline]
   748   C0700276:anatomy [Anatomical Structure]
   748   C1384516:anatomy [Qualitative Concept]

Phrase: "in rat brain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1882598:Rat Brain [Body Part, Organ, or Organ Component]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.207: Neuroscience 15: 11591181, 1985.[CrossRef][ISI][Medline] Clark JT, Kalra PS, Crowley WR, and Kalra SP. 

Phrase: "Neuroscience 15"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0027910:Neuroscience [Biomedical Occupation or Discipline]
   861   C1552241:Neuroscience [Professional or Occupational Group]
   861   C1555991:Neuroscience [Professional or Occupational Group]

Phrase: ":"

Phrase: "11591181,"

Phrase: "1985."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Clark JT,"

Phrase: "Kalra PS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1418867:Ps [Gene or Genome]
   861   C1518860:PS [Geographic Area]
   861   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "Crowley WR,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1420193:WR [Gene or Genome]
   861   C1425679:WR [Gene or Genome]
   861   C1862190:WR [Immunologic Factor]
   861   C3538902:WR [Gene or Genome]

Phrase: "and"

Phrase: "Kalra SP."
Processing 00000000.tx.208: Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. 

Phrase: "Neuropeptide Y"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
  1000   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   861   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "and"

Phrase: "human pancreatic polypeptide"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030298:Human pancreatic polypeptide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
           Pancreatic Polypeptide
  1000   C0063017:pancreatic polypeptide, human [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1418856:pancreatic polypeptide [Gene or Genome]
   827   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   827   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: "stimulate"

Phrase: "feeding behavior in rats."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0015745:Feeding Behavior [Individual Behavior]
   770   C0004927:Behavior [Individual Behavior]
   770   C2707008:Behavior [Clinical Attribute]
Processing 00000000.tx.209: Endocrinology 115: 427429, 1984.[Abstract] Dunbar JC, Ergene E, and Barraco RA. 

Phrase: "Endocrinology 115"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "427429,"

Phrase: "1984."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Dunbar JC,"

Phrase: "Ergene E,"

Phrase: "and"

Phrase: "Barraco RA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]
Processing 00000000.tx.210: Neuropeptide-Y stimulation of insulin secretion is mediated via the nucleus tractus solitarius. 

Phrase: "Neuropeptide-Y stimulation of insulin secretion"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   882   C2245393:stimulation of insulin secretion [Cell Function]
   820   C2259155:stimulation of secretion [Cell Function]
   753   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   753   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "is"

Phrase: "mediated via the nucleus tractus solitarius."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0175518:Nucleus tractus solitarius [Body Part, Organ, or Organ Component]
           Nucleus solitarius
   790   C0175559:Tractus solitarius [Body Part, Organ, or Organ Component]
   783   C1289507:Nucleus solitarius [Body Part, Organ, or Organ Component]
   753   C0007610:Nucleus [Cell Component]
   753   C0086597:mediated [Social Behavior]
   753   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.211: Horm Metab Res 24: 103105, 1992.[ISI][Medline] Geoghegan JG, Lawson DC, Cheng CA, Opara E, Taylor IL, and Pappas TN. 

Phrase: "Horm Metab Res 24"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2347379:RES [Finding]

Phrase: ":"

Phrase: "103105,"

Phrase: "1992."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Geoghegan JG,"

Phrase: "Lawson DC,"

Phrase: "Cheng CA,"

Phrase: "Opara E,"

Phrase: "Taylor IL,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0020898:IL [Geographic Area]
   861   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0022271:IL [Geographic Area]

Phrase: "and"

Phrase: "Pappas TN."
Processing 00000000.tx.212: Intracerebroventricular neuropeptide Y increases gastric and pancreatic secretion in the dog. 

Phrase: "Intracerebroventricular neuropeptide Y"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   901   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   827   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "gastric"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038351:Gastric [Body Part, Organ, or Organ Component]
  1000   C1704242:Gastric [Qualitative Concept]

Phrase: "and"

Phrase: "pancreatic secretion in the dog."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0030296:Pancreatic Secretion [Body Substance]
   806   C0232787:Pancreatic secretion [Organ or Tissue Function]
   760   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   760   C0036536:secretion [Biologic Function]
   760   C0036537:Secretion [Body Substance]
Processing 00000000.tx.213: Gastroenterology 105: 10691077, 1993.[ISI][Medline] Grundemar L and Hakanson R. 

Phrase: "Gastroenterology 105"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017163:Gastroenterology [Biomedical Occupation or Discipline]

Phrase: ":"

Phrase: "10691077,"

Phrase: "1993."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Grundemar L"

Phrase: "and"

Phrase: "Hakanson R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.214: Multiple neuropeptide Y receptors are involved in cardiovascular regulation. 

Phrase: "Multiple neuropeptide Y receptors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0068624:Receptors, Neuropeptide Y [Amino Acid, Peptide, or Protein,Receptor]
   875   C0206476:Receptors, Neuropeptide [Amino Acid, Peptide, or Protein,Receptor]
   812   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "are"

Phrase: "involved in cardiovascular regulation."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0007226:Cardiovascular [Body System]
   770   C0851285:Regulation [Governmental or Regulatory Activity]
   770   C1314939:Involved [Functional Concept]
   770   C1327622:Regulation [Biologic Function]
Processing 00000000.tx.215: Peripheral and central mechanisms. 

Phrase: "Peripheral"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205100:Peripheral [Spatial Concept]

Phrase: "and"

Phrase: "central mechanisms."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.216: Gen Pharmacol 24: 785796, 1993.[Medline] Hamel FG, Upward JL, and Bennett RG. 

Phrase: "Gen Pharmacol 24"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1704351:GEN [Quantitative Concept]
   827   C2239486:Gen [Gene or Genome]

Phrase: ":"

Phrase: "785796,"

Phrase: "1993."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hamel FG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439214:fg [Quantitative Concept]
   861   C2348814:FG [Quantitative Concept]

Phrase: "Upward JL,"

Phrase: "and"

Phrase: "Bennett RG."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412999:RG [Gene or Genome]
Processing 00000000.tx.217: In vitro inhibition of insulin-degrading enzyme by long-chain fatty acids and their coenzyme A thioesters. 

Phrase: "In vitro inhibition of insulin-degrading enzyme"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C0877008:enzyme inhibition [Disease or Syndrome]
   774   C1524081:Enzyme Inhibition [Physiologic Function]
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "by long-chain fatty acids"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   966   C0522095:Long chain fatty acid [Biologically Active Substance,Lipid]
   861   C0015684:Fatty Acids [Lipid]
   812   C0001128:Acids [Chemical]
   812   C0205166:Long [Qualitative Concept]
   812   C0337112:Chain [Manufactured Object]
   812   C1524075:Chain [Idea or Concept]
   812   C1706317:Long [Qualitative Concept]
   779 E C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "their coenzyme A thioesters."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0597572:thioester [Organic Chemical]
   734   C0009226:Coenzyme A [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.218: Endocrinology 144: 24042408, 2003.[Abstract/Free FullText] Harfstrand A. 

Phrase: "Endocrinology 144"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "24042408,"

Phrase: "2003."

Phrase: "[Abstract/Free FullText"

Phrase: "] Harfstrand A."
Processing 00000000.tx.219: Intraventricular administration of neuropeptide Y (NPY) induces hypotension, bradycardia and bradypnoea in the awake unrestrained male rat. 

Phrase: "Intraventricular administration of neuropeptide Y"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0001554:Administration [Occupational Activity]
   760   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "(NPY"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
  1000   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   861   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: ")"

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "hypotension,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020649:Hypotension [Finding]
  1000   C3163620:Hypotension [Pathologic Function]

Phrase: "bradycardia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0428977:Bradycardia [Pathologic Function]

Phrase: "and"

Phrase: "bradypnoea in the awake unrestrained male rat."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0231837:Bradypnea [Sign or Symptom]
Processing 00000000.tx.220: Counteraction by NPY-induced feeding behaviour. 

Phrase: "Counteraction by NPY-induced feeding behaviour."
Processing 00000000.tx.221: Acta Physiol Scand 128: 121123, 1986.[ISI][Medline] Heilig M, Koob GF, Ekman R, and Britton KT. 

Phrase: "Acta Physiol Scand 128"

Phrase: ":"

Phrase: "121123,"

Phrase: "1986."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Heilig M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Koob GF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0016703:GF [Geographic Area]
   861   C1551081:gf [Quantitative Concept]

Phrase: "Ekman R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Britton KT."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1690540:KT [Qualitative Concept]
   861   C3484384:Kt [Quantitative Concept]
Processing 00000000.tx.222: Corticotropin-releasing factor and neuropeptide Y: role in emotional integration. 

Phrase: "Corticotropin-releasing factor"
Meta Candidates (Total=15; Excluded=6; Pruned=0; Remaining=9)
  1000   C0010132:Corticotrophin releasing factor [Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C1295117:Corticotropin Releasing Factor [Laboratory Procedure]
  1000   C1366488:CORTICOTROPIN-RELEASING FACTOR [Gene or Genome]
   884   C0599947:release factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0001655:Corticotrophin [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   827   C1283071:Releasing [Functional Concept]
   827   C1521761:Factor [Functional Concept]
   827   C1523997:Corticotropin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C2827422:Factor [Conceptual Entity]
   793 E C0030685:Release [Health Care Activity]
   793 E C0391871:Release [Functional Concept]
   793 E C0439180:% release [Quantitative Concept]
   793 E C0680255:release [Health Care Activity]
   793 E C1963578:Release [Therapeutic or Preventive Procedure]
   771 E C0718234:Acthar [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "neuropeptide Y"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
  1000   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   861   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: ":"

Phrase: "role in emotional integration."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.223: Trends Neurosci 17: 8085, 1994.[CrossRef][ISI][Medline] Hwa JJ, Witten MB, Williams P, Ghibaudi L, Gao J, Salisbury BG, Mullins D, Hamud F, Strader CD, and Parker EM. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Neurosci 17"

Phrase: ":"

Phrase: "8085,"

Phrase: "1994."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hwa JJ,"

Phrase: "Witten MB,"

Phrase: "Williams P,"

Phrase: "Ghibaudi L,"

Phrase: "Gao J,"

Phrase: "Salisbury BG,"

Phrase: "Mullins D,"

Phrase: "Hamud F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Strader CD,"

Phrase: "and"

Phrase: "Parker EM."
Processing 00000000.tx.224: Activation of the NPY Y5 receptor regulates both feeding and energy expenditure. 

Phrase: "Activation of the NPY Y5 receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1514758:Receptor Activation [Cell Function]
   748   C1879547:Activation [Activity]

Phrase: "regulates"

Phrase: "both feeding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0204695:Feeding [Health Care Activity]
  1000   C2987508:Feeding [Activity]

Phrase: "and"

Phrase: "energy expenditure."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0014272:Energy Expenditure [Physiologic Function]
   861   C0015316:expenditure [Quantitative Concept]
   861   C0424589:Energy [Finding]
   861   C0542479:Energy [Natural Phenomenon or Process]
   861   C1442080:Energy [Quantitative Concept]
Processing 00000000.tx.225: Am J Physiol Regul Integr Comp Physiol 277: R1428R1434, 1999.[Abstract/Free FullText] Kastin AJ, Pan W, Maness LM, and Banks WA. 

Phrase: "Am"

Phrase: "J Physiol Regul Integr Comp Physiol 277"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0056167:COMP [Therapeutic or Preventive Procedure]
   795   C1456376:COMP [Gene or Genome]

Phrase: ":"

Phrase: "R1428R1434,"

Phrase: "1999."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kastin AJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0230613:AJ [Cell Component]

Phrase: "Pan W,"

Phrase: "Maness LM,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1261082:LM [Body Part, Organ, or Organ Component]
   861   C1551056:lm [Quantitative Concept]
   861   C2981682:LM [Quantitative Concept]

Phrase: "and"

Phrase: "Banks WA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043038:WA [Geographic Area]
Processing 00000000.tx.226: Peptides crossing the blood-brain barrier: some unusual observations. 

Phrase: "Peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "crossing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2828360:Cross [Conceptual Entity]

Phrase: "the blood-brain barrier"
Meta Candidates (Total=15; Excluded=7; Pruned=0; Remaining=8)
  1000   C0005854:Blood-Brain Barrier [Body Part, Organ, or Organ Component]
  1000   C1305865:Blood-brain barrier [Organ or Tissue Function]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C0229664:Blood [Body Substance]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C1706912:BARRIER [Medical Device]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: ":"

Phrase: "some unusual observations."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0302523:observations [Research Activity]
   861   C0700325:observations [Health Care Activity]
   861   C3244290:observations [Functional Concept]
   827 E C1964257:Observation [Diagnostic Procedure]
   777 E C1518527:OBSERVATIONAL [Research Activity]
Processing 00000000.tx.227: Brain Res 848: 96100, 1999.[CrossRef][ISI][Medline] Kopp J, Xu ZQ, Zhang X, Pedrazzini T, Herzog H, Kresse A, Wong H, Walsh JH, and Hokfelt T. 

Phrase: "Brain Res 848"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C2347379:RES [Finding]

Phrase: ":"

Phrase: "96100,"

Phrase: "1999."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kopp J,"

Phrase: "Xu ZQ,"

Phrase: "Zhang X,"

Phrase: "Pedrazzini T,"

Phrase: "Herzog H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Kresse"

Phrase: "A,"

Phrase: "Wong H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Walsh JH,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268060:JH [Disease or Syndrome]
   861   C1415529:JH [Gene or Genome]

Phrase: "and"

Phrase: "Hokfelt T."
Processing 00000000.tx.228: Expression of the neuropeptide Y Y1 receptor in the CNS of rat and of wild-type and Y1 receptor knock-out mice. 

Phrase: "Expression of the neuropeptide Y Y1 receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0597360:receptor expression [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in the CNS"

Phrase: "of rat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:Rat, NOS [Mammal]
  1000   C0034721:Rat [Mammal]

Phrase: "and of wild-type"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1883559:Wild Type [Organism Attribute]
   770   C0332307:Type [Qualitative Concept]
   770   C0445392:Wild [Intellectual Product]
   770   C1515981:And [Idea or Concept]
   770   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "Y1 receptor knock-out mice."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   884   C0206745:Knock-out Mice [Mammal]
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]
Processing 00000000.tx.229: Focus on immunohistochemical localization. 

Phrase: "Focus on immunohistochemical localization."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205234:Focus [Spatial Concept]
   770   C1285542:focus [Functional Concept]
Processing 00000000.tx.230: Neuroscience 111: 443532, 2002.[CrossRef][ISI][Medline] Krysiak R, Obuchowicz E, and Herman ZS. 

Phrase: "Neuroscience 111"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0027910:Neuroscience [Biomedical Occupation or Discipline]
   861   C1552241:Neuroscience [Professional or Occupational Group]
   861   C1555991:Neuroscience [Professional or Occupational Group]

Phrase: ":"

Phrase: "443532,"

Phrase: "2002."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Krysiak R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Obuchowicz E,"

Phrase: "and"

Phrase: "Herman ZS."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043459:ZS [Congenital Abnormality,Disease or Syndrome]
Processing 00000000.tx.231: Interactions between the neuropeptide Y system and the hypothalamic-pituitary-adrenal axis. 

Phrase: "Interactions between the neuropeptide Y system"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "the hypothalamic-pituitary-adrenal axis."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0597719:hypothalamic-pituitary-adrenal axis [Body System]
   923   C0032022:pituitary adrenal axis [Body System]
   923   C0678897:hypothalamic pituitary axis [Organ or Tissue Function]
   812   C0004457:Axis [Body Part, Organ, or Organ Component]
   812   C0999597:Axis [Mammal]
   812   C1522496:Axis [Spatial Concept]
Processing 00000000.tx.232: Eur J Endocrinol 140: 130136, 1999.[ISI][Medline] Kuenzel WJ and McMurtry J. 

Phrase: "Eur J Endocrinol 140"

Phrase: ":"

Phrase: "130136,"

Phrase: "1999."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kuenzel WJ"

Phrase: "and"

Phrase: "McMurtry J."
Processing 00000000.tx.233: Neuropeptide Y: brain localization and central effects on plasma insulin levels in chicks. 

Phrase: "Neuropeptide Y"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
  1000   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   861   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: ":"

Phrase: "brain localization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0475264:Localisation [Functional Concept]
   861   C1744691:localisation [Biologic Function]

Phrase: "and"

Phrase: "central effects on plasma insulin levels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "in chicks."
Processing 00000000.tx.234: Physiol Behav 44: 669678, 1988.[CrossRef][ISI][Medline] Larsen PJ and Kristensen P. 

Phrase: "Physiol Behav 44"

Phrase: ":"

Phrase: "669678,"

Phrase: "1988."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Larsen PJ"

Phrase: "and"

Phrase: "Kristensen P."
Processing 00000000.tx.235: The neuropeptide Y (Y4) receptor is highly expressed in neurones of the rat dorsal vagal complex. 

Phrase: "The neuropeptide Y"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
  1000   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   861   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "(Y4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418858:Y4 [Gene or Genome]
  1000   C1419591:Y4 [Gene or Genome]

Phrase: ")"

Phrase: "receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "is"

Phrase: "highly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:Highly [Qualitative Concept]

Phrase: "expressed in neurones of the rat dorsal vagal complex."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   742   C0034693:Rat, NOS [Mammal]
   742   C0034721:Rat [Mammal]
   742   C0205095:Dorsal [Spatial Concept]
   742   C0439855:Complex [Qualitative Concept]
   742   C1704241:Complex [Chemical Viewed Structurally]
   708   C0027882:Neurone [Cell]
Processing 00000000.tx.236: Brain Res Mol Brain Res 48: 16, 1997.[ISI][Medline] Louis-Sylvestre J. 

Phrase: "Brain Res Mol Brain Res 48"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   799   C0006104:Brain [Body Part, Organ, or Organ Component]
   799   C0027960:Mole [Neoplastic Process]
   799   C0324740:Mole [Mammal]
   799   C0439189:Mole [Quantitative Concept]
   799   C1269537:Brain [Body Part, Organ, or Organ Component]
   799   C1456781:mole [Neoplastic Process]
   799   C1824986:mol [Gene or Genome]
   799   C2347379:RES [Finding]
   716 E C0026367:Molar [Body Part, Organ, or Organ Component]

Phrase: ":"

Phrase: "16,"

Phrase: "1997."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Louis-Sylvestre J."
Processing 00000000.tx.237: Preabsorptive insulin release and hypoglycemia in rats. 

Phrase: "Preabsorptive insulin release"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0030685:Release [Health Care Activity]
   827   C0391871:Release [Functional Concept]
   827   C0439180:% release [Quantitative Concept]
   827   C0680255:release [Health Care Activity]
   827   C1283071:Release [Functional Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   827   C1963578:Release [Therapeutic or Preventive Procedure]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "hypoglycemia in rats."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0020615:Hypoglycaemia [Disease or Syndrome]
   718 E C0020616:Hypoglycaemic [Pharmacologic Substance]
Processing 00000000.tx.238: Am J Physiol 230: 5660, 1976.[Abstract/Free FullText] Marks JL and Waite K. 

Phrase: "Am"

Phrase: "J Physiol 230"

Phrase: ":"

Phrase: "5660,"

Phrase: "1976."

Phrase: "[Abstract/Free FullText"

Phrase: "] Marks JL"

Phrase: "and"

Phrase: "Waite K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.239: Intracerebroventricular neuropeptide Y acutely influences glucose metabolism and insulin sensitivity in the rat. 

Phrase: "Intracerebroventricular neuropeptide Y acutely"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   812   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "influences"

Phrase: "glucose metabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0596620:glucose metabolism [Molecular Function]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: "and"

Phrase: "insulin sensitivity in the rat."
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   806   C0920563:Insulin Sensitivity [Pathologic Function]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0036667:Sensitivity [Quantitative Concept]
   760   C0312418:Sensitivity [Mental Process]
   760   C0427965:Sensitivity [Finding]
   760   C1511883:Sensitivity [Quantitative Concept]
   760   C1522640:Sensitivity [Qualitative Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   760   C2346484:SENSITIVITY [Phenomenon or Process]
   760   C2349185:Sensitivity [Qualitative Concept]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.240: J Neuroendocrinol 9: 99103, 1997.[CrossRef][ISI][Medline] Marks JL, Waite K, and Davies L. 

Phrase: "J Neuroendocrinol 9"

Phrase: ":"

Phrase: "99103,"

Phrase: "1997."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Marks JL,"

Phrase: "Waite K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Davies L."
Processing 00000000.tx.241: Intracerebroventricular neuropeptide Y produces hyperinsulinemia in the presence and absence of food. 

Phrase: "Intracerebroventricular neuropeptide Y"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   901   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   827   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "produces"

Phrase: "hyperinsulinemia in the presence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0020459:Hyperinsulinaemia [Disease or Syndrome]

Phrase: "and"

Phrase: "absence of food."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0680146:absence of food [Finding]
   790   C0332197:absence [Quantitative Concept]
   790   C1689985:Absence [Anatomical Abnormality]
   718 E C2699517:ABSENT [Finding]
Processing 00000000.tx.242: Physiol Behav 60: 685692, 1996.[CrossRef][ISI][Medline] Matsuda M, Aono M, Moriga M, and Okuma M. 

Phrase: "Physiol Behav 60"

Phrase: ":"

Phrase: "685692,"

Phrase: "1996."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Matsuda M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Aono M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Moriga M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Okuma M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.243: Centrally administered NPY stimulated gastric acid and pepsin secretion by a vagally mediated mechanism. 

Phrase: "Centrally administered NPY"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   812   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "stimulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "gastric acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0017119:Gastric Acid [Body Substance]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "pepsin secretion by a vagally mediated mechanism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0036536:secretion [Biologic Function]
   748   C0036537:Secretion [Body Substance]
Processing 00000000.tx.244: Regul Pept 35: 3141, 1991.[CrossRef][ISI][Medline] Moltz JH and McDonald JK. 

Phrase: "Regul Pept 35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0080384:PEPT [Organic Chemical,Pharmacologic Substance]

Phrase: ":"

Phrase: "3141,"

Phrase: "1991."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Moltz JH"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268060:JH [Disease or Syndrome]
   861   C1415529:JH [Gene or Genome]

Phrase: "and"

Phrase: "McDonald JK."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1420098:JK [Gene or Genome]
Processing 00000000.tx.245: Neuropeptide Y: direct and indirect action on insulin secretion in the rat. 

Phrase: "Neuropeptide Y"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
  1000   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   861   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: ":"

Phrase: "direct"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439851:Direct [Qualitative Concept]
  1000   C1947931:Direct [Qualitative Concept]

Phrase: "and"

Phrase: "indirect action on insulin secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441472:Action [Functional Concept]
   760   C3266814:Action [Activity]

Phrase: "in the rat."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:Rat, NOS [Mammal]
  1000   C0034721:Rat [Mammal]
Processing 00000000.tx.246: Peptides 6: 11551159, 1985.[CrossRef][ISI][Medline] Morgan DG, Kulkarni RN, Hurley JD, Wang ZL, Wang RM, Ghatei MA, Karlsen AE, Bloom SR, and Smith DM. 

Phrase: "Peptides 6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: ":"

Phrase: "11551159,"

Phrase: "1985."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Morgan DG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1275573:dg [Quantitative Concept]

Phrase: "Kulkarni RN,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540639:RN [Gene or Genome]

Phrase: "Hurley JD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1549972:JD [Intellectual Product]

Phrase: "Wang ZL,"

Phrase: "Wang RM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2951520:RM [Body Location or Region]

Phrase: "Ghatei MA,"

Phrase: "Karlsen AE,"

Phrase: "Bloom SR,"

Phrase: "and"

Phrase: "Smith DM."
Processing 00000000.tx.247: Inhibition of glucose stimulated insulin secretion by neuropeptide Y is mediated via the Y1 receptor and inhibition of adenylyl cyclase in RIN 5AH rat insulinoma cells. 

Phrase: "Inhibition of glucose"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0021467:Inhibition [Mental Process]
   790   C0021469:Inhibition [Molecular Function]
   790   C1628982:% inhibition [Quantitative Concept]
   790   C3463820:Inhibition [Activity]
   718 E C0311403:Inhibited [Qualitative Concept]

Phrase: "stimulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "insulin secretion by neuropeptide Y"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C1256369:insulin secretion [Cell Function]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0036536:secretion [Biologic Function]
   760   C0036537:Secretion [Body Substance]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "is"

Phrase: "mediated via the Y1 receptor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0086597:mediated [Social Behavior]
   760   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   760   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   760   C1419589:Y1 [Gene or Genome]

Phrase: "and"

Phrase: "inhibition of adenylyl cyclase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "in RIN 5AH rat insulinoma cells."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   804   C0007634:Cells [Cell]
   804   C0021670:insulinoma [Neoplastic Process]
   804   C0034693:Rat, NOS [Mammal]
   804   C0034721:Rat [Mammal]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.248: Diabetologia 41: 14821491, 1998.[CrossRef][ISI][Medline] Mullins D, Kirby D, Hwa J, Guzzi M, Rivier J, and Parker E. 

Phrase: "Diabetologia 41"

Phrase: ":"

Phrase: "14821491,"

Phrase: "1998."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Mullins D,"

Phrase: "Kirby D,"

Phrase: "Hwa J,"

Phrase: "Guzzi M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Rivier J,"

Phrase: "and"

Phrase: "Parker E."
Processing 00000000.tx.249: Identification of potent and selective neuropeptide Y Y(1) receptor agonists with orexigenic activity in vivo. 

Phrase: "Identification of potent"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020792:Identification [Mental Process]
   790   C0205396:Identification [Qualitative Concept]

Phrase: "and"

Phrase: "selective neuropeptide Y Y(1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   840   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   804   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: ")"

Phrase: "receptor agonists with orexigenic activity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1149516:receptor agonist activity [Molecular Function]
   760   C0243192:agonists [Pharmacologic Substance]
   760   C2987634:agonists [Pharmacologic Substance]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.250: Mol Pharmacol 60: 534540, 2001.[Abstract/Free FullText] Parker EM, Balasubramaniam A, Guzzi M, Mullins DE, Salisbury BG, Sheriff S, Witten MB, and Hwa JJ. 

Phrase: "Mol Pharmacol 60"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   827   C0027960:Mole [Neoplastic Process]
   827   C0324740:Mole [Mammal]
   827   C0439189:Mole [Quantitative Concept]
   827   C1456781:mole [Neoplastic Process]
   827   C1824986:mol [Gene or Genome]
   743 E C0026367:Molar [Body Part, Organ, or Organ Component]
   727 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "534540,"

Phrase: "2001."

Phrase: "[Abstract/Free FullText"

Phrase: "] Parker EM,"

Phrase: "Balasubramaniam A,"

Phrase: "Guzzi M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Mullins DE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011198:DE [Geographic Area]
   861   C0017480:DE [Geographic Area]
   861   C3541240:DE [Idea or Concept]

Phrase: "Salisbury BG,"

Phrase: "Sheriff S,"

Phrase: "Witten MB,"

Phrase: "and"

Phrase: "Hwa JJ."
Processing 00000000.tx.251: [D-Trp(34)] neuropeptide Y is a potent and selective neuropeptide Y Y(5) receptor agonist with dramatic effects on food intake. 

Phrase: "["

Phrase: "D-"

Phrase: "Trp(34"

Phrase: ")"

Phrase: "] neuropeptide Y"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
  1000   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   861   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "is"

Phrase: "a potent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   900   C3245505:Potential [Qualitative Concept]

Phrase: "and"

Phrase: "selective neuropeptide Y Y(5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   840   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   804   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: ")"

Phrase: "receptor agonist with dramatic effects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2987634:Agonist [Pharmacologic Substance]

Phrase: "on food intake."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013470:Food Intake [Organism Function]
   861   C1512806:Intake [Functional Concept]
Processing 00000000.tx.252: Peptides 21: 393399, 2000.[CrossRef][ISI][Medline] Parker RM and Herzog H. 

Phrase: "Peptides 21"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: ":"

Phrase: "393399,"

Phrase: "2000."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Parker RM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2951520:RM [Body Location or Region]

Phrase: "and"

Phrase: "Herzog H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.253: Regional distribution of Y-receptor subtype mRNAs in rat brain. 

Phrase: "Regional distribution of Y-receptor subtype mRNAs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0520511:distribution [Idea or Concept]
   748   C1704711:Distribution [Functional Concept]

Phrase: "in rat brain."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1882598:Rat Brain [Body Part, Organ, or Organ Component]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.254: Eur J Neurosci 11: 14311448, 1999.[CrossRef][ISI][Medline] Pettersson M, Lundquist I, and Ahren B. 

Phrase: "Eur J Neurosci 11"

Phrase: ":"

Phrase: "14311448,"

Phrase: "1999."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Pettersson M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Lundquist I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Ahren B."
Processing 00000000.tx.255: Neuropeptide Y and calcitonin gene-related peptide: effects on glucagon and insulin secretion in the mouse. 

Phrase: "Neuropeptide Y"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
  1000   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   861   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "and"

Phrase: "calcitonin gene-related peptide"
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
  1000   C0006669:Calcitonin Gene-Related Peptide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
  1000   C1367551:CALCITONIN GENE-RELATED PEPTIDE [Gene or Genome]
   812   C0006668:Calcitonin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0017337:Gene [Gene or Genome]
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   812   C0439849:Related [Qualitative Concept]
   812   C0445223:Related [Finding]
   812   C0770558:Calcitonin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1704385:Calcitonin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C2825090:Calcitonin [Pharmacologic Substance]
   812   C3536753:Calcitonin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   779 E C0163712:Relate [Organic Chemical]
   756 E C0115656:Thyrocalcitonin [Organic Chemical,Pharmacologic Substance]
   741 E C0080103:Relation [Family Group]
   741 E C0869014:Relations [Social Behavior]

Phrase: ":"

Phrase: "effects on glucagon"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1280500:effects [Qualitative Concept]
   756 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "insulin secretion in the mouse."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C1256369:insulin secretion [Cell Function]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0036536:secretion [Biologic Function]
   760   C0036537:Secretion [Body Substance]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.256: Endocr Res 13: 407417, 1987.[ISI][Medline] Polak JM and Bloom SR. 

Phrase: "Endocr Res 13"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2347379:RES [Finding]

Phrase: ":"

Phrase: "407417,"

Phrase: "1987."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Polak JM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: "and"

Phrase: "Bloom SR."
Processing 00000000.tx.257: Regulatory peptidesthe distribution of two newly discovered peptides: PHI and NPY. 

Phrase: "Regulatory peptidesthe distribution of two newly discovered peptides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0520511:distribution [Idea or Concept]
   744   C1704711:Distribution [Functional Concept]

Phrase: ":"

Phrase: "PHI"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0027851:PHI [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1333690:PHI [Gene or Genome]
  1000   C1704947:PHI [Gene or Genome]
  1000   C1706536:Phi [Intellectual Product]

Phrase: "and"

Phrase: "NPY."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
  1000   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   861   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
Processing 00000000.tx.258: Peptides 1: 7989, 1984. 

Phrase: "Peptides 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: ":"

Phrase: "7989,"

Phrase: "1984."
Processing 00000000.tx.259: Sainsbury A, Rohner-Jeanrenaud F, Cusin I, Zakrzewska KE, Halban PA, Gaillard RC, and Jeanrenaud B. 

Phrase: "Sainsbury A,"

Phrase: "Rohner-Jeanrenaud F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]

Phrase: "Cusin I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Zakrzewska KE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022558:KE [Geographic Area]

Phrase: "Halban PA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541314:PA [Idea or Concept]

Phrase: "Gaillard RC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419366:RC [Gene or Genome]

Phrase: "and"

Phrase: "Jeanrenaud B."
Processing 00000000.tx.260: Chronic central neuropeptide Y infusion in normal rats: status of the hypothalamo-pituitary-adrenal axis, and vagal mediation of hyperinsulinaemia. 

Phrase: "Chronic central neuropeptide Y infusion in normal rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0574032:Infusion [Therapeutic or Preventive Procedure]
   744   C1827465:Infusion [Functional Concept]

Phrase: ":"

Phrase: "status of the hypothalamo-pituitary-adrenal axis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0449438:Status [Qualitative Concept]

Phrase: "and"

Phrase: "vagal mediation of hyperinsulinaemia."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0680727:Mediation [Social Behavior]
Processing 00000000.tx.261: Diabetologia 40: 12691277, 1997.[CrossRef][ISI][Medline] Sainsbury A, Rohner-Jeanrenaud F, Grouzmann E, and Jeanrenaud B. 

Phrase: "Diabetologia 40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: ":"

Phrase: "12691277,"

Phrase: "1997."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Sainsbury A,"

Phrase: "Rohner-Jeanrenaud F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]

Phrase: "Grouzmann E,"

Phrase: "and"

Phrase: "Jeanrenaud B."
Processing 00000000.tx.262: Acute intracerebroventricular administration of neuropeptide Y stimulates corticosterone output and feeding but not insulin output in normal rats. 

Phrase: "Acute intracerebroventricular administration of neuropeptide Y"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0001554:Administration [Occupational Activity]
   753   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "stimulates"

Phrase: "corticosterone output"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709366:Output [Conceptual Entity]

Phrase: "and"

Phrase: "feeding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0204695:Feeding [Health Care Activity]
  1000   C2987508:Feeding [Activity]

Phrase: "but"

Phrase: "not insulin output in normal rats."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1709366:Output [Conceptual Entity]
Processing 00000000.tx.263: Neuroendocrinology 63: 318326, 1996.[ISI][Medline] Stanley BG and Leibowitz SF. 

Phrase: "Neuroendocrinology 63"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027827:Neuroendocrinology [Biomedical Occupation or Discipline]

Phrase: ":"

Phrase: "318326,"

Phrase: "1996."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Stanley BG"

Phrase: "and"

Phrase: "Leibowitz SF."
Processing 00000000.tx.264: Neuropeptide Y: stimulation of feeding and drinking by injection into the paraventricular nucleus. 

Phrase: "Neuropeptide Y"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
  1000   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   861   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: ":"

Phrase: "stimulation of feeding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   790   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "drinking by injection"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0001948:drinking [Individual Behavior]
   790   C0684271:Drinking [Organism Function]
   756 E C0452428:Drink [Food]

Phrase: "into the paraventricular nucleus."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0030532:Paraventricular Nucleus [Body Part, Organ, or Organ Component]
  1000   C1289558:Paraventricular nucleus [Body Location or Region]
   861   C0007610:Nucleus [Cell Component]
Processing 00000000.tx.265: Life Sci 35: 26352642, 1984.[CrossRef][ISI][Medline] Stromblad G and Bjorntorp P. 

Phrase: "Life Sci 35"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0376558:Life [Idea or Concept]
   827   C3642273:SCI [Professional or Occupational Group]
   743 E C0595998:lives [Finding]

Phrase: ":"

Phrase: "26352642,"

Phrase: "1984."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Stromblad G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Bjorntorp P."
Processing 00000000.tx.266: Reduced hepatic insulin clearance in rats with dietary-induced obesity. 

Phrase: "Reduced hepatic insulin clearance in rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0449297:Clearance [Qualitative Concept]
   753   C1382187:Clearance [Clinical Attribute]
   753   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "with dietary-induced obesity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0028754:Obesity [Disease or Syndrome]
   827   C1963185:Obesity [Finding]
Processing 00000000.tx.267: Metabolism 35: 323327, 1986.[ISI][Medline] Strubbe JH, Prins AJ, Bruggink J, and Steffens AB. 

Phrase: "Metabolism 35"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: ":"

Phrase: "323327,"

Phrase: "1986."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Strubbe JH,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268060:JH [Disease or Syndrome]
   861   C1415529:JH [Gene or Genome]

Phrase: "Prins AJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0230613:AJ [Cell Component]

Phrase: "Bruggink J,"

Phrase: "and"

Phrase: "Steffens AB."
Processing 00000000.tx.268: Daily variation of food-induced changes in blood glucose and insulin in the rat and the control by the suprachiasmatic nucleus and the vagus nerve. 

Phrase: "Daily variation of food-induced changes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205419:Variation [Qualitative Concept]

Phrase: "in blood glucose"
Meta Candidates (Total=12; Excluded=7; Pruned=0; Remaining=5)
  1000   C0005802:Blood Glucose [Carbohydrate]
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "and"

Phrase: "insulin in the rat"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "the control by the suprachiasmatic nucleus"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0243148:control [Qualitative Concept]
   753   C1550141:Control [Substance]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "the vagus nerve."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0042276:Vagus Nerve [Body Part, Organ, or Organ Component]
           Vagus
   861   C0027740:Nerve [Tissue]
   861   C0027757:NERVE [Tissue]
   861   C1280541:Nerve [Body Part, Organ, or Organ Component]
   805 E C0599851:Neural [Functional Concept]
   789 E C0027769:nervy [Sign or Symptom]
Processing 00000000.tx.269: J Auton Nerv Syst 20: 113119, 1987.[CrossRef][ISI][Medline] Van Dijk G, Bottone AE, Strubbe JH, and Steffens AB. 

Phrase: "J Auton Nerv Syst 20"

Phrase: ":"

Phrase: "113119,"

Phrase: "1987."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Van Dijk G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "Bottone AE,"

Phrase: "Strubbe JH,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268060:JH [Disease or Syndrome]
   861   C1415529:JH [Gene or Genome]

Phrase: "and"

Phrase: "Steffens AB."
Processing 00000000.tx.270: Hormonal and metabolic effects of paraventricular hypothalamic administration of neuropeptide Y during rest and feeding. 

Phrase: "Hormonal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0458083:Hormonal [Qualitative Concept]

Phrase: "and"

Phrase: "metabolic effects of paraventricular hypothalamic administration of neuropeptide Y"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   764   C2945675:metabolic effects [Physiologic Function]
   742   C1280500:effects [Qualitative Concept]
   708 E C2348382:Effect [Qualitative Concept]

Phrase: "during rest"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035253:Rest [Daily or Recreational Activity]
  1000   C1622890:ResT [Molecular Function]

Phrase: "and"

Phrase: "feeding."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0204695:Feeding [Health Care Activity]
  1000   C2987508:Feeding [Activity]
Processing 00000000.tx.271: Brain Res 660: 96103, 1994.[CrossRef][ISI][Medline] Walker HC and Romsos DR. 

Phrase: "Brain Res 660"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   827   C2347379:RES [Finding]

Phrase: ":"

Phrase: "96103,"

Phrase: "1994."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Walker HC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0020268:HC [Hormone,Pharmacologic Substance,Steroid]
   861   C1413512:Hc [Gene or Genome]

Phrase: "and"

Phrase: "Romsos DR."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0031831:DR [Professional or Occupational Group]
   861   C1707664:DR [Biomedical or Dental Material]
   861   C2348314:Dr. [Conceptual Entity]
   861   C3540849:DR [Idea or Concept]
Processing 00000000.tx.272: Similar effects of NPY on energy metabolism and on plasma insulin in adrenalectomized ob/ob and lean mice. 

Phrase: "Similar effects of NPY"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "on energy metabolism"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0014272:Energy Metabolism [Physiologic Function]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]
   861   C0424589:Energy [Finding]
   861   C0542479:Energy [Natural Phenomenon or Process]
   861   C1442080:Energy [Quantitative Concept]

Phrase: "and on plasma insulin"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C0857690:plasma insulin [Laboratory Procedure]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0032105:Plasma [Body Substance]
   770   C1515981:And [Idea or Concept]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "in adrenalectomized ob/ob"

Phrase: "and"

Phrase: "lean mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
Processing 00000000.tx.273: Am J Physiol Endocrinol Metab 264: E226E230, 1993.[Abstract/Free FullText] Wang ZL, Bennet WM, Wang RM, Ghatei MA, and Bloom SR. 

Phrase: "Am"

Phrase: "J Physiol Endocrinol Metab 264"

Phrase: ":"

Phrase: "E226E230,"

Phrase: "1993."

Phrase: "[Abstract/Free FullText"

Phrase: "] Wang ZL,"

Phrase: "Bennet WM,"

Phrase: "Wang RM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2951520:RM [Body Location or Region]

Phrase: "Ghatei MA,"

Phrase: "and"

Phrase: "Bloom SR."
Processing 00000000.tx.274: Evidence of a paracrine role of neuropeptide-Y in the regulation of insulin release from pancreatic islets of normal and dexamethasone-treated rats. 

Phrase: "Evidence of a paracrine role of neuropeptide-Y"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "in the regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0851285:Regulation [Governmental or Regulatory Activity]
  1000   C1327622:Regulation [Biologic Function]

Phrase: "of insulin release"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0030685:Release [Health Care Activity]
   861   C0391871:Release [Functional Concept]
   861   C0439180:% release [Quantitative Concept]
   861   C0680255:release [Health Care Activity]
   861   C1283071:Release [Functional Concept]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   861   C1963578:Release [Therapeutic or Preventive Procedure]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "from pancreatic islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   861   C0030274:Pancreatic [Body Part, Organ, or Organ Component]

Phrase: "of normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "dexamethasone-treated rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
Processing 00000000.tx.275: Endocrinology 135: 200206, 1994.[Abstract] Wiesenthal SR, Sandhu H, McCall RH, Tchipashvili V, Yoshii H, Polonsky K, Shi ZQ, Lewis GF, Mari A, and Giacca A. 

Phrase: "Endocrinology 135"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "200206,"

Phrase: "1994."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Wiesenthal SR,"

Phrase: "Sandhu H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "McCall RH,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0035493:Rh [Element, Ion, or Isotope]
   861   C2699077:Rh- [Classification]
   861   C2699078:Rh+ [Classification]

Phrase: "Tchipashvili V,"

Phrase: "Yoshii H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Polonsky K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Shi ZQ,"

Phrase: "Lewis GF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0016703:GF [Geographic Area]
   861   C1551081:gf [Quantitative Concept]

Phrase: "Mari A,"

Phrase: "and"

Phrase: "Giacca A."
Processing 00000000.tx.276: Free fatty acids impair hepatic insulin extraction in vivo. 

Phrase: "Free fatty acids"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0015688:Free Fatty Acids [Lipid]
   966 E C2698488:Free Fatty Acid [Laboratory Procedure]
   901   C0015684:Fatty Acids [Lipid]
   827   C0001128:Acids [Chemical]
   827   C0332296:free [Functional Concept]
   827   C1880497:Free [Qualitative Concept]
   827   C1996904:Free [Qualitative Concept]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "impair"

Phrase: "hepatic insulin extraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0185115:Extraction [Therapeutic or Preventive Procedure]
   827   C0684295:extraction [Laboratory Procedure]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.277: Diabetes 48: 766774, 1999.[Abstract] Wilding IP, Kruszynska YT, Lambert PD, and Bloom SR. 

Phrase: "Diabetes 48"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "766774,"

Phrase: "1999."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Wilding IP,"

Phrase: "Kruszynska YT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412122:YT [Gene or Genome]

Phrase: "Lambert PD,"

Phrase: "and"

Phrase: "Bloom SR."
Processing 00000000.tx.278: Acute effects of central neuropeptide Y injection on glucose metabolism in fasted rats. 

Phrase: "Acute effects of central neuropeptide Y injection"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "on glucose metabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0596620:glucose metabolism [Molecular Function]
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: "in fasted rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
Processing 00000000.tx.279: Clin Sci (Colch) 89: 543548, 1995.[Medline] Wisialowski T, Parker R, Preston E, Sainsbury A, Kraegen E, Herzog H, and Cooney G. 

Phrase: "Clin Sci (Colch"

Phrase: ")"

Phrase: "89"

Phrase: ":"

Phrase: "543548,"

Phrase: "1995."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Wisialowski T,"

Phrase: "Parker R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Preston E,"

Phrase: "Sainsbury A,"

Phrase: "Kraegen E,"

Phrase: "Herzog H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Cooney G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.280: Adrenalectomy reduces neuropeptide Y-induced insulin release and NPY receptor expression in the rat ventromedial hypothalamus. 

Phrase: "Adrenalectomy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001632:Adrenalectomy [Therapeutic or Preventive Procedure]

Phrase: "reduces"

Phrase: "neuropeptide Y-induced insulin release"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0030685:Release [Health Care Activity]
   804   C0391871:Release [Functional Concept]
   804   C0439180:% release [Quantitative Concept]
   804   C0680255:release [Health Care Activity]
   804   C1283071:Release [Functional Concept]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   804   C1963578:Release [Therapeutic or Preventive Procedure]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "NPY receptor expression in the rat ventromedial hypothalamus."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C0597360:receptor expression [Genetic Function]
   742   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.281: J Clin Invest 105: 12531259, 2000.[Abstract/Free FullText] Woods SC, Porte D Jr, Bobbioni E, Ionescu E, Sauter JF, Rohner-Jeanrenaud F, and Jeanrenaud B. 

Phrase: "J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "105"

Phrase: ":"

Phrase: "12531259,"

Phrase: "2000."

Phrase: "[Abstract/Free FullText"

Phrase: "] Woods SC,"

Phrase: "Porte D Jr,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1708595:Jr [Idea or Concept]
   827   C3280986:JR [Disease or Syndrome]

Phrase: "Bobbioni E,"

Phrase: "Ionescu E,"

Phrase: "Sauter JF,"

Phrase: "Rohner-Jeanrenaud F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Jeanrenaud B."
Processing 00000000.tx.282: Insulin: its relationship to the central nervous system and to the control of food intake and body weight. 

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ":"

Phrase: "its relationship to the central nervous system"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0439849:Relationship [Qualitative Concept]
   748   C1705630:Relationship [Idea or Concept]
   748   C1706279:Relationship [Idea or Concept]
   748   C3540605:Relationship [Intellectual Product]

Phrase: "and to the control of food intake"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0013470:Food Intake [Organism Function]
   748   C0016452:Food [Food]
   748   C0243148:control [Qualitative Concept]
   748   C1512806:Intake [Functional Concept]
   748   C1515981:And [Idea or Concept]
   748   C1550141:Control [Substance]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "body weight."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0005910:Body Weight [Organism Attribute]
           weight
  1000   C1305866:body weight [Diagnostic Procedure]
           weight
   861   C0043100:Weight [Quantitative Concept]
   861   C0242821:body [Human]
   861   C0460148:Body [Anatomical Structure]
   861   C1268086:Body [Anatomical Structure]
   861   C1705104:Weight [Idea or Concept]
   777 E C1995017:Bodies [Cell Component]
Processing 00000000.tx.283: Am J Clin Nutr 42: 10631071, 1985.[Abstract] Yang H, Li WP, Reeve JR Jr, Rivier J, and Tache Y. 

Phrase: "Am"

Phrase: "J Clin Nutr 42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1315013:CLIN [Intellectual Product]

Phrase: ":"

Phrase: "10631071,"

Phrase: "1985."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Yang H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Li WP,"

Phrase: "Reeve JR Jr,"

Phrase: "Rivier J,"

Phrase: "and"

Phrase: "Tache Y."
Processing 00000000.tx.284: PYY-preferring receptor in the dorsal vagal complex and its involvement in PYY stimulation of gastric acid secretion in rats. 

Phrase: "PYY-preferring receptor in the dorsal vagal complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1523873:receptor complex [Cell Component]
   744   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "its involvement in PYY stimulation of gastric acid secretion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1314939:Involvement [Functional Concept]

Phrase: "in rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]
Processing 00000000.tx.285: Br J Pharmacol 123: 15491554, 1998.[Abstract] Yoneda M, Nakamura K, Yokohama S, Tamori K, Sato Y, Aso K, Aoshima M, Kono T, and Makino I. 

Phrase: "Br J Pharmacol 123"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1704648:Br. [Conceptual Entity]

Phrase: ":"

Phrase: "15491554,"

Phrase: "1998."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Yoneda M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Nakamura K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Yokohama S,"

Phrase: "Tamori K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Sato Y,"

Phrase: "Aso K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Aoshima M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Kono T,"

Phrase: "and"

Phrase: "Makino I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.286: Neuropeptide Y stimulates bile secretion via Y1 receptor in the left dorsal vagal complex in rats. 

Phrase: "Neuropeptide Y"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027893:neuropeptide Y [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
  1000   C1417815:NEUROPEPTIDE Y [Gene or Genome]
   861   C0027895:Neuropeptide [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "stimulates"

Phrase: "bile secretion via Y1 receptor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0232754:Bile secretion [Organ or Tissue Function]
   760   C0005388:Bile [Body Substance]
   760   C0036536:secretion [Biologic Function]
   760   C0036537:Secretion [Body Substance]

Phrase: "in the left dorsal vagal complex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0205095:Dorsal [Spatial Concept]
   812   C0439855:Complex [Qualitative Concept]
   812   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "in rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]
Processing 00000000.tx.287: Hepatology 28: 670676, 1998.[ISI][Medline] Zarjevski N, Cusin I, Vettor R, Rohner-Jeanrenaud F, and Jeanrenaud B. 

Phrase: "Hepatology 28"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0086403:Hepatology [Biomedical Occupation or Discipline]
   861   C1555763:Hepatology [Professional or Occupational Group]

Phrase: ":"

Phrase: "670676,"

Phrase: "1998."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Zarjevski N,"

Phrase: "Cusin I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Vettor R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Rohner-Jeanrenaud F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Jeanrenaud B."
Processing 00000000.tx.288: Chronic intracerebroventricular neuropeptide-Y administration to normal rats mimics hormonal and metabolic changes of obesity. 

Phrase: "Chronic intracerebroventricular neuropeptide-Y administration to normal rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0001554:Administration [Occupational Activity]
   744   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "mimics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0393040:mimics [Therapeutic or Preventive Procedure]
  1000   C1176299:mimics [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "hormonal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0458083:Hormonal [Qualitative Concept]

Phrase: "and"

Phrase: "metabolic changes of obesity."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0392747:changes [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   737 E C1705241:Change [Quantitative Concept]
Processing 00000000.tx.289: Endocrinology 133: 17531758, 1993.[Abstract] Zarjevski N, Cusin I, Vettor R, Rohner-Jeanrenaud F, and Jeanrenaud B. 

Phrase: "Endocrinology 133"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "17531758,"

Phrase: "1993."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Zarjevski N,"

Phrase: "Cusin I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Vettor R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Rohner-Jeanrenaud F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Jeanrenaud B."
Processing 00000000.tx.290: Intracerebroventricular administration of neuropeptide Y to normal rats has divergent effects on glucose utilization by adipose tissue and skeletal muscle. 

Phrase: "Intracerebroventricular administration of neuropeptide Y"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0001554:Administration [Occupational Activity]
   760   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "to normal rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]

Phrase: "has"

Phrase: "divergent effects on glucose utilization"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   781   C1158774:glucose effect [Genetic Function]
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "by adipose tissue"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0001527:Adipose tissue [Tissue]
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]
   789   C0028754:Adiposity [Disease or Syndrome]
   789   C1563743:adiposity [Organism Attribute]

Phrase: "and"

Phrase: "skeletal muscle."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0242692:Muscle, Skeletal [Tissue]
  1000   C1280260:Skeletal muscle [Body Part, Organ, or Organ Component]
   861   C0026845:Muscle [Tissue]
   861   C0037253:skeletal [Body System]
   861   C0521324:Skeletal [Spatial Concept]
   789 E C0442025:Muscular [Spatial Concept]
Processing 00000000.tx.291: Diabetes 43: 764769, 1994.[Abstract] This Article Abstract Full Text (PDF) All Versions of this Article: 287/4/E706 most recent 00530.2003v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Search for citing articles in: ISI Web of Science (1) Google Scholar Articles by Gao, J. 

Phrase: "Diabetes 43"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "764769,"

Phrase: "1994."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]"

Phrase: "This Article Abstract Full Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1527021:Text [Intellectual Product]
   812   C1554111:Text [Idea or Concept]
   812   C1705606:Text [Intellectual Product]
   812   C3541382:Text [Intellectual Product]

Phrase: "(PDF)"

Phrase: "All Versions of this Article"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0333052:versions [Functional Concept]
   726 E C2607870:Version [Spatial Concept]

Phrase: ":"

Phrase: "287/4/E706 most recent 00530.2003v1"

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "when"

Phrase: "this article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "is"

Phrase: "cited"

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "if"

Phrase: "a correction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1705565:CORRECTION [Intellectual Product]
  1000   C1947976:Correction [Functional Concept]

Phrase: "is"

Phrase: "posted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0687676:Post [Temporal Concept]
   966   C1704687:Post [Manufactured Object]

Phrase: "Citation Map Services"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0557854:Services [Occupational Activity]
   793 E C2825316:Service [Manufactured Object]
   793 E C3245478:service [Idea or Concept]

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: "this article to a friend Similar articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1706852:Article [Intellectual Product]

Phrase: "in this journal Similar articles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   896   C0282420:Journal Article [Intellectual Product]
   793   C1706852:Article [Intellectual Product]

Phrase: "in ISI Web"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0282111:Web [Manufactured Object]

Phrase: "of Science Similar articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1706852:Article [Intellectual Product]

Phrase: "in PubMed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1138432:PubMed [Intellectual Product]

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me to new issues of the journal Download"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0162443:Journal [Intellectual Product,Manufactured Object]
   744   C0205314:New [Temporal Concept]
   711   C0033213:Issue [Finding]
   711   C1706387:Issue [Intellectual Product]

Phrase: "to citation manager Search"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1552603:search [Intellectual Product]
   827   C1706202:Search [Activity]

Phrase: "for citing articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1706852:Article [Intellectual Product]

Phrase: "in"

Phrase: ":"

Phrase: "ISI Web of Science"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0282111:Web [Manufactured Object]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "Google Scholar Articles by Gao,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1706852:Article [Intellectual Product]

Phrase: "J."
Processing 00000000.tx.292: Articles by Hwa, J. 

Phrase: "Articles by Hwa,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "J."
Processing 00000000.tx.293: J. 

Phrase: "J."
Processing 00000000.tx.294: Articles citing this Article PubMed PubMed Citation Articles by Gao, J. 

Phrase: "Articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1706852:Article [Intellectual Product]

Phrase: "citing"

Phrase: "this Article PubMed PubMed Citation Articles by Gao,"

Phrase: "J."
Processing 00000000.tx.295: Articles by Hwa, J. 

Phrase: "Articles by Hwa,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "J."
Processing 00000000.tx.296: J. 

Phrase: "J."
Processing 00000000.tx.297: HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS Visit Other APS Journals Online Copyright  2004 by the American Physiological Society.

Phrase: "HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0039224:Table [Manufactured Object]
   742   C1706073:Table [Medical Device]
   742   C1706074:Table [Intellectual Product]

Phrase: "Visit"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0545082:Visit [Behavior]
  1000   C1512346:visit [Health Care Activity]
  1000   C2826704:VISIT [Intellectual Product]

Phrase: "Other APS Journals Online Copyright  2004 by the American Physiological Society."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   738   C0009993:Copyright [Intellectual Product]
   738   C0037455:society [Organization]
   738   C0162443:journals [Intellectual Product,Manufactured Object]
   738   C0205394:Other [Qualitative Concept]
   738   C0205463:Physiological [Functional Concept]
   738   C0596070:American [Population Group]
   738   C1552856:copyright [Idea or Concept]

